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Abstract 
Periprosthetic joint infection (PJI) resulting from colonisation of implant surfaces by pathogenic bacteria 
and subsequent biofilm formation is a devastating complication following total hip arthroplasty. It 
significantly reduces a patient’s quality of life and, in severe cases, can result in amputation or mortality. 
Treatment of PJI is associated with a substantial burden on healthcare and economic resources. The 
importance of research towards innovations in PJI prevention and treatment is emphasised. 
 
Local delivery of antimicrobial drugs is an effective approach to prevent and treat PJI as it enables high 
local drug concentrations while avoiding systemic side effects. Current practice is considered sub-optimal 
and appreciable research exists on the improvement of local drug delivery strategies. For cementless hip 
stems the focus tends to be on coatings and conditioning of the external implant surface. A significant 
research gap exists between external and internal drug delivery strategies where ‘internal’ refers to the 
incorporation of reservoir structures within the implant. Therefore, a prototype strategy utilising the 
internal volume of a cementless stem for a reservoir from which an antimicrobial drug can be delivered 
directly to the implant surface was investigated. The challenge of fabricating a cementless hip stem with 
intricate internal geometries can be effectively addressed through metal additive manufacturing (MAM).  
 
Industry is steadily incorporating MAM into process chains as the main production technology for the 
fabrication of high-value functional components. Laser powder bed fusion (LPBF) was applied in this 
study as MAM technology to fabricate a Ti6Al4V ELI demonstrator cementless hip stem with local drug 
delivery functionality. This required an interdisciplinary approach, for which a problem solving 
framework has been synthesised to aid in process chain development from an LPBF-centred perspective. 
 
The overall problem was decomposed into integrated partial and single problems which were 
systematically investigated through literature study and experimentation. An LPBF-centred solution was 
developed for the direct integration of permeable structures in a dense part using an in-process assembly 
method. Different levels of porosity were induced into permeable thin walls according to a systematically 
identified window for ranges of the process parameters, laser power and scanning speed. This resulted in 
tailorable release profiles for the model antibiotic vancomycin from an aqueous formulation. Released 
vancomycin retained its antibiotic efficacy against Staphylococcus aureus Xen 36 (methicillin sensitive) 
and Staphylococcus aureus Xen 31 (methicillin resistant), representing two of the most frequent pathogens 
in PJI. 
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Solutions for single problems were recomposed for integrated solutions to partial problems, and 
subsequently for an overall prototype solution. The overall solution cementless hip stem prototype 
effectively prevented surface colonisation by Staphylococcus aureus Xen 31, confirming the efficacy of 
the developed local drug delivery strategy. These results were used to inductively refine the LPBF-centred 
interdisciplinary problem solving framework. 
 
The original contribution of the research corresponds to the experimentation and framework development 
phases respectively. This involves the systematic investigation of LPBF to enable local drug delivery and 
an LPBF-centred approach for interdisciplinary problem solving. Lastly, it contributes to the advancement 
of LPBF by demonstrating the application efficacy of the prototype solution. 
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Opsomming 
Periprostetiese gewrigsinfeksie (PJI) as ‘n gevolg van implantaatoppervlak kolonisasie deur patogeniese 
bakterieë en biofilm formasie is ’n ernstige komplikasie na totale heupartroplastiek. Dit verlaag ’n pasiënt 
se lewenskwaliteit merkwaardig en kan in ernstige gevalle lei tot amputasie of sterfte. Behandeling van 
PJI word geassosieer met ’n substansiële las op gesondheids- en ekonomiese middele. Die belangrikheid 
van navorsing vir innovasies in PJI voorkoming en behandeling word benadruk. 
 
Lokale toediening van antimikrobiese medikamente is ‘n effektiewe benadering om PJI te voorkom en te 
behandel deurdat hoë lokale antimikrobiese konsentrasies gehandhaaf kan word sonder sistemiese newe-
effekte. Huidige praktyk word beskou as suboptimaal en veel navorsing bestaan vir die verbetering van 
lokale toedieningsstrategieë. Vir ongesementeerde heupstamme is die fokus op bedekkings en 
kondisionering van die eksterne implantaatoppervlak. ’n Beduidende gaping bestaan tussen eksterne en 
interne lokale toedieningsstrategieë waar ‘intern’ verwys na die inkorporasie van reservoirstrukture binne 
die implantaat. Daarom was ’n prototipestrategie vir die benutting van die interne volume van ’n 
ongesementeerde heupstam vir ’n reservoir waar vanuit medikamente direk na die implantaatoppervlak 
toegedien kan word ondersoek. Die uitdaging om ’n ongesementeerde heupstam met ingewikkelde interne 
geometrieë te vervaardig kan effektief aangespreek word deur metaal toevoegingsvervaardiging (MAM). 
 
Industrie is stelselmatig besig om MAM in proseskettings te inkorporeer as die hoof produksietegnologie 
vir die vervaardiging van hoë-waarde funksionele komponente. Laser poeierbed fusie (LPBF) is toegepas 
in hierdie studie as MAM-tegnologie om ’n Ti6Al4V ELI demonstrasie ongesementeerde heupstam met 
lokale medikament toedieningsfunksie te vervaardig. Dit het ’n interdissiplinêre benadering vereis 
waarvoor ’n probleemoplossingsraamwerk gesintetiseer was om die proseskettingontwikkeling vanuit ’n 
LPBF-gesentreerde perspektief te ondersteun.  
 
Die algehele probleem was opgebreek in geïntegreerde deel- en enkelprobleme wat sistematies ondersoek 
was deur literatuur studie en eksperimentasie. ’n LPBF-gesentreerde oplossing was ontwikkel vir die 
direkte integrasie van poreuse strukture in ’n digte part met ’n in-proses monteermetode. Verskeie vlakke 
van porositeit was geïnduseer in deurlaatbare dun wande volgens ’n stelselmatige geïdentifiseerde venster 
vir waardes vir die prosesparameters laser sterkte en skandeer spoed. Dit het geresulteer in aanpasbare 
vrystellingsprofiele vir die modelantibiotika vankomisien vanuit ’n wateroplossing. Vrygestelde 
vankomisien het antibiotiese effektiwiteit behou teen Staphylococcus aureus Xen 36 (metisillien sensitief) 
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en Staphylococcus aureus Xen 31 (metisillien weerstandig), verteenwoordigend van twee van die mees 
frekwente patogene in PJI. 
 
Oplossings vir enkelprobleme was geherkombineer tot geïntegreerde oplossings vir deelprobleme, en 
gevolglik vir ’n algehele prototipe-oplossing. Die algehele oplossing ongesementeerde heupstam prototipe 
het oppervlakkolonisasie deur Staphylococcus aureus Xen 31 effektief verhoed wat die funksionaliteit van 
die ontwikkelde lokale medikament toedieningsstrategie bevestig. Die resultate was induktief gebruik om 
die LPBF-gesentreerde interdissplinêre probleemoplossingsraamwerk te verfyn.  
 
Die oorspronklike bydrae van die navorsing korrespondeer respektiewelik tot die eksperimentele- en 
raamwerkontwikkelingsfases. Dit betrek die sistematiese ondersoek van LPBF om lokale 
medikamenttoediening te bewerkstellig en ’n LPBF-gesentreerde raamwerk vir interdissiplinêre 
probleemoplossing. Laastens dra dit by tot die bevordering van LPBF deur die toepassingseffektiwiteit 
van die prototipe-oplossing te demonstreer. 
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1.  Introduction 
The aim of this chapter is to provide the reader with a context for the study. Relevant background 
information is presented, from which the problem statement was derived. Based on this, the research 
aim and objectives were formulated, along with an overview of the research methodology followed 
throughout various stages of the project. Considerations regarding the scope and novelty of the study 
are highlighted and the chapter is concluded with a roadmap for the remainder of the document. 
1.1 Background 
1.1.1 Total Hip Arthroplasty Overview 
Systematic deterioration or the occurrence of trauma can leave joints within the human body in a state 
of permanent disrepair (Mancuso et al., 1996). Primary total joint arthroplasty (TJA) is a procedure 
during which a joint is reconstructed with implanted artificial components, for example total knee 
arthroplasty (TKA) for knee joints and total hip arthroplasty (THA) for hip joints (Siopack & Jergesen, 
1995). Implant components are fixed either by the application of polymer bone cement between the 
implant and the host bone, or by osseointegration in the absence of bone cement, where the implant 
surface directly integrates with the host’s physiological environment (Laupacis et al., 2002). The aim is 
to restore functionality to the joint and quality of life (Salih & Hamer, 2013). In general, THAs are 
highly successful procedures, with a vast repository of literature testifying to its state of continual 
refinement (Learnmonth et al., 2007; Soffin & YaDeau, 2016). 
 
The average functional lifetime of an implant is 12-15 years for THA (Rack & Qazi, 2006), but several 
complications can occur, resulting in premature failure and the need for revision surgery. The two main 
categories of revision surgery are aseptic and septic (Barrack et al., 2000; Romanò et al., 2010). 
Aseptic revision indicates failure mainly due to mechanical, biochemical, and physiological 
phenomena in the absence of microorganisms whereas septic revision refers to failure due to 
periprosthetic joint infection (PJI) (Lombardi Jr et al., 2014). Revision rates are reported to vary 
between 4 and 15% for primary THA (Labek et al., 2011; Bozic et al., 2015) (Kandala et al., 2015). 
Figure 1-1 presents the aetiology of revision THA surgeries recorded in the Norwegian Arthroplasty 
Register for the period 2005 to 2017 (Furnes et al., 2018). 
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Figure 1-1: Revision THA recorded in the Norwegian Arthroplasty Register for the period 2005 to 2017 
(adapted from Furnes et al., 2018) 
 
The majority of revision surgeries for primary THA is represented by aseptic causes owing to its 
greater encompassing definition. However, trends are showing an increase in the fraction of primary 
revision due to PJI (Ayers et al., 2018; Springer et al., 2017). Languerrand et al. (2017) reported an 
increase in PJI within three months after surgery incidence during the years 2005-2013 of 2.3- and 3.0-
fold for primary and revision hip arthroplasty, respectively. The risk of infection also increases 
significantly after revision surgery, regardless of reason for revision (Wyles et al., 2014; Lenguerrrand 
et al., 2017). Infection has been reported to have become the main cause of multiple revisions 
(Kärrholm et al., 2018). 
1.1.2 Periprosthetic Joint Infection 
The leading cause of PJI is the colonisation of implant surfaces by pathogenic bacteria and subsequent 
biofilm formation (Zmistowski et al., 2013). Upon introduction into the human body, biomaterial 
surfaces are rapidly covered with host proteins (Kamath et al., 2008). This surface conditioning 
provides adhesion sites to bacteria with corresponding adhesins (Costerton et al., 2005). Once adhered, 
bacteria can multiply, form microcolonies, and produce an extracellular matrix which encases the 
organisms, enabling evasion of the host innate immune system and effecting antibiotic resistance 
(Høiby et al., 2010; Ter Boo et al., 2015). Systemic antibiotic treatment is generally not effective and 
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Different treatment procedures exist for PJI, the selection of which is primarily based on the time after 
surgery (Zimmerli & Ochsner, 2003). Within 6 weeks after primary surgery, irrigation and debridement 
with implant retention can be considered (Grammatopoulos et al., 2017). Thereafter, infection is treated 
with one- or two-stage exchange procedures. If the pathogens are known and the patient has sufficient 
healthy bone and soft tissue, or the risk of repeated surgery is high, a one-stage exchange is preferred 
(Osmon et al., 2013). However, the two-stage exchange protocol is considered the standard treatment 
for deep PJI. The first stage includes implant removal, debridement of infected tissue, and an initial 
antibiotic treatment for a typical period of six weeks (Puhto et al., 2014). This period can be extended 
significantly in the case of persistent pathogens, during which the patient has impaired mobility (Lai et 
al., 1996; Hsieh et al., 2004). Only once evidence of complete eradication is obtained can the second 
stage commence where a new functional implant is introduced (Scharfenberger et al., 2007). Reported 
treatment success rates are challenged due to prolonged interim periods, repeated surgeries, and 
increasing mortality (Jhan et al., 2017; Gomez et al., 2015). The need to research and develop 
innovations to aid in PJI prevention and treatment is therefore emphasised (Kheir et al., 2017). 
 
When administering antibiotic drugs it is important to maintain effective concentration levels to the 
respective site without eliciting systemic side effects. Local drug delivery directly to the site of 
infection, as opposed to systemic administration, allows for maintaining effective drug concentrations 
without eliciting systemic toxicity (Young et al., 2014). To achieve effective local drug administration, 
delivery vehicles are required from which the drug can be released without degradation. For cementless 
hip stems, local drug delivery strategies are less available (Winkler, 2009). Although bone substitute 
and biodegradable augmentation materials such as calcium phosphate cements and collagen fleece are 
available, drug release and biodegradation rates often do not match (Ginebra et al., 2006; Kluin et al., 
2013). Studies tend to focus on coatings and conditioning of the outer implant surface (Campoccia et 
al., 2013; Lyndon et al., 2014; Raphel et al., 2016). Drug delivery from implant surfaces remains 
challenging (Ter Boo et al., 2015). Rethinking implant design to utilise the implant itself as a drug 
reservoir has received much less attention. This is likely due to constraints regarding the conventional 
design and manufacture of commercialised cementless hip stems. Metal additive manufacturing 
(MAM) is a process that allows the developing of innovative designs to produce cementless implants 
for drug delivery (Müller et al., 2012). This study, therefore, aims to develop an interdisciplinary 
MAM-centred approach to enable local drug delivery from implants, with the emphasis on cementless 
hip stems. 
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1.1.3 Metal Additive Manufacturing-based Process Chains for Medical Implants 
In the past decade, various studies have investigated MAM for the fabrication of a diverse range of 
medical devices (Vandenbroucke & Kruth, 2007; Petrovic et al., 2012; Jardini et al., 2014). The 
utilisation of MAM-produced medical implants is occurring in human patients and the innovative use 
of MAM in the fabrication of custom medical devices is on the increase (Murr et al., 2012). Figure 1-2 




Figure 1-2: Projected number of implants manufactured with MAM to the year 2026 (adapted from Park, 
2018) 
 
The projection, unfortunately, does not include details with regards to the specific implants other than 
consisting of metal. Furthermore, although many implants have been successfully manufactured and 
introduced into patients, reported cases are often study-specific and only a few companies have 
commercialised MAM-produced implants (Table A-1 in Appendix A). With MAM, high value 
components such as medical implants can be re-engineered to enhance functionality of the final part, to 
shorten manufacturing process chains, and to reduce waste (Holmström et al., 2010). Laser powder bed 
fusion (LPBF) is an MAM technology which has been used to produce conceptual titanium alloy 
specimens with internal reservoirs containing antibiotic loaded bone cement (ALBC) to prevent 
bacteria from forming biofilms (Bezuidenhout et al., 2015; Cox et al., 2016). These studies serve as a 
point of departure for evaluating the concept of drug delivery from LPBF specimens with conceptual 
features, which is expanded in this project to the application of LPBF for the production of a 
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1.2 Problem Statement 
Colonisation of THA cementless femoral stems by opportunistic pathogenic bacteria, most frequently 
staphylococci (Oliveira et al., 2018), and subsequent biofilm formation is one of the most devastating 
complications following THA. The protective biofilm shields the bacteria from both the host’s immune 
system and presents a barrier to the diffusion of antibiotic molecules, thus enabling the bacteria to 
persist on the implant surface (Arciola et al., 2018). Exogenous sources of pathogenic contamination 
during the arthroplasty procedure include microorganisms present on the skin and mucous membranes 
of the patients and operating theatre staff as well as environmental aspects such as surfaces, surgical 
instruments and operating theatre airflow (Zimmerli & Moser, 2012; Graves et al., 2016). Pathogens 
can also adhere to implant surfaces through endogenous contamination via haematogenous routes due 
to bacteraemia or the presence of other infected sites (Murdoch et al., 2001; Luthringer et al., 2016). 
 
Current strategies for local drug delivery approved by regulatory boards and implemented for 
prophylaxis and treatment of PJI are considered to be sub-optimal. Furthermore, in literature it is 
expressly stated that there is an urgent need for innovations that could aid in prevention and treatment 
of PJI (Rezapoor & Parvizi, 2015; Kheir et al., 2017). 
 
Reported research tends to focus on the development of antimicrobial coatings and surface 
modifications, interfacial material chemistry and topography, with comprehensive reviews published 
(Campoccia et al., 2013; Ter Boo et al., 2015; Chouirfa et al., 2019). Significantly less literature exists 
on the utilisation of the bulk implant as a drug reservoir for local drug delivery. A potential reason is 
the geometrical constraints imparted on implant design by conventional manufacturing processes. Most 
cementless femoral stem bulk parts are produced from wrought titanium alloys (Garellick et al., 2014) 
with conventional manufacturing processes such as casting, forging, and machining. To overcome 
these constraints, an alternative would be the MAM route, which affords the realisation of highly 
complex geometries.  
 
It is important to note that MAM, and specifically LPBF, is not constraint free and that within each step 
of the process several aspects need to be considered, which are material- and machine-specific. 
Furthermore, with LPBF as enabler technology, aspects from other disciplines critical to the drug 
delivery functionality of the implant are also included throughout the entire process chain. The 
utilisation of LPBF for internal drug delivery features is not yet applied in the current range of 
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cementless hip stems. An area therefore exists for the development of novel manufacturing process 
chains towards the production of such products which are interdisciplinary in nature. A cementless hip 
stem with enhancements such as a built-in drug delivery system requires the design of a new integrated 
process chain with the manufacturing focus centred on enabling the functional requirements from the 
beginning of the product’s life cycle (Wu & Grainger, 2006).  
1.3 Research Objectives 
The overall aim of this research was to contribute a prototype strategy for the potential prevention of 
PJI related to cementless hip stems. Supporting this aim was the development of a framework for 
interdisciplinary problem solving that guided the creation of an LPBF-centred process chain aimed at 
enabling local drug delivery from cementless hip stems. This included the identification of the required 
interdisciplinary knowledge areas to be integrated into the LPBF-centred process chain. It should 
provide insight for potential manufacturers into the necessary skills requirements for such projects 
whilst emphasising the need for interdisciplinary education programmes and collaborative research. In 
support of the overall aim, the following objectives were identified to provide a systematic roadmap for 
execution of the research: 
 
 Identify the disciplines and required subsets of knowledge for developing the LPBF-centred 
manufacturing process chain and derive a high-level framework aimed at interdisciplinary 
problem solving from an LPBF-centred perspective 
 Study the LPBF process, investigate how it can be utilised to create permeable structures for 
local drug delivery, and evaluate the drug release of a demonstrator vancomycin formulation  
 Collaboratively study, specify, and develop a custom experimental setup for evaluating an 
alternative vancomycin formulation for sustained release demonstration  
 Determine a method for integration of permeable structures with solid reservoir components 
and evaluate drug release from integrated reservoir specimens 
 Expand the integrated reservoir specimens to design and fabricate a cementless femoral stem 
implant prototype with internal reservoir and integrated permeable structures 
 Evaluate the potential of the prototype to prevent bacterial colonisation through the release of 
an antibiotic from the implant internal reservoir 
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 Update the interdisciplinary problem solving framework with knowledge gained from the 
previous objectives  
1.4 Research Approach 
The research in this thesis followed a mixed-methods approach. The bulk of the research was executed 
under the work package title “Passive Functionalisation of the Implant Inner Structure” as part of an 
international collaborative project on intelligent implants that involved several disciplines. It was 
divided into four phases namely 1) analysis, 2) synthesis, 3) experimentation and integration, and 4) 
refinement. Phases 1 and 3 followed a deductive approach while phases 2 and 4 followed an inductive 
approach.  
 
Phase one (analysis) concerned the undertaking of a literature review on the various aspects of 
applying LPBF for the enabling of local drug delivery for infection prevention. This encompassed 
studying the relevant aspects of microbiology, polymer science, and engineering. Frameworks for an 
LPBF-centred interdisciplinary approach to process chain development and problem solving were 
reviewed to establish a basis from which a high-level interdisciplinary framework for the problem in 
this study could be synthesised.  
 
In phase two (synthesis), the high-level framework was synthesised. This involved consolidating the 
relevant information obtained in phase 1 to the context of this study, identifying the main knowledge 
areas within the different disciplines that required integration. A point of departure was identified from 
the VDI 2221 standard which concerns a level based representation of decomposing the overall 
problem into single problems and recomposing single solutions into an eventual overall solution (VDI, 
1993). Viewing this approach from an LPBF-perspective formed the basis of the interdisciplinary 
process chain development process. A breakdown of the overall problem into partial and single 
problems was then performed to guide the experimental section of the project.  
 
The third phase (experimentation and integration) involved a series of experimental investigations 
based on the breakdown structure developed in phase 2. Insight was obtained regarding the sustained 
release of vancomycin from a poly(lactic-co-glycolic acid) (PLGA) matrix after which a sustained 
release formulation was developed by the Department of Microbiology at Stellenbosch University 
(SU). The experimental setup for vancomycin release testing from the developed drug formulation 
required a collaborative effort during which custom release wells were designed and manufactured.  
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The bulk of the experimental work, however, encompassed studying the LPBF process and how it can 
be utilised for drug delivery application. Porosity was especially important in this study for its effects 
on drug release. Typically, the focus within LPBF is towards minimising porosity by identifying 
appropriate process parameter settings for specific machine and material combinations (Gong et al., 
2014). Viewed from a perspective of functional enhancement, this implies the existence of parameter 
setting windows that would induce controllable levels of porosity.  
 
One of the key aspects of the LPBF-centred process chain was based on the proposition of integrating 
features with tailorable porosity through varying the process parameters. This strategy was investigated 
through a series of design of experiments (DoE) approaches. Firstly, a DoE was performed to ascertain 
the influence of the three main process parameters, laser power, scanning speed, and hatch spacing. A 
subsequent experiment was aimed at establishing a range of volumetric energy density (VED) values 
within which permeable thin walls (PTWs) could be produced. Once this range was established a DoE 
was set up to investigate the effects of the selected process parameters on resulting vancomycin release. 
The main reason for this strategy is that process induced porosity created smaller pore sizes than the 
geometric limitations of current commercial LPBF machines. Where current lattices are typically 
constraint to feature size designs greater than 300 µm (Hassanin et al., 2018), process induced pores are 
reported to be in the order of 50 µm (Kasperovich et al., 2016). The integration part of phase three 
involved two aspects. Firstly, the PTWs were integrated with solid reservoir specimens and the drug 
release evaluated. The resulting knowledge gained was then utilised as input for integration in the 
design and manufacture of a demonstrator prototype which proved to be able to prevent bacterial 
colonisation.  
 
Phase four (refinement), in essence, ran concurrently with phase three and utilised the generated 
knowledge in an inductive manner to update and improve the high-level framework. The 
implementation of the framework was then summarised to demonstrate a concrete example within the 
boundaries of the application case of this study, namely a cementless hip stem.  
1.5 Limits and Exclusions 
To evaluate antimicrobial efficacy, a model drug and pathogen combination was specified as 
vancomycin and two strains of Staphylococcus aureus (S. aureus), one methicillin sensitive (MSSA) 
and one methicillin resistant (MRSA), two of the most frequent offending pathogens with the ability to 
colonise implant surfaces and form biofilms, leading to serious PJI (Parvizi et al., 2010; 
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Triantafyllopoulos et al., 2017). The drug formulation for release and antimicrobial efficacy testing 
from LPBF-produced specimens was fixed as an aqueous vancomycin solution as this formulation 
could be prepared freshly for testing at any given time and did not depend on the progress of other 
stages within the collaborative project. Vancomycin is a glycopeptide antibiotic drug which is clinically 
endorsed for prophylactic use due to its efficacy against both MSSA and MRSA (Young et al., 2014). 
 
For manufacturing of the prototype, LPBF was used as the MAM technology. In the current state of 
commercial MAM technologies, LPBF has the capability to produce components at the highest 
resolution and with the greatest dimensional accuracy (Schmidt et al., 2017; De Pasquale et al., 2019). 
 
Challenges to the large scale adoption of LPBF technologies for load-bearing components include 
anisotropy in the mechanical properties of as-built parts due to the resulting grain morphology, 
crystallographic texture, and processing defects such as porosity and insufficient layer bonding (Kok et 
al., 2018). However, mechanical properties comparable to the wrought counterpart can be obtained 
through appropriate finishing and thermomechanical post processing methods (Li et al., 2016; Ter Haar 
& Becker, 2018). For this study, it was therefore assumed, based on literature, that the required 
mechanical properties are achievable with appropriate post processing techniques.  
 
The body of the cementless stem was based on a commercial design that was fixed within the larger 
project mentioned in Section 1.4. The focus was therefore on design of the internal reservoir only and 
not the implant body.  
1.6 Scientific Contribution of the Research 
On a high level, the research contributes to local drug delivery strategies for the prevention of bacterial 
colonisation onto a cementless hip stem surface. An interdisciplinary framework has been synthesised 
to aid in problem solving and process chain development to enable such local drug delivery from an 
LPBF-centred perspective. The framework is also intended to be sufficiently generic to be applicable to 
interdisciplinary problem solving for local drug delivery within a broad range of implants and drugs. 
 
More specific contributions regarding the LPBF process is the development of a method to produce 
permeable structures with smaller pores than is currently achievable with lattice structure designs on 
commercial LPBF machines. A method was developed to integrate such permeable structures with 
solid components with an in-process assembly approach without the need for expensive machine 
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manufacturer add-on software. In order to further the industrialisation of MAM, it is of high 
importance to demonstrate novel applications with the production of physical prototypes. Thus, in this 
study it was demonstrated that LPBF as an MAM technology provides the possibility to enhance the 
functionality of a cementless hip stem by enabling local drug delivery and prevent bacterial 
colonisation. It therefore contributes to the application examples of MAM to promote its relevance as 
manufacturing technology for implants of the future. A list of journal and conference papers published 
during the duration of the project, with either direct relevance or required background work to the 
research reported in this thesis, is presented in Appendix A. 
1.7 Document Roadmap 
A schematic of the document roadmap is presented in Figure 1-3. The preceding introduction described 
the context of the study. The problem statement addressed why the research is relevant and the 
objectives that were to be reached in order to achieve the overall aim. The research approach briefly 
described how the study was undertaken. Chapter 2 begins with an overview of infection in total hip 
arthroplasty to elaborate on the seriousness of the problem. This is followed by an overview of drug 
delivery within which the research gap of utilising an inner implant bulk as reservoir for drug delivery 
is emphasised. The LPBF process is then analysed with specific implications for its utilisation for 
inducing porosity for the generation of permeable structures. Chapter 2 ends with a review of 
frameworks for interdisciplinary problem solving from an LPBF-centred perspective. Chapter 3 
presents the derivation of the high-level framework and is concluded with a problem breakdown 
structure which systematically organises the experimentation required to converge on an overall 
solution. The respective experiments, results and conclusions are presented in Chapters 4-7. The 
insights obtained from the experimentation are then utilised in the design and manufacture of a 
demonstrator prototype which was evaluated for its efficacy in Chapter 8. The high-level framework, 
updated with an inductive approach is discussed in Chapter 9. It was built on the insights obtained 
throughout the systematic experimentation according to the initial problem structure defined in 
Chapter 3. An implementation summary of the framework is also provided. The document is brought to 
a conclusion in Chapter 10 with recommendations for future research. 
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Figure 1-3: Roadmap of document 
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2. Strategy to Apply LPBF for Local Drug Delivery: Literature Study  
The application of LPBF for enabling drug delivery from a cementless hip stem to prevent bacterial 
colonisation encompasses knowledge areas of different disciplines. To gain an understanding of how to 
develop a strategy, it was important to study the basic principles of the relevant aspects within each of 
the involved disciplines. The review starts by describing the problem of infection in THA, its burden on 
resources, selected aspects of microbial infection, and the available treatment procedures which 
emphasise the need for local drug delivery innovations. Clinically applied local drug delivery strategies 
as well as strategies in development are then discussed, after which the scientific gap and opportunity 
regarding the application of LPBF for fabricating internal reservoirs are identified. Relevant aspects of 
LPBF for the processing of Ti6Al4V extra low interstitial (ELI) are then discussed, followed by an 
overview of frameworks to provide a basis for the derivation of an interdisciplinary problem-solving 
framework with an LPBF-centred perspective.  
2.1 Infection in Total Hip Arthroplasty 
Infection is one of the most serious complications following THA (Tsang et al., 2018). Colonisation of 
hip replacement implants by pathogenic bacteria and the formation of biofilms is the leading cause of 
PJI (Costerton et al., 2005; Zmistowski et al., 2013). Although PJI is relatively uncommon, occurring 
in 0.5-2.2% of primary arthroplasties, the implications are devastating (Shukla & Della Valle, 2015; 
Davidson et al., 2019). This includes poor clinical outcomes, heavy burden on healthcare and financial 
resources, and a significant risk of patient mortality (Shahi et al., 2017). Furthermore, PJI occurrence is 
steadily increasing (Springer et al., 2017). Lenguerrand et al. (2017) reported an increase in the PJI 
incidence per 1000 of 2.3- and 3.0-fold within 3 months following primary and revision hip 
arthroplasty, respectively, between the years 2005 and 2013. The number of reported PJI cases caused 
by antibiotic resistant Gram-positive bacteria is also increasing (Triantafyllopoulos et al., 2017). The 
importance of the development of novel antibiotic formulations and innovative drug delivery methods 
in joint replacement surgery is therefore underlined (Parvizi et al., 2010). This section discusses the 
costs and burden of infection, mechanisms of infection after hip replacement surgery, treatment 
procedures and prophylactic strategies. It is important to note that many themes with regard to the 
pathogenesis and persistence of infection, microbial behaviour and communication, are expert fields in 
their own right and therefore the review is presented at a level of detail as to maintain relevance to the 
aim of the current study. 
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2.1.1 Costs and Burden of Infection 
Revision due to infection poses a greater challenge than aseptic complications (Ulrich et al., 2008). An 
average increase in costs has been reported as 1.6- and 4.44 times that of primary THA for aseptic and 
septic revision respectively (Bozic & Ries, 2005). As a quantitative indication, separate studies have 
reported estimated treatment costs around $60,000.00 to $100,000.00 per patient (Bozic & Ries, 2005; 
Springer, 2015; Kapadia et al., 2016). These estimations exclude secondary costs that may arise from 
economic effects such as sick leave and disability claims.  
 
The main cost drivers include multiple operations required, length of hospital stay, expensive long term 
antibiotics, and new prostheses (Parvizi et al., 2010; Briggs 2015; Kapadia et al., 2016). Figure 2-1 
presents cost breakdowns from three different studies for comparison. The charts are adapted or created 
from data reported on the contributions of various cost drivers to the overall treatment cost at the 
respective care centre (Klouche et al., 2010; Kapadia et al., 2016; Akindolire et al., 2020). The hospital 
bed cost is not explicitly indicated by Klouche et al. (2010) which make the direct comparison of this 
cost driver not clear in Figure 2-1(c), however their results reported an average length of stay of septic 
revision was 30.6 ± 14.9 days in comparison to an average aseptic length of stay of 8.9 ± 2.2 days. 
 
The cost of prostheses and anaesthesia is included in Figures 2-1(a) and (b) under operating room costs, 
but only anaesthesia is included in the “Surgical unit + anaesthesia” costs in Figure 2-1(c). The main 
two cost drivers in all three studies can be identified as hospital stay and operating theatre costs. This 
would imply that costs can be reduced with strategies that would lead to shortening of hospital stay or 
reduction in number of surgeries required. Springer et al. (2017) evaluated infection burden as the 
number of septic revisions to the total number of primary arthroplasties for a given period from 
information reported in national arthroplasty registries from 6 different countries and found that the 
infection burden steadily increased. As the incidence of PJI is continuing to rise, this amounts to a 
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Figure 2-1: Reported costs for treatment of PJI as reported by (a) Kapadia et al. (2016) (b) Akindolire et 
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However, not only the economic burden, but also the reduced quality of life and risks of amputation 
and mortality should be emphasized. Gundtoft et al. (2017) evaluated the Danish Arthroplasty Register 
for the years 2005 to 2014 and found that patients who underwent septic revision had a significant 
higher risk of mortality than aseptic revision (p = 0.019) within one year after surgery. These findings 
are corroborated by other studies regarding increased risks of mortality after septic revision 
(Zmistowski et al., 2013; Patel et al., 2016; Shahi et al., 2017). It should be noted that PJI risk is also 
elevated after aseptic revision (Wyles et al., 2014; Goldman et al., 2020). Furthermore, septic revision 
often requires multiple surgeries during treatment (Bozic & Ries, 2005), with the risk of patient 
mortality compounding with each surgical admission, leading to an elevated mortality rate (Shahi et al., 
2017). In fact, for septic revision, a mortality rate of 5 times higher than that for aseptic revision has 
been reported together with a re-infection rate of up to 20% (Davidson et al., 2019).  
 
The above discussed issues do not differentiate between the pathogenic origins. In the case of bacteria 
resistant to antibiotics, however, the outcomes are typically worse (Parvizi et al., 2010). This 
encompasses increased treatment failure, longer hospital stay, and poor quality of life for the patient 
(Walls et al., 2008). Zmistowski et al. (2013) found trends of increased mortality regarding PJI caused 
by MRSA as opposed to MSSA with 15.9% and 7.4% of investigated cases respectively.  
 
A worrying statistic is reports of increasing incidence of infection by resistant organisms (Kapadia et 
al., 2016). The variety of resistant microorganisms is also increasing, further adding pressure on the 
problem (Kapadia et al., 2016). It therefore comes as no surprise that the importance of improving both 
PJI treatment and prevention strategies is unanimously emphasised throughout literature. 
2.1.2 Microbial Infection 
Infection can be regarded as a disturbance in the homeostatic balance between microorganisms and the 
host cells (Zilberman & Elsner, 2008). It starts with the adherence of microorganisms to the surface of 
the implanted biomaterial (Darouiche, 2001; Arciola et al., 2012). The origin of the microorganisms 
can vary and is classified as follows, perioperative if contamination occurred during surgery or shortly 
thereafter, haematogenous if the organisms reached the implant surface through blood circulation or 
lymph which transported the organism from a distant site, and contiguous if the pathogen has spread 
from one or more nearby foci of infection (Trampuz & Zimmerli, 2005). Time lapse since primary 
surgery is also a key parameter in classifying PJI. If PJI occurs within three months after primary THA 
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it is termed ‘early’, ‘delayed’ if occurrence is 3-24 months after primary THA, and ‘late’ after 24 
months (Trampuz & Zimmerli, 2005; Anagnostakos et al., 2009).  
 
The leading cause of PJI is the colonisation of joint replacement implant surfaces by pathogenic 
bacteria and subsequent biofilm formation (Zmistowski et al., 2013). A biofilm consists of surface-
adhering microorganisms which are embedded in an extracellular matrix (ECMx). The ECMx is 
generated from secretions of the microorganisms and components from the surrounding environment 
(Gallo et al., 2003).  
 
After implantation, the surface of an implant is covered with host extracellular matrix (ECMx) proteins 
including fibrinogen, fibronectin, collagen and elastin (Garcia-Gareta et al., 2016). This conditioning of 
the surface with host ECMx proteins provides sites to which planktonic bacterial cells can adhere 
through cellular features referred to as microbial surface component recognising adhesive matrix 
molecules (MSCRAMMs) (Patti et al., 1994). On unconditioned areas of the surface, initial attachment 
can be mediated through hydrophobic effects, van der Waals, acid-base, and electrostatic forces 
(Arciola et al., 2018). The risk of bacterial cell adhesion to the conditioned implant surface is further 
increased by the existence of an immune-compromised zone in the vicinity of the implant which 
impairs the ability of the host to clear intrusive microorganisms (Rochford et al., 2012). Once adhered, 
bacteria can multiply, form microcolonies, and produce an ECMx which encases the organisms, 
enabling evasion of the host innate immune system and effecting antibiotic resistance (Høiby et al., 
2010; Ter Boo, et al., 2015).  
 
To address the problem of infection in an interdisciplinary environment, it is required for all parties 
involved in such a project to have a basic understanding of the process of biofilm formation. A 
fundamental understanding, however, would entail an extensive amount of detail regarding the 
differences in gene expression and virulence factors of a wide variety of pathogens which is not 
necessarily relevant. The following sections thus aim to present a description of the biofilm formation 
process at a level of detail which would be required in order for the various disciplines involved in such 
a manufacturing process chain to take cognisance of the factors which could either increase or decrease 
the risk of bacterial colonisation and biofilm formation.  
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Biofilm formation can be regarded as a four step process, attachment, accumulation, maturation, and 
dispersal (Arciola et al., 2012). These are presented in the simplified schematic in Figure 2-2, which 
serves as the basis for the process description. 
 
 
Figure 2-2: Simplified schematic representation of biofilm formation, (adapted from Arciola et al., 2012; 
Otto, 2013; Bresco et al., 2017) 
 
Initial cell attachment to the biomaterial is a reversible adhesion and can be effected by different 
mechanisms as described above. The administering of prophylactic antibiotics strives to eliminate 
planktonic and reversibly attached bacteria, prohibiting them from reaching the state of irreversible 
adhesion (Garcia-Gareta et al., 2016). Once adhered, a rapid increase in the number of adhering 
bacteria follows, leading to the progressive establishment of the biofilm (Gallo et al., 2003). S. aureus 
can detect the cell density or “quorum” through a process termed “quorum sensing” with the accessory 
gene regulator (agr) system which signals the cells to respond with changes in gene expression, 
typically accompanied by an increase in expression of virulence factors (Yarwood et al., 2004; Le & 
Otto, 2015). 
 
During the maturation phase, the biofilm develops structural features which are specific to the primary 
bacterial species (Arciola et al., 2012). Figure 2-3 shows a SEM image of an S. aureus biofilm on a 
Ti6Al7Nb substrate which has been incubated for seven days (Post et al., 2017). This involves the 
production of an extracellular polymer matrix which provides structural stability and protects the 
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biofilm which serve as conduits for nutrients between the multiple layers of cells (Høiby et al., 2010; 
Otto 2013). In addition to the diffusional barriers provided by the structural components of the biofilm, 
bacteria in biofilm mode of growth undergo changes in metabolic activity, which typically slows down 
in lower layers due to decreased availability of oxygen and nutrients. These changes in metabolism 
further reduce the efficacy of antibiotics (Kiamco et al., 2018). The high cell density in biofilms further 
provides an environment for mutation and amplification of both natural and acquired resistance 
(Francolini & Donelli, 2010). 
 
 
Figure 2-3: Scanning electron microscopy images of an S. aureus biofilm on Ti6Al7Nb discs after 7 days of 
incubation (Post et al., 2017) 
 
In the fourth phase, a range of different surfactants and exo-enzymes are produced which degrades the 
ECMx with cells being able to revert from the biofilm to the planktonic state (Lister & Horswill, 2014). 
This enables the cells, now possibly with acquired mutations as indicated by the slight change in colour 
in Figure 2-2, to further spread over the biomaterial surface and initiate the biofilm process anew 
(Arciola et al., 2012).  
 
Several factors regarding the physico-chemical properties of the implant material surface affect the 
attachment of S. aureus (Crawford et al., 2012). Two key parameters are the combined roughness and 
topographical features of the surface as well its hydrophobicity (Kasimanickam et al., 2013). Rough 
surfaces, although useful for osseointegration, tend to also promote the adhesion of bacteria if 
prophylactic measures are not taken (Campoccia et al., 2013). This is especially true in the case of 
LPBF where a significant reduction in biofilm growth has been observed on manually polished 
compared to as-built surfaces (McGaffey et al., 2019). Sarker et al. (2019) found that S. aureus biofilm 
area coverage reduced with decreasing hydrophobicity on LPBF-produced Ti6Al4V coupons. These 
issues should be taken into consideration when producing Ti6Al4V implants with LPBF. 
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2.1.3 Treatment Procedures 
Treatment of a PJI in hip replacement aims to completely eradicate all offending microorganisms and 
restore functionality to the articulating implant components (Haddad et al., 2000). Current treatment 
procedures include irrigation and debridement with implant retention, one-stage exchange arthroplasty, 
and two-stage exchange arthroplasty (Zimmerli & Ochsner, 2003). 
 
The option of PJI treatment with debridement and retention of the implant is subdued to strict selection 
criteria if it is to be successful, such as, the implant must be stable, infection is in its early stage and 
that the patient must be able to tolerate an aggressive and an extensive period of antibiotic therapy, both 
intravenously and orally (Zimmerli et al., 1998). This strategy consists of a thorough debridement of all 
infectious evidence at the prosthetic site without the removal of the prosthesis, accompanied by an 
intensive and prolonged period of antibiotic treatment (Brandt et al., 1997; Zimmerli et al., 1998). More 
than one debridement procedure might be required and the period between debridement procedures can 
vary (Westberg et al., 2012) The advantages of this treatment, if successful, are reduction in patient 
morbidity, lengths of hospital stay, resource burden and costs in comparison to one- or two-stage 
exchange arthroplasty (Fisman et al., 2001). 
 
The one-stage exchange procedure involves thorough debridement of all infected soft tissue, complete 
removal of the prosthesis and associated components (for example bone cement in the case of 
cemented components), and debridement of the bone-implant interface in the medullary canal, after 
which a new prosthesis is fixed in place (Buchholz et al., 1981). Between removal of infected 
components and re-implantation, a full rescrub and re-preparation is required to reduce the risk of 
recontamination (Jiranek et al., 2015). Traditionally, cemented components and the use of antibiotic 
loaded bone cement (ALBC) are indicated, but, successful treatment has also been demonstrated with 
cementless components (Hansen et al., 2013). It is however, subject to strict patient selection criteria. 
This includes the absence of any host comorbidities, the presence of adequate and healthy host soft 
tissue and bone stock, accurate preoperative identification of the infecting microorganisms, and 
absence of a sinus tract (Masri & Salvati, 1998; Klouche et al., 2012). Advantages of successful one-
stage to two-stage exchange are reduced risks for patient morbidity, less surgical procedures and 
hospital stay time, and a reduced cost (Klouche, et al., 2012). 
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Two-stage exchange is regarded as the standard procedure for PJI, especially for patients with 
developed abscesses and sinus tracts (Scharfenberger et al., 2007; Nett, 2015). During the first stage, 
the implant is resected together with a thorough debridement of all infected tissue. This is followed by 
a period of both local and systemic antibiotic treatment to target organisms identified from tissue 
biopsies (Sukeik & Haddad, 2009). There is controversy around the optimal period between stages, and 
subsequently a wide range has been reported. While some studies have shown little to no benefit of 
periods longer than 6 weeks, a delay between stages of 12 months or more have been reported for 
resistant pathogens (Zimmerli & Ochsner, 2003; Bernard et al., 2010; Babis et al., 2015). A temporary 
spacer which can be either static or articulating, typically made from ALBC, is utilised to locally elute 
antibiotics at the target infection site while maintaining limb length and allowing a certain amount of 
mechanical support (Rava et al., 2019). Evidence of complete eradication of the infecting 
microorganisms is required before the second stage, re-implantation of new components, can 
commence (Scharfenberger et al., 2007). Successful eradication can however not be guaranteed and 
repetition of the whole procedure might be required, which is associated with poor outcomes (Brown et 
al., 2018). 
 
Despite continual efforts in improving the treatment of PJI, for some patients, treatment or repeated 
procedures eventually fail (Jiranek et al., 2015). In these cases, the remaining options are resection 
arthroplasty, arthrodesis, amputation, or chronic antibiotic suppression (Fagotti et al., 2018). In 
resection arthroplasty (also termed modified Girdlestone arthroplasty) all infected components are 
completely removed and the patient is left with a rough articulation and shortened limb (Vincenten et 
al., 2019). In some cases the femur may be fused to the acetabulum (arthrodesis) (Kliushin et al., 2016). 
These procedures are performed as a last resort and are clearly undesired outcomes. 
 
Prophylaxis for PJI aims to reduce the bacterial presence at the bone-implant interface (Meehan et al., 
2009). Currently this is done through parenteral and local delivery of antibiotics. Despite optimisation 
efforts in clinical practise, several studies emphasises the need for the development of innovative 
prophylactic approaches (Getzlaf et al., 2016; Kapadia et al., 2016; Kheir et al., 2017). Winkler et al. 
(2018) argues that if even a single infection could be prevented through the use of local drug delivery, a 
care institution would save a significant amount of money.  
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2.2 Local Drug Delivery 
In local drug delivery, drugs are delivered in close proximity to the target site. As the focus in this 
study is on microbial colonisation of the foreign body implant, the target site can be regarded as the 
immediate volume surrounding the implant surface. Since a significant portion of this volume is 
situated within the proximal and distal femur, it can therefore also be considered in this particular case 
as intraosseous drug delivery. Administering drugs locally to the target site for prevention and 
treatment of PJI is an accepted practice and demonstrated to be safe (Gogia et al., 2009; Hafeman et al., 
2010). Furthermore, with local antibiotic delivery, the burden on healthcare resources is reduced which 
is reflected in its lower cost compared to parenteral administration (Gogia et al., 2009). Wu and 
Grainger (2006) summarised the advantages of local drug delivery as follows:  
 Smaller doses of the drug are needed 
 More control can be achieved over the toxicity and bioavailability of the dose 
 It is less likely to promote antibiotic resistance 
 An extended release duration is possible 
 Local drugs can be combined with systemic drugs exhibiting different kinetics 
 From surfaces of combination devices drugs can be released directly to the required site 
 Systemic exposure of the drug can be avoided 
 It offers a direct method to mitigate device related infection 
 
The following subsections briefly present methods in clinical use and those in development. It also 
serves to indicate the opportunity that exists for the development of a local drug delivery strategy based 
on the utilisation of the implant itself as a reservoir. 
2.2.1 Clinically Applied Local Antimicrobial Delivery for Cementless Hip Stems 
The application of PMMA beads and spacers as local drug delivery vehicles has been a standard in 
both prophylaxis and treatment for decades (Wu & Grainger, 2006). Commercial preparations are 
available and suitable antimicrobial agents able to withstand the exothermic polymerisation reaction 
can additionally be added manually prior to polymerisation. For example, vancomycin can be delivered 
locally via PMMA in concentrations far greater than the respective minimum inhibitory concentration 
(MIC) of the S. aureus strain in question (Kelm et al., 2004; Wu & Grainger, 2006; Anagnostakos et 
al., 2009). Limitations for the use of PMMA, however, exist which raise serious questions to its 
continued use. PMMA is non-biodegradable, requiring additional invasive procedures for removal, 
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risking renewed pathogen intrusion (Hanssen & Spangehl, 2004; Swearingen et al., 2016). Drug release 
efficiency is low with the majority of the drug remaining in the polymer matrix. This can lead to 
prolonged drug leaching in sub-effective concentrations, promoting the development of resistant 
bacterial mutations, and the PMMA material can present a new substrate for colonisation (van de Belt 
et al., 2001; Campoccia et al., 2010). Nevertheless, it is still employed clinically as a local drug 
delivery medium for both infection prophylaxis and treatment (Kluin et al., 2013; Bistolfi et al., 2019). 
 
Bone substitute and biodegradable augmentation materials such as calcium phosphate cements and 
collagen fleece are available for local drug delivery, but drug release and biodegradation rates often do 
not match (Ginebra et al., 2006; Kluin et al., 2013). Biodegradable drug delivery vehicles offer the 
advantage of not requiring removal surgery and can also be used to manage dead space during its 
degradation period (Waghmare et al., 2019). Wahl et al. (2017) used a biodegradable calcium sulphate 
cement to both manage dead space and locally deliver vancomycin. Concentrations above the MIC 
were maintained for at least 4 weeks with no systemic side effects. Calcium sulphate can be mixed with 
vancomycin into either pellets or a paste and typically are absorbed within three months (George et al., 
2015). In addition to calcium-based bone cements, natural and synthetic biodegradable polymers also 
offer promising alternative solutions for the local delivery of vancomycin. Rai et al. (2016) used 
poly(ε-caprolactone) (PCL) as carrier and demonstrated vancomycin delivery sufficient to successfully 
treat osteomyelitis in a rabbit model. Liu et al. (2002) described the use of PLGA biodegradable beads 
in a rabbit model and found effective levels of vancomycin for over 55 days.  
 
Recently, a hydrogel based on hyaluronic acid (HA) and poly(lactic acid) (PLA) has been clinically 
approved for cementless implants. Evidence has been reported in support of its efficacy, however 
publicly available literature at this time is still sparse and the use of coatings is not yet defined in 
treatment algorithms (Zagra et al., 2019). It is nevertheless evident that biodegradable alternatives are 
receiving more attention for local drug delivery. When combined with a drug eluting functionally 
enhanced implant as proposed in this study, it has the potential to offer a novel configuration of device 
and drug delivery combination for both prophylaxis and treatment of implant-related infections. 
Antibiotic prophylaxis can also be augmented by direct application of antibiotic powder in the open 
wound. 
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2.2.2 Investigated Local Antimicrobial Delivery Strategies for Cementless Implants 
The literature on local drug delivery strategies in development is vast. Examples of investigated 
strategies are presented in Table 2-1. Strategies are classified here as either external, internal, or the use 
of porous metal. For the purpose of demonstration, selected examples were restricted to specimens 
consisting of a metallic substrate and bacterial target pathogens. Furthermore, the selected examples 
include the application of different types of antimicrobial agents such as antibiotics, metallic cations, 
and antimicrobial peptides to convey the different possibilities for enhancing antibacterial functionality 
from cementless metallic implants. 
 
External strategies mostly regard the development of coatings. For titanium implants this especially 
involves bioactive or biodegradable formulations. Typical approaches for external strategies are, but 
not limited to, the application of hydroxyapatite, films, hydrogels, microparticles, nanoparticles, 
electrospun nanofibers, TiO2 nanotubes, TiO2 layers formed by plasma electrolytic oxidation, and 
direct immobilisation of drugs onto the implant surface (Hickock & Shapiro, 2012; Barik & 
Chakravorty, 2019). Nevertheless, drug delivery from coated implant surfaces remains challenging, 
especially as it offers once-off release only and coatings bear the risk of excessive abrasion and 
delamination under the forces exerted on the implants during surgery (Ter Boo et al., 2015).  
 
Internal strategies, as is the focus of this study, refer to the utilisation of a reservoir inside a cementless 
implant for drug loading and subsequent release. Rethinking implant design to utilise the implant itself 
as a drug reservoir has received much less attention than external strategies. This is likely due to 
constraints regarding the conventional design and manufacture of commercialised cementless hip 
stems.  
 
Porous metal encompasses commercially available options such as tantalum trabecular metal as well as 
lattice structures manufacturable with MAM. With the geometrical freedoms afforded by MAM, 
researchers are investigating the use of various lattice structure designs for local drug delivery by either 
using the pores as reservoir sites or the large surface area for coatings or direct antimicrobial agent 
implantation (Bakhshandeh et al., 2017). 
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Table 2-1: Examples of external, internal, and porous metal local antimicrobial delivery strategies in research for metallic implants 
Parent Strategy Specific Strategy Microorganism Antimicrobial Reference 
External Antimicrobial agent covalently bonded to 
surface of Ti6Al4V rods 
S. aureus ATCC 25923 Vancomycin (Antoci et al., 2007) 
 Polyelectrolyte multilayers of HA and 
chitosan on Ti foil 
S. aureus 25923 Chitosan (Chua et al., 2008) 
 Formation of Cu / Ti oxide layer on 
Ti6Al4V plate 
S. aureus 25923 Cu
2+
 (Burghardt et al., 2015) 
 Formation of Zn / TiO2 coating on Ti 
plate 






(Hu et al., 2012) 
 Formation of Ag / TiO2 film on NiTi plate E. coli ATCC 2259 Ag
+
 (Luo et al., 2013) 
 Drug loaded mesoporous TiO2 coating on 
Ti discs 
E. coli (DH5α) Cephalothin (Xia et al., 2012) 
 Ag nanoparticle containing 







E. coli (ATCC 8739) 
Ag
+ 
(Xie et al., 2014) 
 PLGA covered gentamicin coating on 
Ti6Al4V coupons 
S. aureus ATCC 12600 




S. aureus 7388 
S. aureus 5298 
Gentamicin (Neut et al., 2011) 
 Electrospun PLGA coating containing 
vancomycin on Ti implants 
S. aureus ATCC 29213 Vancomycin (Zhang et al., 2014) 
 Antimicrobial loaded TiO2 nanotubes on 
Ti plates 
F. nucleatum ATCC 25586 
P. gingivalis ATCC 33277 
GL13K AMP
e
 (Li et al., 2017) 
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 Drug loaded chitosan microspheres with 
nano-HAp precipitate 
S. aureus ATCC 29213 Ciprofloxacin (Doymus et al., 2021) 
     
Internal PMMA ALBC in LPBF produced 
Ti6Al4V specimens 
S. aureus Xen 36 (MSSA) 
S. aureus Xen 31 (MRSA) 
Gentamicin (Bezuidenhout et al., 2015) 
 Brushite ALBC in LPBF produced 
Ti6Al4V specimens 
S. aureus NCTC 8532 
S. epidermidis
b
 NCTC 11047 
Gentamicin (Cox et al., 2016) 
 Drug loaded mesoporous silica 
microparticles inside a commercial hollow 
stainless steel pin with porous wall 
S. aureus ATCC 29213 Linezolid (Perez et al., 2011) 
 Drug loaded mesoporous silica inside a 
macroporous Ti dental implant 
S. mutans
f
 (Clarke) Chlorhexidine (De Cremer et al., 2017) 
     
Porous metal / 
lattice reservoir 
PLGA microspheres manually loaded into 
Ta trabecular metal specimens 
S. aureus ATCC 49230 Tobramycin (Ambrose et al., 2014) 
 PMMA ALBC in Ta trabecular metal 
acetabular cup 
n/a (release only test) Gentamicin (Mooney et al., 2019) 
 Bacterial cellulose saturated with drug 
loaded into LPBF produced Ti6Al7Nb 
lattice  
S. aureus ATCC 6538 Gentamicin (Dydak et al., 2018) 
 Multi-drug chitosan/gelatin based coating 
deposited on DMP
g
 produced Ti lattice  




(Bakhshandeh et al., 2017) 
 Drug loading in EBM
h
 produced and 
micro arc oxidised Ti6Al4V lattice 






American Type Culture Collection; 
d






Direct Metal Printing; 
h
Electron Beam Melting 
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2.2.3 Opportunity for Novel Prophylactic Strategy 
Much research has and is being done in the area of developing prophylactic measures against bacterial 
colonisation of implant surfaces with comprehensive reviews published on the topic (Campoccia et al., 
2013; Ter Boo et al., 2015; Getzlaf et al., 2016; Mohammed et al., 2020). The research focus up to the 
present was by far on external strategies, for example coatings, topographical and physico-chemical 
modifications to the outer surface of the implants, and tailoring of the material chemistry to render 
intrinsic antibacterial properties. Conversely, a limited number of studies reported on the delivery of 
antibiotics through utilisation of the inner implant as a reservoir. This is demonstrated in Figure 2-4. 
For simplicity, as in the previous section, the classification is split between internal, external, and the 
use of porous metal or lattice structure approaches. To construct the figure, 171 relevant publications 
from reference lists in the respective reviews were classified according to the predominant approach 
followed for functionalisation as described above (Campoccia et al., 2013; Lyndon et al., 2014; Getzlaf 
et al., 2016; Mohammed et al., 2020). 
 
 
Figure 2-4: Implant functionalisation strategies for drug delivery 
 
Currently there is paucity in the research of internal and porous metal functionalisation compared to 
that of external. A possible reason for this is the limitations imposed on internal geometries of implants 
with conventional manufacturing methods. This argument is supported by the fact the cited internal 
approaches in the reviews pertains to specimens manufactured by additive manufacturing methods 



























Implant Functionaliisation Strategy 
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With powder bed MAM being a reasonably new technology, this could also explain the large difference 
in research focus between external and internal approaches. Nonetheless, the opportunity for 
functionalisation of inner implant volumes through LPBF is emphasised with promising results in these 
studies.  
 
The above identified opportunity thus forms the main theme of the research presented in this thesis. 
Furthermore, the application of LPBF as an MAM method to address this scientific gap not only 
contributes to local drug delivery strategies for cementless implants, but also to the arsenal of 
demonstrator applications for furthering of the industrial uptake of the LPBF technology. In the 
following sections the LPBF process is discussed in the context of processing a biomaterial used for the 
manufacturing of cementless hip stems, Grade 23 titanium (Ti6Al4V ELI). 
2.3 Laser Powder Bed Fusion (LPBF) 
LPBF is an MAM process in which thermal energy from a laser beam is used to fuse material powder 
particles. The term AM has collectively been defined as “the process of joining materials to make parts 
or objects from 3D model data, usually layer upon layer, as opposed to subtractive manufacturing 
methodologies” (ASTM International, 2012). Due to this layer-by-layer nature, part fabrication is often 
referred to as “building” and jobs can be referred to as “builds”.  
 
Fabrication of near net shape titanium alloy functional parts with MAM processes is being incorporated 
in the aerospace and biomedical industries for the production of high-value components in small 
batches (Caggiano et al., 2019). MAM offers production benefits through its efficient use of material, 
integration of components, topologically optimised and lightweight structures, and the capability for 
free form internal features (Petrovic et al., 2011). Such parts entail complex geometries unsuited to 
conventional manufacturing processes. Furthermore, geometrically complex parts can be fabricated by 
MAM processes with reduced lead times and tooling requirements (Holmström et al., 2010).  
 
At present, LPBF processes offer the greatest dimensional accuracy and highest resolution in powder 
based MAM (De Pasquale et al., 2019). The term LPBF consolidates the previously used terms such as 
selective laser melting (SLM), LaserCUSING, and direct metal laser sintering (DMLS), to refer to the 
manufacturing process without directly distinguishing between machine manufacturers. A simplified 
schematic of the LPBF process inside the build chamber is presented in Figure 2-5. 
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Figure 2-5: Simplified schematic representation of the LPBF process inside the build chamber 
 
The LPBF process fabricates three dimensional (3D) parts one layer at a time. A thin layer of metal 
powder is coated onto a horizontal building platform. A laser beam is then used to selectively irradiate 
and heat the powder particles in the x-y plane to beyond its melting temperature. Consequently, powder 
particles are fused according to the part’s two-dimensional (2D) geometry at the respective z-
coordinate. The building platform is then lowered by the specified layer thickness and the process 
repeats until the full 3D-part is built. To shield the material being processed from excessive oxidation 
and hydrogen pickup, the building chamber is flooded with an inert gas, typically nitrogen or argon 
(Sing et al., 2016). 
2.3.1 Overview of LPBF Process Chain 
In generic terms, the high-level process chain of producing components with LPBF reflects that of the 
general AM process chain to a large extent. Figure 2-6 presents the general LBPF process chain. Each 
of the high-level processes in Figure 2-6 contains several specific steps, which can have differing 
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Figure 2-6: Basic LPBF high level process chain (adapted from Hugo et al., 2018)  
 
The part design process involves the description of the part to be manufactured in the form of a digital 
solid 3D model. This model could be obtained in several different ways, for example, customer 
supplied, in-house designed and evaluated, generated through software which runs a solid model 
optimisation algorithm based on user specified boundary conditions, reverse engineering methods, or 
any combination of such methods. The digital integrity of the model to not contain any geometrical 
descriptive flaws such as any parts of the solid not enclosed is essential for streamlining subsequent 
model processing during downstream processes (Kim et al., 2015). Commercial CAD software 
packages have built in functions for evaluating the “water tightness” of the solid model which the user 
should utilise to confirm model integrity.  
 
In the data processing procedure, the 3D model is digitally translated into different formats containing 
specific details for eventual input into the LPBF machine control software. The first step is the 
generation of an STL file, which is a mesh of triangles that approximates the surfaces of the solid 
model (Ma et al., 2001). The file can be exported in either binary or ASCII format and consist of all the 
coordinates of the vertices of the triangles which collectively approximate the original 3D CAD model 
(Grimm 2004). Figure 2-7 presents a solid model and its triangulated STL approximation.  
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Figure 2-7: Solid CAD model on the left with STL approximation format on the right (in-house example) 
 
Apart from potential accuracy issues due to the discretisation effect, several errors can exist in the 
triangulated mesh. These include inward facing surface normals, intersecting triangles, gaps between 
triangles, holes in the mesh caused by missing triangles, bad edges from adjacent triangles not sharing 
two vertices, and shell (cloud of uninterrupted triangles) errors such as noise shells or intersecting 
shells (Yau et al., 2003; Materialise, 2020). Care should be taken to fix all these errors before 
continuing with data preparation. In some instances, it might be necessary to revise the CAD solid 
model and re-export it as an STL file to fix or eliminate some of the features that could lead to difficult-
to-fix errors.  
 
The next step in data preparation is part orientation and support generation. Part orientation can affect 
several aspects of the component. One of the aspects is the need for support structures when certain 
features are oriented in a certain way. Support structures serve as attachment of these features to the 
building platform, to aid in heat dissipation during the process, and to help prevent part warping or 
collapse (Salmi et al., 2018). For example, supports are typically required for overhangs, holes or 
channels greater than a certain diameter (depending on machine), and features angled lower than a 
certain threshold with the horizontal (x-y plane) (typically 45° but can differ according to machine). 
Support structures not only increases the total amount of material required and building time, but also 
need to be removed afterwards and therefore influence part removal and post processing strategies, 
which further affect other properties of the final part and can significantly increase the production costs 
(Mirzendehdel & Suresh, 2016; Jiang et al., 2018).  
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Next in the data preparation process is the generation of the build file. Machine manufacturers typically 
have specific software plugin(s) for their respective machines to translate the build configuration for 
communication with the machine control. These plugins are typically implemented in third party 
commercial pre-processing software such as MAGICS by Materialise. It encompasses the specification 
of parameters to use during slicing of the part as configured by the upstream processes. This includes 
the layer thickness and some parameters regarding the laser scanning strategy of each layer. Once build 
files are created successfully, they can be transferred to the machine control software for build 
preparation. 
 
The build preparation process involves both digital and physical steps. Build files of parts created in the 
data preparation process are loaded on the machine control software and process parameters for each 
build file are specified. Machine parameters for the build job are also configured. Depending on the 
machine control software and output of the respective data preparation process, part orientation can still 
be adjusted by translation in the x-y plane and rotation around the z-axis. Machine setup typically 
involves preventative cleaning of any residue from the previous build, monitoring of the gas supply, 
sieving and loading of the power feed stock, mounting and levelling of the powder coater blade, 
preparation and mounting of the building plate as well as confirmation of even powder coating across 
the entire building platform. Preparation of the building plate involves levelling of the building plate 
surface with CNC milling, sand blasting to prevent laser reflection, and demagnetisation to avoid 
magnetic effects on the powder particles obstructing powder flow. 
 
Prior to initiating the building process, a contour exposure scan can be performed to confirm correct 
translation of all part placements on the building plate from machine software to hardware. Next it is 
important to expose the first layer a few times in order to ensure strong fusion between this layer and 
the building plate. If no errors or malfunctions have been detected, the building process can be started. 
The building process should ideally be monitored periodically by the operator either on site or remotely 
so that corrective actions can be taken if possible, in order to save the build. Build failures are costly 
and online process monitoring options are being introduced in commercial machines and intensively 
researched, the details of which are outside of the scope of this study (Clijsters et al., 2014; Everton et 
al., 2016; Kolb et al., 2018). 
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When the build is finished, unconsolidated powder is present around the fabricated parts as well as on 
various surfaces of the machine’s building module. As much as possible of this powder should be 
recycled and difficult to access powder can be removed by an immersion separating vacuum. Powder is 
also removed from the individual parts and part features. Details regarding the powder recycling steps 
vary from machine to machine and can either be manual or automated. The build plate can then be 
safely removed, and it is recommended to first be stress relieved before the parts are removed. Parts are 
generally removed by wire electrical discharge machining (w-EDM), bandsaw, or manual processes in 
special cases. After removal, parts should first be inspected visually for obvious defects such as 
excessive oxidation (Figure 2-8(a)), cracks (Figure 2-8(b)), delaminated layers (Figure 2-8(c)), 
excessive distortion (Figure 2-8(d)), and failed features (Figure 2-8(e)). Causes of defects need to be 
traced and if it is due to effects from actions in the data and build preparation steps, these need to be 
revised before rebuilding the parts, whereas hardware problems typically need to be addressed by a 
machine manufacturer certified technician. 
 
                





Figure 2-8: Defects on Ti6Al4V ELI parts fabricated by LPBF with (a) excessive oxidation, (b) cracking, 
(c) delamination, (d) distortion (Hagedorn-Hansen et al., 2017), (e) failed features (in-house examples) 
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Post processing of fabricated parts depends on the application and required mechanical and material 
properties (Wauthle et al., 2015). It includes steps to alter the microstructure and mechanical properties, 
reduce porosity, improve surface finish, and modify surface chemistry (Liu & Shin, 2019). Post 
processing steps are important for parts intended for load bearing applications (Masuo et al., 2018). It is 
possible that parts are designed for applications which require little to no post processing.  
 
Parts intended for functional application can be inspected through non-destructive testing (NDT) 
techniques while sacrificial samples which accompanied the actual parts through the same process 
chain can be tested destructively. Sacrificial specimens provide information on the microstructural and 
mechanical properties that could be expected from the actual part (Roach et al., 2018). However, the 
limitations should be noted which arises from the nature of the LPBF process and the effects of several 
process parameters and part geometries on defect generation and subsequent mechanical behaviour 
(Dordlofva & Törlind, 2018). Furthermore, when applying NDT techniques to LPBF produced parts, it 
should be respected that generated defects would be not similar to defects arising during conventional 
processes such as casting and welding. Due to the highly customisable ability, once-off part designs, 
and lack of standardised NDT detection limits for associated defects, acceptance criteria would 
currently be part-specific (Waller et al., 2016; Seifi et al., 2017). Destructive testing refers to standard 
testing methods for evaluation of material and mechanical properties as specified in the respective 
international standards. 
2.3.2 Overview of the LPBF Building Process 
The cyclic nature of the LPBF process together with the main processes and influencing factors are 
presented in Figure 2-9. The powder layer deposition process is influenced by the properties of the 
metal powder and the powder coating subsystem. The powder coating subsystem configuration is 
machine specific and subject to the manufacturer’s design. Typically a roller or blade (flexible or rigid) 
is used to evenly coat a layer of powder. Properties of the coated powder layer are powder packing 
density, layer thickness, absorptivity, and thermal conductivity (Spierings et al., 2016). Powder layer 
properties are affected by the following parameters from the coating system and powder properties, 
coater type, layer thickness, coating speed, dose step, powder chemical composition, particle 
morphology, particle size distribution, van der Waals forces, moisture, powder flowability, and powder 
apparent and tap density (Sutton et al., 2017). 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2                               Industrial Engineering 
   Page 34 
 
 
Figure 2-9: Main processes and factors influencing the LPBF process and part performance (adapted 
from Spierings et al., 2016) 
 
The powder layer in turn affects the performance of the specified processing parameters for the 
exposure, melting, and fusion of the powder layer with the laser beam according to the part cross 
section geometry (Strondl et al., 2015). In reality, a multitude of process parameters affect the melting 
process, many of which are predefined according to machine and material supplier and therefore 
outside of user control (Spears & Gold, 2016). The key controllable process parameters however, 
which affect the melting process are laser power, laser spot size, scanning speed, scanning pattern, 
hatch spacing, powder size distribution, powder layer thickness, build plate temperature, and oxygen 
content in the build chamber (Song et al., 2012; Kasperovich et al., 2016; Li et al., 2018). 
 
Figure 2-10 presents a schematic of the scanning and melting of powder particles in the coated layer to 
generate scan tracks. Scan tracks are the result of the vectors that define the laser path, and can be 
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melt pool, demonstrated in Figure 2-10(a) together with its simplified heat transfer aspects. These 
tracks need to be sufficiently fused both to the preceding layers (or build plate in case of the first layer) 
as well as to adjacent tracks. The scan tracks are spaced in reference to each other with the parameter, 
hatch spacing (Figure 2-10(b)).  
 
Stability and fusion of the tracks to the preceding layers are largely influenced by the properties of the 
melt pool (Gusarov et al., 2007). Formation and behaviour of the melt pool is a complex procedure and 
is governed by multiple physical mechanisms, which is outside the scope of this study (Yadroitsev et 
al., 2010; Khairallah et al., 2016). Nevertheless, these properties are largely influenced by the 
controllable laser beam parameters such as type of beam, spot size, power, scanning speed, and 
exposure mode (pulsed or continuous). Generally, laser beams with Gaussian intensity profiles are 
applied with heat flux density according to Equation 2-1, indicated by the Gaussian curves side and top 
views in Figure 2-10 (Hann et al., 2011; Song et al., 2012; Xiang et al., 2018). 
 
 











Where 𝑟 is the radial distance from the beam centre, 𝐴𝑝 is the absorptivity of the powder layer, 𝑃 is the 
laser power, and 𝑟𝑏 is the effective beam radius at which the laser intensity decreases to 
1
𝑒2
 of its peak 
value at the centre. The average area heat flux density across the spot size can then be written as, 
 
 















The performance of the melting step has direct influences on part properties, performance, and quality. 
Once this process has finished, the building platform is lowered by the layer thickness and the cycle 
continues with coating of a new powder layer. 
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Figure 2-10: Schematic representation of scanning and melting the coated powder layer with a Gaussian 
laser beam with (a) scan track longitudinal view and (b) scan track cross sectional view (adapted from 
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2.3.3 LPBF of Ti6Al4V ELI 
Grade 23 titanium alloy, Ti6Al4V extra low interstitial (ELI), is a material widely used for the 
manufacture of femoral hip stems due to its biocompatibility, lower Young’s modulus compared to the 
approved alternative metals of stainless steels and cobalt-chromium (CoCr) alloys, high strength-to-
weight ratio, and corrosion resistance (Long & Rack, 1998; Geetha et al., 2009). It contains less 
interstitial impurities in the lattice structure of the elements Iron (Fe), Carbon (C), and Oxygen (O) than 
the known Grade 5 Ti6Al4V (Murr et al., 2009). The chemical composition (wt%) of Ti6Al4V ELI 
after LPBF processing, as specified in the ASTM F3001-14 (2014) standard is presented in Table 2-2. 
 
Table 2-2: Specified composition of Ti6Al4V ELI after LPBF processing (ASTM International, 2014) 
Element Minimum Maximum 
Aluminium 5.50 6.50 
Vanadium 3.50 4.50 
Iron … 0.25 
Oxygen … 0.13 
Carbon … 0.08 
Nitrogen … 0.05 
Hydrogen … 0.012 
Yttrium … 0.005 
Other elements, each … 0.10 
Other elements, total … 0.40 
Titanium remainder  
 
Titanium is an allotropic element that can exist in two different crystal structures, an α phase with a 
hexagonal close packed (HCP) atomic arrangement (Figure 2-11(a)) and a ß phase with a body centred 
cubic (BCC) atomic arrangement (Figure 2-11(b)). A solid-state phase transformation from α to ß 
phase occurs when commercially pure titanium (cpTi) is heated through 882.5 °C at atmospheric 
pressure (Long & Rack, 1998). To retain a percentage of ß phase in the microstructure at lower 
temperatures, Ti is alloyed with phase stabilising elements (Figure 2-11(c)) (Donachie, 2000). The 
temperature above which a complete transformation to ß phase occurs is termed the transus temperature 
and it depends on the mass fraction of phase stabilising alloying elements. Ti6Al4V ELI contains Al 
which strengthens and stabilises the α phase while raising the ß-transus temperature, which is 980 ± 20 
°C, and V as ß stabiliser, which stabilises the ß phase and allows a fraction of it to be retained at 
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temperatures below the ß-transus temperature (Chavez-Diaz et al., 2018; Liu & Shin, 2019). The 
presence of ß phase enhances the ductility and toughness of the alloy (Wauthle et al., 2015). In a 
commercially produced wrought Ti6Al4V ELI bar with a slightly elongated α and intergranular ß 







Figure 2-11: Titanium phases with (a) α phase in HCP unit cell arrangement, (b) ß phase in BCC unit cell 
arrangement, and (c) positioning of α+ß Ti6Al4V on a pseudobinary phase diagram with regards to the ß 
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During LPBF processing of Ti6Al4V ELI, however, the generated microstructure is dominated by an 
acicular α’ martensitic phase (Figure 2-12(a)). As the melt pool temperature nears that of the solidus 
temperature (~1604 °C), prior ß grains are formed, after which a fine acicular α’ martensitic phase 
forms within prior ß grains due to the high cooling rate (in the order of 10
6
 K/s (Rafi et al., 2013)). The 
orientation and morphology of the prior ß grains are affected by the thermal cycles experienced within 
the material during laser exposure of each new layer and presents a characteristic columnar structure 
preferentially elongated in the building direction (Figure 2-12(b)) (Thijs et al., 2010; Qiu et al., 2013; 
Ali et al., 2018; Zhao et al., 2018).  
 
 
                                        (a)                                                                             (b) 
Figure 2-12: As-built microstructure of LPBF produced Ti6Al4V with (a) top view (perpendicular to build 
direction) and (b) side view (parallel to build direction) (adapted from Zhou et al., 2018) 
 
This microstructural texturing effect imparts anisotropy to the mechanical properties and the 
arrangement of the texture throughout the part features depends on the build orientation of the part on 
the build plate (de Formanoir et al., 2020). Table 2-3 presents a summary of some of the mechanical 
properties of as-built tensile specimens from various LPBF machines with ASTM F136-13 
specification of wrought Ti6Al4V ELI for reference. The referenced data were reported for specimens 
with microstructure in the as-built condition. Although the tensile strength of the as-built condition is 
typically higher than that of the wrought material, the ductility can be significantly lower and also tend 
to differ considerably more between studies compared to the ultimate tensile strength (UTS) and yield 
strength (σy). The percentage difference in the data between the referenced studies of the UTS is around 
20% for both the vertical and horizontal orientations whereas the yield strength differs by 44% in the 
vertical and by 21% in the horizontal direction respectively. The % elongation, however, differs by 
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only does anisotropy exist in the mechanical properties of parts built on the same machine, but 
differences in the properties are present in parts built on different machines with different process 
parameters, environmental conditions, and powder stock. 
 














1080 1008 1.6 (Thöne et al., 2012) 
LM-Q
a
 Horizontal / 
Wire EDM 





1250 ± 50 1070 ± 50 5.5 ± 1 (Qiu et al., 2013) 
Vertical / As-
built 
1050 ± 40 1180 ± 30 8.5 ± 1.5 
EOS M270 Horizontal / 
Machined 
1269 ± 19 1195 ± 19 5 ± 0.5 (Rafi et al., 2013) 
Vertical / 
Machined 
1219 ± 20 1143 ± 30 4.89 ± 0.6 
MTT 250 Horizontal / As-
built 

































~1265 ± ~5 ~1125 ± 70 ~9.2 ± ~0.6 (Yadroitsev et al., 2018) 
Vertical / As-
built 






1257 ± 2 1082 ± 55 9.2 ± 0.9 (de Formanoir et al., 
2020) 
Vertical / As- 1289 ± 1 1146 ± 33 9.3 ± 0.5 
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DMP 320 build 
Diagonal / As-
built 
1229 ± 4 1084 ± 45 9.3 ± 0.6 
ASTM F136-13
e
 860 (min) 795 (min) 10 (min) (ASTM International, 
2013) 
a
 custom developed machines 
b
 mean value in brackets  
c
 orientation not specified, but based on standard specimen dimensions it is likely to be vertical 
  due to custom build volume reduction unit of 66 mm x 66 mm x 125 mm used 
d 
estimated from graph 
 
With appropriate post processing heat treatments, the microstructure can be altered to yield tensile 
strength and ductility comparable to that of the wrought counterpart (Ter Haar & Becker, 2018). 
However, defects in parts can arise from the LPBF process such as porosity from entrapped gas (Figure 
2-13(a)), lack of fusion (Figure 2-13(b)), and surface roughness (Figure 2-13(c)) which significantly 
reduce the number of cycles to failure of standard axial fatigue test specimen geometries (Leuders et 
al., 2014). These defects act as stress concentration areas and promote early crack initiation 








Figure 2-13: Example defects (a) porosity from entrapped gas, (b) lack of fusion, and (c) surface 
roughness (Ali et al., 2018; Wycisk et al., 2014; Fousova et al., 2018) 
 
Currently, the most effective way of addressing these are through a combination of hot isostatic 
pressing (HIP) and surface finishing post processing operations (examples are presented in Table 2-4) 
(Kasperovich & Hausmann, 2015; Li et al., 2016; Du Plessis & Macdonald, 2020). HIPing is typically 
performed for two hours at a temperature of 920 °C and a pressure of 1000 bar. Although the details 
regarding the mechanisms behind phase transformations and precipitation of phases in the 
microstructure are outside the scope of this study, it is important to bear knowledge of the different 
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microstructures and resulting mechanical properties when developing a LPBF centred process chain as 
it significantly influences the functional performance of the part. 
 
Table 2-4: Fatigue life of as-built and HIPed LPBF produced specimens 











SLM 250HL Vertical build; 
As-built; 
Machined; 
2 × 106 275 -1 (Leuders et al., 2014)* 
Vertical build; 
HIP; Machined 





5 × 107 250 -1 (Benedetti et al., 2018)* 
Vertical build; HIP 5 × 107 400 
SLM 250HL Vertical build; 
stress relieved; 
machined 
2 × 109 250 -1 (Günther et al., 2017)* 
Vertical build; 
HIP; Machined 
1 × 109 425 
Concept Laser 
M2 
Vertical build; HIP 1 × 107 200 -1 (Kasperovich & Hausmann, 
2015) Vertical build; 
HIP; machined 
1 × 107 350 
*values estimated from graphs in respective publication 
2.3.4 Influence of Selected Process Parameters 
The LPBF process is influenced by many parameters. Spears and Gold (2016) lists fifty parameters 
which they classified into four groups, laser and scanning parameters, powder material parameters, 
powder bed properties and recoat parameters, and build environment parameters. Many of these 
parameters, however, are fixed based on for example, machine hardware such as laser wavelength and 
focal diameter or on third party suppliers such as powder material properties and shielding gas purity 
(Spears & Gold, 2016). Figure 2-14 presents a summary of LPBF process parameters as presented by 
Aboulkhair et al. (2014). Although their classification is not exhaustive, it demonstrates the complexity 
of the process, as a multitude of possible settings exist for each parameter, rapidly increasing the 
computational requirements for more comprehensive simulation studies (Khairallah et al., 2016). 
Studies therefore rely largely on empirical approaches in order to elucidate the effects of parameters on 
different aspects of LPBF produced parts. 
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Figure 2-14: Summary of LPBF process parameters (recreated from Aboulkhair et al., 2014) 
 
In order to relate a combination of the main controllable parameters listed in Figure 2-14, volumetric 
energy (VED) is often used. The VED (J.mm
-3
) is expressed as a function of laser power, scanning 
speed, layer thickness, and hatch spacing according to Equation 2-4, 
 





where, P is laser power (W), v the scanning speed (mm.s
-1
), h the hatch spacing (mm), and 𝑡𝑙 the layer 
thickness (mm). Although the VED is a useful expression incorporating the key process parameters, 
concerns exist in using VED as a key criterion (Bertoli et al., 2017). For example, it is evident that 
aliasing exist within the expression where different values of the parameters can yield the same VED. 
 
It also does not account for the complex physics during melt pool formation and solidification (Bertoli 
et al., 2017). Nevertheless, it is a useful tool to relate the parameter settings to process performance, 
especially with regards to stable melting zones, microstructure, mechanical properties, and resulting 
porosity within applicable ranges for the respective parameters (Dilip et al., 2017) (Han et al., 2017). 
Depending on the specific LPBF machine hardware configuration and limitations, different value 
ranges for VED have been identified in literature for processing of Ti6Al4V ELI. This suggests the 
existence of local optimum points in the parameter settings which all provide acceptable outcomes. For 
example Gong et al. (2015) achieved a local maximum in density at a VED of 42 J.mm
-3
 (120 W laser 
power, 960 mm.s
-1 
scanning speed, 0.1 mm hatch spacing, and 0.03 mm layer thickness), Thijs et 
Process parameters
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al.(2010) reported their optimal parameters at 93 J.mm
-3
 (42 W laser power, 200 mm.s
-1
 scanning 
speed, 0.075 mm hatch spacing, and 0.03 mm layer thickness), and Mierzejewska (2019) reported an 




Strong corroboration exists between studies with regards to the porosity effects when deviating from 
the respective value ranges identified for VED (Kasperovich et al., 2016; Mierzejewska, 2019; Du 
Plessis, 2019). Identification of suitable VEDs is generally based on minimising the porosity. Deviation 
from the identified values in both lower and higher directions results in increased porosity as 
demonstrated in Figure 2-15. For each level of laser power, the energy density decreases from left to 
right with increasing scanning speed. 
 
 
Figure 2-15: Graphic representation of porosity as a function of laser power and scanning speed at 
constant hatch spacing of 0.1 mm, layer thickness of 0.03 mm, and laser spot size of 0.1 mm (adapted from 
Mierzejewska, 2019) 
 
The porosity in Figure 2-15 can be classified into two main categories, porosity due to overheating 
when the energy input is too high (region indicated with blue dashed line) or porosity due to 
insufficient energy input (region indicated with red dashed line) (Kasperovich et al., 2016). It can be 
observed in Figure 2-15 that pores formed due to insufficient energy input tend to be larger and more 
Scanning speed [mm.s-1]
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irregular in shape than pores generated from excessive energy input. In both cases the pore formation 
mechanisms are complex with regards to melt pool physics and are addressed here more qualitatively. 
 
When the energy input is too high, near spherical defects are typically observed. Gong et al. (2014) 
attributed these defects to a combination of the formation and entrapment of gas bubbles near the 
bottom of the melt pool during keyhole mode of melting, ejection of material from the molten pool due 
to recoil pressure from the generated vapour, and pitting from spherical particles which were ejected 
from the melt pool, weakly bonded to the top surface during solidification (also observed for suitable 
energy input levels as shown in Figure 2-16(a)) and subsequently removed by the powder coater during 
deposition of a new layer. Porosity due to inclusions of inert gas in the melt pool released upon 
solidification has also been reported (Kasperovich et al., 2016). 
 
With low energy input, phenomena such as insufficient and intermittent melting, lack of fusion 
between layers, lack of overlap between scan tracks, and balling occurs (Gong et al., 2014; 
Kasperovich et al., 2016). During balling, the scan tracks contain discontinuities from the formation of 
spheroid particles of solidified material Figure 2-16(b). When the melt pool does not sufficiently wet 
the preceding layers, the surface tension of the melt pool tends to generate bead like particles 
(Cardaropoli et al., 2012). Balling is likely to occur when the total surface area of the melt pool 






Figure 2-16: Single scan tracks produced at 400 W laser power and 200 µm layer thickness Ti6Al4V with 
(a) sufficient energy input (top to bottom scanning speeds of 40, 60, and 80 mm.s
-1
 ) and (b) insufficient 
energy input (top to bottom scanning speeds of 160, 180, and 200 mm.s
-1
) (adapted from Shi et al., 2016) 
 
Ejected and solidified material Discontinuity
Balling
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The focus within MAM part quality is typically towards minimizing porosity by identifying appropriate 
process parameter settings for specific machine and material combinations. For this study, however, the 
interest is in identifying a process window for the parameter settings that would induce different levels 
of porosity to impart permeability. Whereas the abovementioned studies demonstrated the two different 
porosity cases generated either by overheating or insufficient energy input, permeability of resulting 
specimens containing different levels of porosity was not investigated. 
 
Reported permeable structures produced with LPBF are typically designed as lattices and fabricated 
with parameters optimized for minimum strut porosity (Ghouse et al., 2017; Zadpoor, 2019; Burton et 
al., 2019). Consequently, pore sizes are limited by pre-processing (data preparation) software and 
machine capabilities. These minimum dimensions are, at present, limited to around 450 - 500 µm for 
pore size depending on the machine (Warnke et al., 2009; Zhang et al., 2014). Furthermore, unit cell 
designs are by their nature highly structured and pores typically align (Wang et al., 2016; Bobbert et 
al., 2017). The relatively large size of the pores combined with the low tortuosity potentially risks the 
passage of S. aureus into the implant, allowing for colonisation of the internal surfaces.  
 
Pores induced by incomplete melting or overheating are stochastically distributed through the material 
with smaller diameters than that of lattice structures currently achievable with LPBF machines. The 
stochastic distribution of the pores throughout the material would significantly increase the tortuosity, 
possibly obstructing free movement of pathogens as well as provide the ability to tailor drug release by 
constraining the diffusion of vancomycin molecules.  
 
Little readily available literature exists on tailoring of porosity for permeability through the process 
parameters itself. A possible reason for this sparsity of reported literature is the laser control software 
limitations regarding assigning different process parameters for various volumetric regions within a 
part. Abele et al. (2015) reported LPBF produced gas permeable thin wall structures of 250 µm 
thickness in 1.4542 stainless steel, investigated according to a Design of Experiments (DoE) approach 
with hatch spacing, laser power, and scanning speed as independent variables. Within the ranges 
investigated for the independent variables, hatch spacing was identified as the main factor influencing 
porosity. Pore morphology and distribution and the effects on permeability of molecules in liquid 
solution were not reported (Abele et al., 2015). Integration of such permeable structures, built with 
parameters for induced porosity, into larger components with a dense bulk was also not addressed.  
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2.3.5 Post Processing Considerations 
Depending on application, parts fabricated by LPBF may require further processing in order to impart 
properties that would enable it to meet the functional requirements (Benedetti et al., 2017). This 
includes, among others, the geometrical and dimensional accuracy, surface roughness, surface 
chemistry, surface and internal residual stresses, porosity, and microstructure. For reference, these are 
termed part properties, which in turn affect the mechanical properties of a part and its functionality. 
Some of these part properties can be addressed simultaneously during a single post processing 
operation, for example, porosity and microstructure can both be addressed through HIP treatment. 
Geometrical and dimensional accuracy, surface roughness, and surface residual stresses can be 
addressed simultaneously through material removal processes, or surface residual stresses can be 
addressed individually through, for example shot peening (Benedetti et al., 2017; Conradie et al., 2017; 
Bezuidenhout et al., 2020). The eventual process chain is therefore highly dependent on part 
application. For LPBF components, as presented in Table 2-4, one of the main challenges regarding 
part functionality is the relatively low fatigue strength of as-built LPBF parts compared to 
conventionally processed Ti6Al4V (Benedetti et al., 2018). Consequently, the focus of post processing 
tends to be on reducing surface roughness, eliminating porosity, and recrystallization of the as-built α’ 
martensite dominated microstructure to a more ductile α + ß configuration (Kasperovich & Hausmann, 
2015; Li et al., 2016).  
2.3.6 Design Constraints 
Although much design freedom is afforded with MAM, it is not entirely constraint free. Attention is 
required to process details as well as machine limitations. Design for additive manufacturing (DFAM) 
approaches therefore plays an important role in achieving successful builds. Practical guidelines and 
frameworks are continuously being developed and some have been published by researchers for the 
considerations of alterations to features to ensure AM suitable designs and build orientations (Kranz et 
al., 2015; Vaneker et al., 2020). Specifically this encompasses considerations for angled and 
overhanging surfaces, edges and corners, walls, radii, holes, cavities and internal channels, support 
structures, access for powder removal, and material tolerances for finishing post processing operations 
(Kranz et al., 2015). These aspects are subject to machine capability and also machine hardware setup 
and software control system configuration. 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2                               Industrial Engineering 
   Page 48 
 
2.4 Frameworks for Deriving an LPBF-Centred Interdisciplinary Approach 
An opportunity exists for the expansion of available AM frameworks, which generally focus on the 
challenges and characterisation of the emerging design paradigm, DFAM, and its relation to existing 
bodies of knowledge (Rosen, 2007; Kranz et al., 2015; Laverne et al., 2017; Mingareev & Richardson, 
2017; Zaman et al., 2018). Renjith et al. (2020) presents a summary of published DFAM approaches 
classified according to focus area. The main areas identified involve design problem analysis, idea 
generation, the design phases, and incorporation of AM capabilities in the conceptualisation phase. A 
framework that is applicable to the specific requirements of this study does not appear to exist. In this 
section, AM-centred and interdisciplinary problem solving frameworks are discussed. The reviewed 
frameworks provide a base from which an interdisciplinary framework for this study was derived.  
 
To highlight the relevance of DFAM to the product development process, Kumke et al. (2016) divides 
the term into ‘DFAM in the strict sense’ and ‘DFAM in the broad sense’. ‘DFAM in the strict sense’ 
regards the core design process and refers to the appropriate application of emerging AM design rules 
in order to ensure appropriate designs while respecting AM’s unique capabilities, and ‘DFAM in the 
broad sense’ encompasses generic upstream and downstream DFAM-related processes, for example 
process selection, part or application selection, manufacturability analysis, and the AM building 
process itself Figure 2-17 (Kumke et al., 2016).  
 
 
Figure 2-17: Classification of DFAM approach according to Kumke et al. (2016) (recreated) 
 
DFAM in the broad sense
DFAM in the 
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Since DFAM in essence addresses the entire product development cycle, a suitable point of reference 
can be considered as the established general procedure of systematic development and design 
according to VDI 2221: Systematic approach to the development and design of technical systems and 
products, from the Verein Deutscher Ingenieure (VDI) (VDI, 1993; Kumke et al., 2016). However, a 
main shortcoming of current DFAM frameworks has been identified as a lack of integration with 
reference to design and manufacturing process phases, as well as integration of multiple disciplines 
throughout the process phases from idea to detailed design as prescribed in VDI 2221, namely 
clarification and definition of the problem, conceptual design, embodiment design, and detail design 
(VDI, 1993; Krehmer et al., 2009; Kumke et al., 2016; Zaman et al., 2018). 
 
Whereas frameworks have been proposed for the integration of product development phases, such as 
material, process, and machine selection with early design stages, published literature on the integration 
of AM, or more specifically LPBF, with other disciplines is sparse. A promising approach to draw 
analogies from is offered by the Integrated Product/Process Development (IPPD) management method 
which aims to systematically integrate different disciplines throughout the entire product life cycle 
(Schrage, 1999; Oyesola et al., 2019). The generic IPPD methodology is shown in Figure 2-18(a). Four 
key elements namely, Systems Engineering Methods (SE), Quality Engineering Methods (QE), Top 
Down Decision Support (T3DS), and Computer Integrated Environment (CIE), form an umbrella under 
which three main columns of sub-elements are presented. The system to be developed is decomposed 
(top down) on the right hand side under SE, and recomposed (bottom up) under the QE on the left hand 
side. The SE and QE elements feed into the TD3S process where trade-offs are evaluated in a CIE. The 
trade-off process flow in the presented context of rotorcraft design is presented in Figure 2-18(b) with 
the right half representing the decomposition from Conceptual Design to Detail Design and the 
recomposition from Manufacturing Process to the System (Schrage, 1999). For this study the focus is 
shifted towards the right-hand side of Figure 2-18(b) for enhancing part functionality and subsequently 
the costing and return on investment aspects  
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Figure 2-18: IPPD with (a) the generic methodology and (b) the hierarchical trade-off assessment process 
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Zaman et al. (2018) proposed an IPPD framework for resource selection to integrate material, process, 
and machine selection during the conceptual and embodiment design stages. It is based on a summary 
of the potentials offered by AM and the factors that need to be considered in order to achieve them. 
Figure 2-19 presents this summary with AM potentials in the inner circle and factors for obtaining 
these potentials in the outer circle. 
 
 
Figure 2-19: IPPD with AM potentials and factors to achieve them (Zaman et al., 2018) 
 
The framework is presented in Figure 2-20. Respective decision areas are indicated with the shaded 
boxes. Decisions were guided by axioms and multi criteria decision making (MCDM) tools such as 
Analytical Hierarchy Process (AHP). AHP is a particularly useful MCDM tool in the manufacturing 
sector since it allows for the incorporation of both subjective and objective attributes in the decision 
making process (Emrouznejad & Marra, 2017). 
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Figure 2-20: Integrated design oriented framework for resource selection in AM (Zaman et al., 2018) 
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Renjith et al. (2020) proposed a framework to aid designers and product developers with the early 
integration of AM capabilities by combining Axiomatic Design (AD) and Theory of Inventive Problem 
Solving (TRIZ). The design problem is decomposed into functional requirements through AD and 
design parameters for satisfying the functional requirements are determined through TRIZ. An AM 
capabilities database is then used to find the appropriate AM capability for the respective design 
parameters to satisfy the functional requirement. The framework was demonstrated with the case of 
redesign for a housing cover (consisting of a cover, gasket, and threaded socket) (Renjith et al., 2020).  
 
Kaspar et al. (2019) proposed an integrated AM development framework that emphasises the 
importance of integrating downstream processes such as post-processing and NDT (non-destructive 
testing) into early stages of product development (Figure 2-21). It aims at aiding both experienced and 
inexperienced engineers to consider details regarding the manufacturing, post-processing, and quality 
control processes from the beginning in order to guide the design of parts. To demonstrate the 
integration of downstream processes, their framework was applied to the theoretical design of a multi-
material rotor shaft and turbine blade assembly (Kaspar et al., 2019). 
 
 
Figure 2-21: Integrated AM product development framework with focus on post processing and quality 
management (Kaspar et al., 2019) 
 
In reference to Kumke et al. (2016), this framework considers DFAM in both the broad and strict sense, 
however it is limited to mostly the design stages within the engineering product development process 
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and does not specifically incorporate different disciplines. Nevertheless, the holistic approach provides 
the potential user with a more focused overview of the multitude of various processes and the details 
that require consideration when developing products and process chains centred on AM, specifically 
LPBF (referred to as SLM in Figure 2-21). This aids in defining restrictions for conceptual design and 
thus rendering the solution space more manageable than an open canvas approach, especially regarding 
the design freedom offered by PBF AM processes. Furthermore, by elucidating the details of 
downstream processes early in the design phases, potential users obtain an idea of the challenges and 
opportunities in integrating AM into conventional process chains, which is highlighted as a major 
organisational obstacle towards further industrialisation of AM (Kaspar et al., 2019).  
 
Kim et al. (2015) adopted a systems engineering approach for the conceptualisation of information 
management system architecture for the digital information generated throughout the AM process 
chain. In their work, the process chain is divided into eight “phases”, part geometry/design, 
raw/tessellated data, tessellated 3D model, build file, machine data, fabricated part, finished part, and 
validated part. The framework is coupled both to the main generic phases within the AM chain as well 
as to supporting factors such as standards, methods, techniques, hardware, and software. This is not 
unlike that of the Integrated AM product development from Kaspar et al. (2019) in Figure 2-21, 
however, the focus is not so much on part realisation as on management and systematic integration of 
the information resulting from the different phases of the process chain. The importance of 
multidisciplinary issues is highlighted within a layer termed “Interoperability” and while it is 
emphasised for its importance in information flow and transparency, it is not concretised with specific 
details or application cases (Kim et al., 2015).  
 
A set-based approach, termed Integrated Product and Production Engineering (IPPE) for the integration 
of design, process selection, and material selection has also been proposed, with the high-level 
overview of the framework presented in Figure 2-22 (Stoffels et al., 2018). The three areas of 
consideration are Product Definition, Production Definition, and Material Definition, each sharing four 
phases, Specification Phase, Concept Phase, Component / Detailed Phase, System Integration Phase, 
each with its respective detail. It is emphasised that integration of processes and methods are required 
on a deeper level than merely the integration of organizational units. In their framework, the results of 
each of the individual domains are evaluated together in the integrated phases. This allows for 
consideration of all requirements as well as the interactions between the individual domains (product, 
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process, and material) with the aim of converging to an appropriate solution. Kaspar et al. (2018) 
demonstrated this approach for a comparative assessment in terms of technical, economic and 
ecological criteria, of AM to conventional manufacturing methods in the early phases of concept 
development. 
 
Figure 2-22: Overview of IPPE Framework (Stoffels et al., 2018) 
 
Whereas the preceding frameworks aim at integrating AM into the product development and 
manufacturing process chains, a focus on the integration of LPBF with detailed aspects of different 
disciplines does not yet appear to be formalised. Nonetheless, in the seeming dearth of interdisciplinary 
frameworks aimed specifically at LPBF for drug delivery applications, analogies can be drawn to 
frameworks aimed at integrating different organisational entities within a product or process 
development cycle for deriving the framework for this study. 
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Krehmer et al. (2009) presented a process model developed through extensive research collaboration 
(FORFLOW) by four universities in order to guide a multidisciplinary product development process. 
The general design of their FORFLOW-process is presented in Figure 2-23. It contains three levels, 
each containing a number of steps. The first prescribes the six main steps to be executed in a 
recommended order with more detailed steps in Level 2 for each step in Level 1. Level 3 contains all 
the steps required, to satisfy the respective step in Level 2. These steps are situation specific with 
regards to both their details and execution order. It is based on an integrative approach for systems with 
high complexity and identifies the following challenges, “integration of mechatronic aspects”, 
“situation-specific process planning”, “integration of design iterations”, “integration of lessons 
learned”, “supporting aspects of Design for X (DFX)”, “support of CAx-aspects”, “multi-level 
safeguarding” and “integration of simultaneous and concurrent engineering”. This model specifically 
highlights two important aspects, the documentation of lessons learned from iterations, regarding them 
as learning opportunities for improvement rather having than an exclusively negative impact on project 
time and cost, and the parameterisation of a search space to aid engineers in the finding of relevant 
information, especially in early development phases when they do not necessarily know what they are 
searching for. Here, the search space refers to organisational data, but this can be extrapolated to 
information search within literature. Thus, the question becomes how to reduce the time spent in 
finding information when the “knowledge does not yet exist” and the search space is exploratory. 
 
 
Figure 2-23: Integrated design oriented framework for resource selection in AM (recreated from 
Krehmer et al., 2009) 
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This framework, however, seems to mostly consider conventional manufacturing and assembly 
processes with an emphasis on mechatronic systems embedded in modern products. The integrative 
approach, aiming at different disciplines, both technical and organisational, serves as a strong 
foundation, based on established theories (V-Modell XT, process models from Pahl and Beitz (1988), 
and VDI guidelines), which can be incorporated in the derivation of the framework in this study (VDI, 
1993; Broy & Rausch, 2005). 
 
Eigner et al. (2016) presented an interdisciplinary framework to integrate information and data of 
different disciplines for the development of cybertronic (mechatronic system which interfaces with 
computer software in order to automate its behaviour based on data collected and communication with 
other systems) systems termed the mecPro
2
 model framework. Derivation of the framework considered, 
among other, discipline specific frameworks from mechanical design, systems engineering, and 
software development from which they concluded that typically frameworks share four main phases 
termed RFLP, requirements, function, logical system element (principle solutions and preliminary 
layouts), and physical element (definite layouts and product documentation). The abstract structure of 
the level based framework is presented in Figure 2-24.  
 
 
Figure 2-24: General structure of level based mecPro
2
 model framework (recreated from Eigner et al., 
2016) 
 
The “Detail” axis refers to the gathering of information without limiting the solution space. When 
further detailing without concretization is not possible, a transition is made to a deeper level of the 
framework on the “Concretization” axis. The “Variation” axis indicates that concretization of a solution 
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boundaries within which the system is analysed. The functional level aims at a solution-neutral 
description of the required functionality within the specific context. The principle solution level 
indicates the investigation of technical aspects which could enable the functionality. In this level, 
solution variants should be evaluated both individually with regards to a specific function as well its 
capability for integration with function structures within the specified context. The technical solution 
level dictates the full concretization of the solution (Eigner et al., 2016). 
 
Whereas the previous models address integration of different disciplines or organisational entities, the 
positioning of additive manufacturing knowledge (AMK) is not specifically addressed. Laverne et al. 
(2017) proposed a model for the integration of AMK in the conceptual and embodiment design phases. 
The aim in their work was to improve the creativity and innovation potential of the solution space 
through reducing restrictive thoughts and self-censorship within designers during the early 
development stages. In view of this a Design with X (DWX) perspective was linked with a DFAM 
perspective. The final model is presented in Figure 2-25 with the DWX component bordered by the red 
dashed line and the DFAM component bordered by the blue dashed line. The diamond shapes represent 
divergence (widening from left to right) and convergence (narrowing from left to right) both within the 
individual processes and the overall model. The DWX approach aids to widen the solution space for 
originality and innovation in concept generation whereas the DFAM approach provides necessary 
guidelines for convergence towards manufacturable designs (Laverne et al., 2017). A series of 
experiments performed with both experienced and inexperienced AM users elucidated the requirements 
regarding the timing, media, and content with which to introduce AMK as the introduction of too much 
AMK too early not only quickly becomes overwhelming, but it can also restrict the width of the 
divergence process within the initial solution search space. This combination of DWX and DFAM with 
the timed introduction of AMK is termed by Laverne et al. (2017) as Design with Additive 
Manufacturing (DWAM).  
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Figure 2-25: DWAM model for conceptual and embodiment design phases (recreated from Laverne et al., 
2017) 
 
Building on the DWAM framework, Segonds (2018) proposed a five-step modular framework termed 
Design by Additive Manufacturing (DBAM), presented in Figure 2-26. This framework integrates 
DWAM (which integrates DWX and DFX) with Creativity through Additive Manufacturing (CTAM) 
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Figure 2-26: DBAM framework for enhancing innovation (recreated from Segonds, 2018) 
 
DBAM aims to address three main shortcomings of existing DFAM, DWAM and CTAM frameworks 
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standardisation due to fragmented and independent development of DFAM, DWAM and CTAM 
frameworks, and a lack of attention to the creative phases. It is divided into 5 main steps, Knowledge 
Synthesis, Product Specification, Concept Generation, Design and Evaluation, and Control, each with 
a number of sub-steps including iterative processes where applicable. In the Knowledge Synthesis step 
the aim is to study and apply the identified required knowledge related to the product and the AM 
process. The Product Specification phase strives to precisely define the product through specifying the 
requirements. During Concept Generation the DBAM framework encourages the use of CTAM 
methods as presented by Rias et al. (2016). The Design and Evaluation step ensures the generated 
concept is AM feasible and here specific DFAM guidelines (DFAM in the strict sense according to 
Kumke et al. (2016)) and optimisation methods should amount to the fabrication of the physical 
prototype. The control step is intended for quality assurance and data capturing during design and 
manufacturing. The DBAM framework has been demonstrated with an optronic part. Through 
utilisation of the framework a component consisting of 5 parts and performing 16 functions has been 
consolidated to a single part performing 20 functions (Segonds, 2018). In relation to the DBAM 
framework, this study aims to build further on the concept by specifically aiming at integrating 
paradigms of different frameworks towards an effective, but generalizable LPBF-centred framework 
for enabling drug delivery. 
 
The frameworks discussed above form a basis from which the high level framework for this study was 
derived. The reviewed frameworks, together with the identified established methods for conventional 
design and manufacturing processes, were used as a theoretical base from which the framework for the 
application case of this study was derived.  
2.5 Conclusion 
Four main areas related to the interdisciplinary problem solving in the application of LPBF for enabling 
local drug delivery from cementless hip stems were addressed in this chapter. Issues regarding 
infection in THA were discussed. The importance of addressing the problem of infection was 
emphasised by providing an overview of its devastating effects on the patient’s quality of life as well as 
on the medical and financial resources required for its treatment. To gain a basic understanding of the 
infection process and the current treatment procedures, microbial infection and specifically biofilm 
formation were discussed, providing information on why established PJI can be such a challenge to 
eradicate. A need exist for the development of novel drug delivery strategies that can be used both in 
treatment and prophylaxis applications. 
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Secondly, local drug delivery strategies in clinical use as well strategies in development were briefly 
reviewed. It was demonstrated that a large research gap currently exists between the development of 
local drug delivery strategies based on external conditioning of the implant surface and the 
development of strategies focusing on the utilisation of internal reservoirs. This gap can be addressed 
by the application of LPBF for the fabrication of implants with internal reservoirs. 
 
Thirdly, the LPBF process was reviewed in the context of processing Ti6Al4V ELI which is used to 
manufacture cementless hip stems. Several process parameters exist that affects part quality produced 
with LPBF, with many of these parameters hard to control. Therefore the main user controllable 
parameters were identified as laser power, scanning speed, and hatch spacing. A criterion often used 
that consolidates these parameters is the VED. When approached with caution, due to its aliasing and 
simplified nature, this criterion can provide valuable insights regarding the effects of the main process 
parameters to resulting part density. Specifically, the use of VED in attempts to optimise process 
parameters with respect to resulting part porosity has received much focus in research. Tailoring of the 
LPBF process parameters to induce porosity for the production of permeable structures however, is an 
identified area with little publically available research data. This study therefore contributes to the 
literature by developing a process window within which permeable structures can be produced in 
Ti6Al4V ELI through LPBF. Although the LPBF technology allows for great design freedom, process 
and machine specific limitations do exist and need to be respected to ensure a manufacturable design. 
This study contributes to the application cases of LPBF by demonstrating how one of these limitations 
could be overcome to enable the direct integration of permeable and dense components with an in-
process assembly method. 
 
Fourthly, to build a theoretical base for the derivation of an LPBF-centred interdisciplinary problem 
solving framework for the application case of this study, selected frameworks from literature were 
reviewed. These frameworks span across different disciplines and application areas namely, established 
design and product development methods, AM and MAM specific, IPPD, IPPE, and multidisciplinary 
product development in the context of mechatronic systems. This study contributes to the literature by 
building on these frameworks to derive a new interdisciplinary LPBF-centred framework for enabling 
drug delivery from cementless hip stems. 
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3. High-Level LPBF-Centred Interdisciplinary Framework 
The developed framework consists of three parts namely, an overall procedural approach for 
interdisciplinary problem solving, a perspective from which the problem solving process was 
approached, and tools for ensuring integrated solution concepts. The framework highlights the 
importance of structured LPBF knowledge for integrated conceptual and embodiment design phases to 
foster creativity and innovation. To derive the high-level framework, analogies were drawn to the 
existing frameworks discussed in Section 2.4 in the abstract domain and concretised with regards to the 
specifics of the application case in this study.  
3.1 Positioning of Framework Application within Product Life Cycle Phases 
The application area of the framework in this study mainly focuses on the prototyping stages of a 
traditional product life cycle (PLC), indicated with the dashed line in Figure 3-1. Although the 
framework is intended to be sufficiently generic for tailoring to different applications, in this study it 
mainly concerns the design and prototype manufacturing phases. The positioning in Figure 3-1 
therefore marks the boundaries of the scope for application of the developed framework in this study 
within the context a traditional PLC representation (Chen et al., 2009; Ali et al., 2019). 
 
 
Figure 3-1: Positioning of framework (indicated with dashed line) within PLC phases, (adapted from 
Chen et al., 2009; Ali et al., 2019) 
 
Since the framework falls within the design and manufacturing phases of the PLC, the approach is 
mainly focused on a theoretical background within these areas as discussed in Section 2.4. The main 
areas requiring an LPBF-centred interdisciplinary integration were identified based on the overall 
problem of bacterial colonisation of medical implant surfaces and the concept of local drug delivery 
through utilising the bulk of the implant itself as a reservoir. These areas also derive from the structure 
of the literature reviewed in Chapter 2. The areas are, pathogen, drug, drug delivery vehicle, LPBF 
process, LPBF materials, post processing, and design constraints. These areas form the main thematic 
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elements of the framework which are to be integrated through the perspective of an LPBF knowledge 
base, since this is the main generative component for physical prototype realisation.  
3.2 High-Level Framework 
The entire framework consists of three parts, an overall interdisciplinary problem solving framework, 
an LPBF-centred perspective, and tools for ensuring integrated solution concepts. The high-level 
interdisciplinary problem solving framework for developing an integrated LPBF process chain for drug 
delivery is presented in Figure 3-2. The framework, with its structure based on the VDI 2221 (1993), 
consists of five levels, each with the aim of an integrated outcome for input to the following level.  
 
In the first level, an overall problem is identified. This problem is decomposed in the second level into 
partial problems according to the disciplines involved and structured to ensure an understanding of the 
various aspects and required knowledge areas of the problem. The expected communication 
requirements between the partial problem areas should also be defined. In the third level, the partial 
problems are detailed into single problems. An essential factor within this level is the maintaining of 
communication between single problems within a partial problem as well as between the partial 
problems across all discipline specific areas. For example, details regarding a drug and drug delivery 
vehicle need to communicate not only in relation to each other and pathogen to ensure activity of the 
released drug molecules, but also with geometry and material of the reservoir to be manufactured. Thus 
the outcome of this level in the form of single solutions should also bear consensus before proceeding 
to the recomposition of the individual problem solutions towards an eventual overall solution. The 
partial solution recomposition takes place in the fourth level. Here possible interlayer iterations may be 
necessary, as insights obtained during individual and partial solutions may reveal that an effective 
integrated understanding of the partial problems was not adequately achieved during the second level. 
If consensus on the partial solutions is reached, the overall solution can be assembled from the partial 
solutions in the final layer and evaluated for its efficacy. Again here, interlayer iterations may occur 
which would indicate that the overall problem identified is not solved, and thus need to be redefined.  
 
This systematic process is generic for application regarding the problem complexity. That is, for 
complex problems, the tool could also be applied within partial problems to further decompose them 
within a certain identified discipline. When a problem is decomposed into its most basic form as a 
single problem, the dashed levels are redundant and can collapse to directly go from overall problem to 
overall solution. 
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Figure 3-2: High level overall interdisciplinary problem solving framework 
 
In the context of this study, it is important that the perspective of integration be rooted within the LPBF 
process. This aims to aid in exploiting the potential benefits of LPBF while avoiding unrealistic 
solution concepts. To graphically present this perspective in Figure 3-3, satellites representing 
discipline specific knowledge areas are arranged around an LPBF knowledge base for integration 
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For the specific application of this study, the main high-level disciplines identified are Microbiology, 
Polymer Science, and Manufacturing Engineering. Albeit Manufacturing Engineering in the context of 
LPBF can be regarded as multidisciplinary with regards to the four identified satellite areas, LPBF 
process and machine, materials, post processing, and geometry, it is regarded here as a single high-
level discipline for simplicity. The satellite areas are positioned to intersect with the LPBF-centred 
process chain. This indicates that certain ‘knowledge packages’ are required from each of the satellite 
areas and each of the satellite areas requires a certain LPBF ‘knowledge package’. Communication 
takes place both to and from each of the contributing satellite areas and relevant knowledge is 
consolidated for decision making in the integrative space in the centre.  
 
Building on the overall framework and perspectives, high level systematic tools are derived from the 
IPPD trade-offs representation (Figure 2-18(b)) and the DWAM and DBAM knowledge package 
proposition (Figure 2-25 and Figure 2-26). The aims of these tools are to ensure effective integration 
and to promote creativity and innovation during the project. These tools are indicated under the 
“Integrated Solution Concepts” heading in Figure 3-3.  
 
The entire high-level framework in Figure 3-3 is thus structured as three main parts, an overall problem 
solving procedure which guides the user with process steps, a perspective approach which emphasises 
the need for integrated knowledge packages from a LPBF-centred view, and tools to aid in creativity 
and innovation through the beneficiation of trade-offs and structured integrated knowledge packages. 
 
The IPPD-based trade-off and integration potentials tool (refer Figure 2-18) is presented in Figure 3-4. 
The right hand side represents the processes related to the decomposition of the problem into single 
problems and the left hand side represents the processes of recomposition of solutions towards an 
overall solution. The arrow connecting “Overall Solution” and “Problem Definition” represents the 
evaluation of the solution in terms of the actual problem defined. The addition of integration potentials 
within each of the five levels of the overall problem solving framework is intended to strengthen 
interdisciplinary communication, collaborative work and skills development, and creativity and 
innovation. For example, active collaboration between parties during testing phases could lead to more 
efficient utilisation of in-house resources (example presented in Section 4.2), which might otherwise be 
overlooked due to insufficient communication. 
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Figure 3-3: High-level interdisciplinary framework for developing an integrated LPBF process chain for drug delivery 
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Figure 3-4: Systematic procedure for integrative decomposition and recomposition of problems and 
solutions 
 
For the trade-offs and potentials to be identified and evaluated, a certain amount of knowledge is 
required from each of the satellite disciplines in Figure 3-3 and each of the satellite disciplines requires 
a certain amount of LPBF knowledge. This is demonstrated in the DWAM/DBAM-based (refer Figure 
2-25) tool in Figure 3-5. The triangular shapes represent divergent processes when widening from left 
to right and convergent processes when narrowing from left to right. The five levels of the overall 
framework are represented here as a linear process, each encompassing divergent and convergent 
phases. The required knowledge for each phase, termed Integrated Knowledge Package (IKP) is 
indicated with the external input arrows. Also indicated in the tool is the changeover point from an 
overall divergent (decomposition) to a convergent (recomposition) process. The IKPs are ideally 
intended to streamline the processes within the five levels by, amongst others, provide users with 
sensible boundaries within the solution space regarding the different disciplines while aiming to avoid 
restrictive thoughts which may reduce the creativity and innovation within the divergent processes. 
This is also a bidirectional communication process, as not all the interactions, trade-offs, or potentials 
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historical data and a general knowledge database is limited. Subsequently, when new knowledge is 
generated during the problem solving process it is communicated to the IKPs. 
 
Figure 3-5: Interaction of integrated knowledge packages with divergent and convergent processes during 
problem decomposition and recomposition 
 
As indicated in Figure 3-5, IKP’s should be available at the required time points during the problem 
solving process. In order to optimise the content of each IKP, extensive experimentation and iterations 
are required which is beyond the scope of this study. Rather, the focus in this study is on the early 
identification of the different knowledge areas which would form part of IKPs. It is argued that for an 
integrated process chain development, a basic understanding of each IKP should be shared by the 
involved parties.  
 
The identified knowledge areas, based on the literature reviewed in Chapter 2, is presented in Table 3-1 
with respect to the three main identified disciplines in Figure 3-3. In view of the paucity of historical 
data for the application of this study, it could be expected that optimised IKPs would not be structured 
from the outset. Therefore, an emphasized component during iterations is the necessity of data 
capturing regarding lessons learned and improved IKP structuring. For example, in Chapter 7 it is 
shown that LPBF can be used to induce different levels of porosity in Ti6Al4V ELI thin wall 
components and subsequently release vancomycin with different diffusion profiles. This can be 
regarded as the generation of an IKP regarding material, LPBF process, drug formulation, and drug 
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Table 3-1: Summary of Identified disciplines, satellite topic, and required knowledge areas for process 
integrated LPBF-centred process chain development 
Identified Discipline Satellite Topic Required Knowledge Areas 
Microbiology Pathogen  Size and key morphological features  
 Minimum inhibitory concentration for 
selected drug 
 Adhesion to surfaces and biofilm 
formation 
Microbiology / Polymer 
Science 
Drug  Target pathogen 
 Molecular weight 
 Chemical structure 
 Physical properties 
 Chemical properties 
 Stability 
 Antimicrobial activity 
Polymer Science Drug delivery 
vehicle 
 Material 
 Drug compatibility 
 Biocompatibility 
 Biodegradability 
 Polymerisation reaction (temperature) 




 Drug release profile 
Manufacturing Engineering Process and 
machine 
 Build envelope 
 Build chamber properties 
 Laser properties and parameters 
 Powder bed properties and parameters 
 Powder coater properties and 
parameters 
 Machine properties and parameters 
 Materials  Biocompatibility 
 Melting and solidification properties 
 Relevant material properties 
 Post processing  Post process details 
 Jigs and fixtures 
 Effects on relevant material properties 
 Geometry  Project defined constraints 
(organisational) 
 Manufacturability 
 Post processing 
 Accuracy 
 Effects on drug release 
 Effects on relevant material properties 
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3.3 Project Problem Breakdown Structure 
To generate a roadmap for the experimental investigations of this study, the problem was broken down 
according to the high-level framework in Figure 3-2. This problem breakdown structure is presented in 
Figure 3-6 below. Main responsible collaborative parties are indicated by first listing where applicable 
(e.g. MB/IE indicates that MB was the main responsible party for a given problem). The dashed border 
surrounding the respective single problems under the partial problem “Drug formulation” indicates that 
they were executed independently of the development of the cementless implant demonstrator. As 
presented in Chapter 4, these dashed single problems resulted in an independent demonstrator for an 
alternative sustained release formulation for vancomycin. 
 
 
Figure 3-6: Problem breakdown structure 
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4. Sustained Release Vancomycin Drug Formulation 
This chapter addresses the partial problem “Drug formulation” from Figure 3-6, focusing on the single 
problems within the dashed border for the development of a sustained release vancomycin drug 
formulation. It demonstrates an option for loading vancomycin into a cementless implant for sustained 
release. The work was executed collaboratively according to Figure 3-6 and published as a standalone 
research paper (Booysen et al., 2019). Insight was gained for materials selection and procurement 
followed by fabrication of a sustained release formulation, and release testing. The first part relied on 
the study of available literature and the second part on effective collaboration to develop a customised 
setup for release testing. 
4.1 Gaining Insight for Formulation Material Selection 
Insight for material selection was gained through the execution of two tasks. A literature study was 
performed on the use of biodegradable polymers for the encapsulation of vancomycin. It was found that 
PLGA is an FDA approved polymer available in different grades which can be specified to tailor the 
biodegradation rate and subsequent drug release profile. Secondly, a qualitative understanding of the 
polymer erosion and drug release process was gained through a stochastic simulation adopted from 
literature (Göpferich, 1997). 
4.1.1 Sustained Vancomycin Release Formulation  
Vancomycin is a hydrophilic glycopeptide antibiotic produced by the species Streptomyces orientalis 
(Bryskier & Veyssier, 2005). It is targeted against resistant Gram-positive bacterial infections, 
especially MRSA (Mascaretti, 2003). The molecular structure of vancomycin is presented in Figure 
4-1. Due to its chromophores (for example the aromatic carbon rings and carbonyl groups), the 
molecule can be detected and quantified with UV absorption methods. 
 
Figure 4-1: Vancomycin molecule 2D representation 
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A functional, clinically approved alternative for sustained drug release is encapsulation of the drug into 
polymer micro- or nanoparticles (Prajapati et al., 2015). Such a formulation can be suspended in a fluid 
medium and injected into the reservoir structure within the implant (Wang et al., 2011). 
Biodegradability is regarded of high importance, especially as it delivers the entire drug load during 
degradation, eliminates the risk of carrier toxicity, and does not necessitate removal surgery. Figure 4-2 
shows a classification of the various biodegradable polymers used for drug delivery. 
 
 
Figure 4-2: Biodegradable polymers for drug delivery (recreated from Prajapati et al., 2015) 
 
Depending on several factors, drug release can vary from hours to months (Hachicha et al., 2006; Sayin 
et al., 2006). These factors include, among other, the polymer composition and structure, crystallinity, 
its molecular weight, hydrophilicity and other chemical properties related to both polymer and drug, 
and drug distribution (Freiberg & Zhu, 2004). Selection of polymer for vancomycin encapsulation is 
therefore no trivial task. An initial screening from the lists presented in the reviews of Prajapati et al. 
(2015) and Song et al. (2018) was performed based on whether the material is approved by the FDA for 
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A serious disadvantage of natural biodegradable polymers is difficulty in controlling the degradation 
rate whereas synthetic biodegradable polymers can be modified for a wide range of mechanical and 
degradation properties (Song et al., 2018). An important example on the control offered by synthetic 
polymers is the ability to alter the initial burst release and maintain a steady sustained release of the 
remainder of the drug. Burst release of drug is generally attributed to accumulation of drugs at the 
surface and near the surface of the micro- or nanoparticles (Freiberg & Zhu, 2004).  
 
Consider the drug release profiles in Figure 4-3. Both represent the in vitro release of vancomycin from 
a PLGA microparticulate formulation, however, the grades of the PLGA (lactic acid to glycolic ratio 
and average molecular weight), preparation method, resulting particle size, and drug loading conditions 
differ. Both studies evaluated the release over 30 days, but significantly different profiles can be 
observed. A high burst release (> 30% of loaded vancomycin over 24 hours) can be observed in Figure 
4-3(a) with complete release at ~20 days. In comparison, the formulation in Figure 4-3(b) had a well 
suppressed burst release and loaded drug was not yet all released at 30 days. With the possibility of 
combining an antibiotic intraosseous injection or HA gel coating as prophylaxis, it is argued that for 
treatment of PJI the focus should be on reducing in burst release and aim for steady sustained release of 
vancomycin to either prevent or treat PJI from susceptible organisms. 
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Figure 4-3: PLGA encapsulated vancomycin microparticulate formulations with (a) showing burst release 
(PLGA 50:50, 33,000 Da) (Hsu et al., 2018) and (b) showing sustained release with a suppressed burst 
release (PLGA 75:25, 30,000) (Wang et al., 2011)) 
Using the list in Table 4-1 as a point of departure, a literature search has been performed using the 
Scopus database. The objective was to compile a list of peer reviewed publications that encapsulated 
vancomycin in micro- or nanoparticles prepared from FDA approved biodegradable polymers. The 
search string was as follows, “TITLE-ABS-KEY(“POLYMER” AND (“nanoparticles” OR 
“microparticles” OR “microspheres”) AND “vancomycin” AND NOT “chitosan”)”. For each search 
the word “POLYMER” was replaced with the name of the respective polymer including alternative 
spellings or naming conventions (for example “poly(lactic acid)” and “poly lactide” for PLA) where 
relevant. The command “AND NOT “chitosan”” was included to clarify the search results since 
chitosan is not FDA approved for micro- or nanoparticulate drug formulations and several publications 
report on hybridising an FDA approved biodegradable polymer with chitosan (Hu et al., 2013; Li et al., 
2017). The resulting list is included in Table B-1 in Appendix B. 
 
Figure 4-4 visualises the relative number of relevant publications found per biodegradable polymer. It 
is clear that for the encapsulation of vancomycin the vast majority of available literature involved 
PLGA. Furthermore, PLGA dominates a list of commercial biodegradable microspheres presented in a 
review by Prajapati et al. (2015). Given the available historical data, the current market dominance, and 
the objective of material selection rather than investigation or development, PLGA is identified as a 
suitable material for encapsulation and sustained delivery of vancomycin.  
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Figure 4-4: Number of relevant publications of biodegradable polymers from Scopus search 
 
PLGA is available in a wide range of grades. This entails the PLA:PGA ratio, average molecular 
weight or inherent viscosity, and the polymer chain end chemistry (carboxylic acid or ester terminated). 
All these factors significantly influence the biodegradation and release behaviour. These factors are all 
identified as important for consideration during further material specification for vancomycin delivery 
within the framework (Kapoor et al., 2015).  
4.1.2 Gaining Insight into PLGA Erosion and Drug Release 
PLGA is a biodegradable aliphatic copolymer consisting of adjustable ratios of PLA, usually in an 
equal ratio of the poly D-lactic acid (PDLA) and poly L-lactic acid (PLLA) enantiomers, and PGA 
(Makadia & Siegel, 2011). The structure of the polymer is shown in Figure 4-5. Commercial variations 
typically offer either a carboxylic acid or methyl ester end group, indicated by the R in Figure 4-5.  
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PLGA undergoes bulk erosion in aqueous environments through random hydrolysis of ester linkages 
along the polymer backbone (Makadia & Siegel, 2011). This means that degradation happens 
heterogeneously throughout the polymer and the process can be divided into a sequence of four steps 
(Lanao et al., 2013). First the polymer is hydrated as water enters through the amorphous regions and 
disrupts the hydrogen bonds and van der Waals forces, leading to a decrease in the glass transition 
temperature. Second is the initial degradation which involves the cleavage of covalent bonds, 
decreasing the molecular weight of the polymer. Third is the continuous degradation, autocatalysed 
through carboxylic acid end groups, resulting in mass loss by extensive cleavage of the backbone and 
subsequent loss of structural integrity. Fourth is solubilisation where remains (fragments) are further 
cleaved into molecules that are soluble in the aqueous environment (Lanao et al., 2013; Gentile et al., 
2014). The end products of PLGA degradation are lactic acid and glycolic acid Figure 4-6 which are 
processed through metabolic routes and excreted as carbon dioxide and water.  
 
 
Figure 4-6: Hydrolysis of PLGA (recreated from Makadia & Siegel, 2011) 
 
The objective of this section is to develop a basic understanding of the PLGA bulk erosion and drug 
release mechanism through a stochastic simulation approach according to that of (Göpferich, 1997). 
The stochastic model was implemented in MATLAB, with the algorithm code provided in Appendix B. 
For simplicity, the model currently does not take polymer swelling into account. It distinguishes 
between polymer degradation, loss in molecular weight due to hydrolysis of the ester linkages, and 
polymer erosion, mass loss due to diffusion of degradation products out of the polymer matrix. It is 
further based on the assumption that degradation necessarily precedes erosion, and that erosion can 
only proceed by an open pathway to the polymer surface.  
 
A two dimensional (2D) computational grid Figure 4-7 is initialised which represents the polymer 
matrix. The grid size can be altered by specifying different values for the number of elements in the x 
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Figure 4-7: 2D computational grid for simulation of PLGA bulk erosion and drug release 
 
In Figure 4-7, a periodic boundary condition exists on the x-axis, 
 𝑥𝑖,0 =  𝑥𝑖,𝑛𝑥 
1 ≤ 𝑖 ≤ 𝑛𝑦 (4-1) 
 𝑥𝑖,𝑛𝑥+1  =  𝑥𝑖,1 
and a reflective boundary condition is imposed on the y-axis. 
 𝑦𝑛𝑦+1,𝑗 =  𝑦𝑛𝑦,𝑗 1 ≤ 𝑗 ≤ 𝑛𝑥 (4-2) 
Each element (subsequently referred to as pixels) represents a part of the polymer matrix and, utilising 
a greyscale colour map, can be in one of three states, intact (black pixel = 0), degraded (grey pixel = 
0.5), or eroded (white pixel = 1), that is. 
 
 Intact 𝑥𝑖,𝑗 = 0 
1 ≤ 𝑖 ≤ 𝑛𝑦 
1 ≤ 𝑗 ≤ 𝑛𝑥 
(4-3)  Degraded 𝑥𝑖,𝑗 = 0.5 
 Eroded 𝑥𝑖,𝑗 = 1 
 
Described above is the effective erosion and drug release matrix. Other matrices are initialised and 
utilised which communicates and control erosion and drug release processes from the effective matrix. 
These are the polymer state, pixel lifetime, and drug distribution matrices. Interactions between the 
matrices are presented in the schematic below. An additional matrix (not shown in Figure 4-8) is also 
created for visualisation purposes which represents the complete state of the starting polymer matrix 
with respect to crystalline (black), amorphous (grey), and drug (white) pixels. 
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Figure 4-8: Schematic of communication between matrices 
 
First a polymer state matrix is initialised where the indices represent amorphous or crystalline regions. 
Whether a pixel is crystalline or amorphous is determined by a Bernoulli trial in which the probability 
of success is the user specified percentage of the polymer matrix expected to have a crystalline 
structure (Wang et al., 2007). 
 
Once the polymer state is determined, the lifetime for each pixel is determined. It is assumed that 
degradation arrival times follow a Poisson process and is calculated according to Equation 4-4 below 
derived by (Göpferich, 1997), 
 
 
𝑡𝑖,𝑗 =  
1
𝜆𝑖,𝑗𝑙𝑛 (𝑛2)
𝑙𝑛 (1 − 𝜖) (4-4) 
 
where 𝜆𝑖,𝑗  is the degradation rate constant for pixel i,j, 𝑛 is the number of pixels in either x- or y-
direction for a square grid, and 𝜖 is a random variable distributed between 0 and 1 which represents the 
probability that a pixel erodes within the respective time interval (Göpferich, 1997). When the iteration 
time step 𝑡𝑖,𝑗 is reached, the corresponding pixel degrades and turns grey in the effective matrix, unless 
the pixel is already eroded, in which case it remains white. 
 
The drug distribution matrix is initiated according to Bernoulli trials where the probability of success is 
the fraction of drug loading within the polymer matrix. Pixels that represent drugs are set to grey in the 
effective matrix. If a path to the surface exists, the pixel is eroded, which in this case represents release 
of the drug, and said pixel turns white. 
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Currently, the model is in a generic format with regards to the required parameters that would need to 
be determined empirically in order to tailor the model for a specific PLGA grade. These parameters 
include the ratio of crystalline to amorphous structure, arrival rate (𝜆) of bond hydrolysis for the 
respective structures, and the fraction of drug loading. The model currently allows for changing any of 
these parameter settings. The following example aims to demonstrate the simulation program with 
parameter values set to obtain typical profiles witnessed in literature (Makadia & Siegel, 2011). 
 
Firstly, the program uses Bernoulli trials to populate the computational grid (300 x 300 pixels) with 
either crystalline, amorphous, or drug pixels (Figure 4-9). This figure can be used as reference to trace 
back the identity of uneroded pixels at the end of an execution scenario. 
 
 
Figure 4-9: Output matrix of the starting polymer matrix 
 
Based on this matrix, the polymer matrix for erosion, presented in Figure 4-10(a) is created. Since drug 
pixels are assumed to be able to erode on contact with a path leading to the surface, they act as already 
degraded bonds. Black pixels indicate intact bonds and grey pixels degraded bonds. A black pixel 
(intact bond) first needs to turn grey (degraded bond) before it can turn white (erode out of matrix). The 
eroded and degraded bonds are represented in Figure 4-10(b).  
 
Starting Polymer State: Crystalline (black), Amorphous (grey), and Drug (white) 
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Figure 4-10: Pixel matrices representing (a) polymer state at initiation of program and (b) polymer state 
after program execution 
 
In order to trace back the drug pixels to the original distribution, the program outputs both scenarios as 
figures during execution of the program. Represented by the two matrices in Figure 4-11 below are the 







Figure 4-11: Simulated drug distribution (a) at the start of the program and (b) at the end of the program 
 
Starting Polymer Matrix Eroded Polymer after Release Period 
Drug Distribution through Polymer Matrix Drug Distribution after Release Period 
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The resulting degradation and erosion profiles as the average of three executions from the current 
program are presented in Figure 4-12(a) along with the output from that of Göpferich (1997) (Figure 
4-12(b) and (c)). Users can specify the amount of times the program should loop. The resulting general 
profile from the MATLAB code appears to be in close agreement with that of Göpferich (1997). The 
degradation profile begins at 1 - Probability(drug pixel) since the drug pixels are assumed to behave as 







Figure 4-12: Degradation and erosion profiles of (a) simulation program, (b) from the simulation of 
Göpferich (1997), and (c) experimentally obtained mass loss profile for Resomer RG 502H (triangles), 
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The erosion profile indicates a percolation threshold effect in bulk erosion. An underlying condition for 
bulk erosion is that the dissolution medium penetrates into the matrix faster than the degradation 
products can diffuse out (Makadia & Siegel, 2011). Several tiny paths for erosion thus develop all at 
once, which lead up to a critical point that when reached, causes large amounts of degraded bonds to 
erode all at once. It is reported in literature that this can occur on smaller scales during the bulk erosion 
process (Duvvuri et al., 2006; Ramchandani & Robinson, 1998), and the stochastic nature of the 
program manages to capture these random occurrences as shown in Figure 4-13. The encircled area 
indicates a period in the program where pixels had not yet a connected erosion path which, when 
coming to existence, creates small erosion bursts within the overall mass erosion. 
 
Figure 4-13: Degradation (black) and erosion (red) from a single program execution 
 
Resulting drug release profiles from the simulation are presented in Figure 4-14(a) and (b). A typical 
sigmoidal profile can be observed which is often reported for drug release from PLGA matrices without 
any additives. This is demonstrated with the profiles reported by (Amann et al., 2010) in Figure 4-14(c) 
and by (Duvvuri et al., 2006) in Figure 4-14(d). Degradation and Release profiles can however be 
difficult to accurately predict due the relatively large amount of possible variables, all adding 
complexity to the process. These include copolymer composition, average molecular weight of the 
chains, crystallinity and glass transition temperature, and autocatalytic effects due to locally reduced 
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Figure 4-14: Drug release profile from (a) single program execution, (b) average of three executions, (c) 
modelled release profiles in literature (key indicates lactic acid to glycolic acid ratio) (Amann et al., 2010), 
(d) cumulative release profile of ganciclovir from Resomer RG 502H in literature (Duvvuri et al., 2006) 
 
A useful result of the model is that it can also give an indication of the effect of drug-polymer ratio on 
time shifts in reaching the percolation threshold. This is demonstrated in Figure 4-15, the average of 5 
program executions where the probability of a pixel being a drug is varied between 0.2 (Figure 4-15(a) 
and (b)) and 0.35 (Figure 4-15(c) and (d)). When taken into consideration that, if drug molecules can 
readily diffuse out of the matrix instead of first degrading into smaller parts, it is likely that the higher 
the drug loading, the quicker the percolation threshold will be reached and subsequently mass erosion 
occurs. This, however, needs to be substantiated with further empirical evidence, but is outside the 
scope of this study. 
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Figure 4-15: Average degradation and erosion (a), average cumulative fractional drug release (b) for a 
drug probability of 0.2, and average degradation and erosion (c) with average cumulative fractional drug 
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Although simplifications in the model most likely impart several causes of inaccuracies, the basic 
profile holds well when compared to literature where PLGA without further modifications has been 
used. At this point it is concluded that the model reasonably captures the bulk erosion and drug release 
process in a simplified form. The model can be further developed and adapted to a specific employed 
formulation by empirical refinement of the model parameters. From here the model can be improved 
through incorporation of specialised function modules such as polymer swelling and time or geometry 
dependent degradation behaviour, thereby defining the lifetime of pixels as a function of time and 
space within the computational grid. Nevertheless it aids in providing a basic level of insight to the 
non-polymer scientist within the context of the interdisciplinary framework into the expected erosion 
and drug release profiles resulting from encapsulation of a drug in PLGA. 
4.2 Vancomycin Encapsulated Nanoparticles Preparation and Release Testing 
Fabrication of vancomycin encapsulation PLGA nanoparticles was performed by the Department of 
Microbiology using an electrospraying preparation method (Figure 3-6). The experimental details 
regarding the preparation and testing of the nanoparticles can be found in Booysen et al. (2019). 
Resomer RG 753 H PLGA was procured from Evonik Nutrition & Care GmbH for nanoparticle 
preparation. Material selection was mainly based on the properties of the polymer regarding 
vancomycin release profiles reported in literature (Wang et al., 2011). The properties are lactic acid to 
glycolic acid ratio of 75:25, inherent viscosity of 0.32-0.44 dl/g which corresponds to a molecular 
weight of roughly 30,000 – 35,000 Da, and non-end capped (carboxylic acid terminated). A field 
emission scanning electron microscope (FE-SEM) image of the PLGA nanoparticles with encapsulated 
vancomycin is presented in Figure 4-16. The mean size of the nanoparticles is 247 nm with a 
polydispersity index (PI) of 0.385. The relatively high PI can possibly be related to the electrospraying 
setup and specifically the flow rate of polymer solution to the spray nozzle (Booysen et al., 2019).  
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Figure 4-16: FE-SEM image of vancomycin encapsulated PLGA nanoparticles 
 
A customised setup was required for release testing of the nanoparticles. Challenges involved the size 
of the nanoparticles and the requirement for simultaneous release testing of several batches which 
enhances testing efficiency. These challenges were addressed through a collaborative effort in which a 
tailored solution was developed using the design freedom within AM. A custom diffusion cell was 
designed using Autodesk PowerSHAPE and manufactured with a commercial fused deposition 
modelling (FDM) Zortrax M200 3D-printer (Figure 4-17). The diffusion cell (Figure 4-17(a)) consisted 
of a press fit assembly of three parts: (1) a frame to fit a 5 kDa molecular weight cut off 
polyethersulfone membrane for the donor reservoir, (2) a foot piece to fix the frame to the buffer 
reservoir with space for a magnetic stirrer bar to enable continuous agitation of the buffer medium, and 
(3) an acceptor reservoir. The assembly (Figure 4-17(b)) was closed off with a cap to reduce 
evaporation (Figure 4-17(c)). Vancomycin release sampling and analysis details can be found in 
Booysen et al. (2019). 
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Figure 4-17: Custom made diffusion cell with (a) CAD model (adapted from Booysen et al., 2019), (b) 
assembled cell, and (c) diffusion cells in release testing with magnetic stirring at 600 rpm 
 
The vancomycin release profile from PLGA nanoparticles is presented in Figure 4-18. Release was 
monitored for a period of 240 h and effective vancomycin concentrations (5 µg/mL) were detected after 
24 h. Importantly, no significant burst release was observed, which confirms the selection of a suitable 
PLGA grade for the objective of steady sustained release. Furthermore, after 10 days, 50% of the total 
vancomycin content was released, which indicates that the formulation can sustain vancomycin release. 
An important finding was a reduction effect of vancomycin encapsulation on the MIC against both S. 
aureus Xen 36 (MSSA) and S. aureus Xen 31 (MRSA). PLGA encapsulated vancomycin had an MIC 
of 1 µg/mL for both strains of S. aureus whereas the MIC of free vancomycin was found to be 3µg/mL 
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Figure 4-18: Vancomycin release profile from PLGA nanoparticles (Booysen et al., 2019) 
 
4.3 Conclusion 
This chapter addressed the single problems for developing a demonstrator formulation for the sustained 
release of vancomycin. Based on the results, the following conclusions were made: 
 PLGA was identified to be the most frequently used clinically approved polymer for sustained 
release 
 A simplified stochastic model has been implemented in MATLAB to aid non-polymer scientists 
in gaining an understanding of the polymer bulk erosion and drug release process 
 Trade-offs regarding the PLGA grade and effects on erosion need to be carefully studied in 
order to select a grade which offers the appropriate potentials for the application 
 Vancomycin can be encapsulated in PLGA through an electrospraying process to yield 
vancomycin encapsulated PLGA nanoparticles 
 An IKP was generated through interdisciplinary collaboration within the single problems 
through the development of a custom experimental setup for vancomycin release testing 
 Release of vancomycin can be sustained for at least 240 h by a PLGA nanoparticle formulation 
while supressing a significant burst release 
 Encapsulation of vancomycin in PLGA reduced the MIC against both S. aureus Xen 36 and 
Xen 31, thereby reducing the total amount of vancomycin required to maintain antimicrobial 
efficacy 
 An IKP on the release considers the fact that therapeutic vancomycin concentrations was 
reached after 24 h and therefore immediate prophylactic availability of vancomycin released 
locally through a cementless hip stem should also be investigated using a low viscosity 
formulation in which vancomycin has high solubility, for example an aqueous vancomycin 
solution 
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5. Inducing Porosity in LPBF for Drug Release 
A study was performed to identify the effects of the key process parameters namely, laser power, 
scanning speed, and hatch spacing, on the resulting relative porosity within Ti6Al4V ELI cylindrical 
specimens. It represents a point of departure in the decomposition process within the overall framework 
for the partial problem of “Enabling drug release from implant reservoir”. The screening study 
provided insight into the effects of these LPBF process parameters from the in-house available 
M2 cusing LPBF machine from Concept Laser GmbH. IKPs generated in this chapter were 
implemented in subsequent experimental designs regarding the production of components with induced 
porosity for drug delivery from a cementless hip stem. 
5.1 LPBF Machine and Material 
Unless otherwise specified, all titanium alloy parts within this study were fabricated using an 
M2 cusing system (Concept Laser GmbH, Lichtenfels, Germany) (Figure 5-1(a)), fitted with a 200 W 
ytterbium fiber laser emitting at 1070 nm wavelength. Gas atomized Ti6Al4V ELI powder (TLS 
Technik GmbH & Co, Bitterfeld-Wolfen, Germany) (Figure 5-1(b)) with a particle size distribution of 
d10 = 25.51 µm, d50 = 37.63 µm, and d90 = 50.47 µm and chemical composition as reported on the 
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Table 5-1: Chemical composition of the Ti6Al4V ELI powder (wt%) 








Balance 6.5 4.5 0.25 0.13 0.08 0.05 0.012 0.005 0.1 0.4 
 
The build chamber was flooded with argon gas prior to the building process to maintain an inert 
atmosphere (oxygen content < 0.1%) and reduce the risk of oxidation. The laser scanning strategy was 
kept constant as the default island pattern throughout all experiments (Figure 5-2). Briefly, the 2D layer 
is divided into islands of 5 x 5 mm resulting in a chessboard-like pattern (Figure 5-2(a)). The islands 
are exposed in a random order. Each island is filled with vectors alternating in direction and 
neighbouring islands are oriented with their fill vectors perpendicular to each other (Figure 5-2(b)). To 
reduce compounding effects of exposing vectors directly on top of each other, each subsequent layer 
the island pattern is moved by 1 mm in both the x- and y-direction (Figure 5-2(c)) (Carter et al., 2014). 








Figure 5-2: Default island scanning strategy with (a) a layer being exposed inside the building chamber, 
(b) a schematic of the islands and fill vector directions, and (c) a schematic of the pattern shift between 




Layer 2 Layer 3 Layer 4 Layer 5, …
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5.2 Influence of Key Parameters - Experimental Setup and Design 
5.2.1 Process Parameter Variation 
The values of the parameters were varied according to a DoE approach with a spherical central 
composite design (CCD) with star points at a distance of ±√𝑘 (𝑘 is the number of factors) at a level of 
significance (α) of 0.05, using Design Expert (Statease) statistical software. Three centre points were 
included as well as an extra point which represents the machine manufacturer’s default parameters for 
Ti6Al4V ELI, which are 100 W laser power, 600 mm.s
-1
 scanning speed, 0.7d µm hatch spacing, where 
d is the aperture which is specified in the control software as 150 µm, yielding a default hatch spacing 
of 105 µm. The layer thickness was kept constant at 30 µm. The manufacturer specified parameters are 
henceforth referred to as ‘default parameters’. The CCD parameter variations are presented in Table 
5-2. 
 
Table 5-2: Spherical CCD DoE investigation of influences of key parameters on part porosity 










1 80 1215 130.95 16.76 5.35 
2 122.5 825 105 47.14 0.28 
3 80 435 79.05 77.55 0.78 
4 165 435 79.05 159.95 1.28 
5 80 1215 79.05 27.76 2.58 
6 165 435 130.95 96.55 0.89 
7 165 1215 79.05 57.26 0.18 
8 196.11 825 105 75.46 0.46 
9 122.5 825 105 47.14 0.44 
10 122.5 825 60.05 82.42 0.28 
11 122.5 825 105 47.14 0.30 
12 122.5 825 149.95 33.01 0.53 
13 48.89 825 105 18.81 1.52 
14 122.5 435 130.95 46.81 0.28 
15 122.5 1500.5 105 25.92 1.24 
16 165 1215 130.95 34.57 0.92 
17 122.5 149.5 105 260.13 0.72 
18* 100 600 105 52.91 0.26 
* Manufacturer specified default parameter set 
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5.2.2 Relative Porosity Measurement 
Relative porosity of cylindrical specimens was analysed non-destructively at the computed tomography 
(CT) unit of the Central Analytical Facilities (CAF) at SU. A General Electric Phoenix VTOMAX L240 
micro computed tomography (µCT) machine was used with standardised data acquisition parameters as 
specified by du Plessis et al. (2017). The scan resolution was set to a voxel size of 20 µm. Porosity 
analysis was performed by the CAF CT-unit using VGStudio Max 2.1 (Volume Graphics). Received 
CT data were reviewed, and images created using the viewer version of the analysis software, myVGL. 
5.3 Influence of Key Parameters - Results and Discussion 
The fabricated specimens are presented in Figure 5-3. Obtained relative porosity (prel) values are 
included in Table 5-2 (refer Section 5.2.1 above).  
 
 
Figure 5-3: Cylindrical specimens for porosity measurement 
 
Three dimensional reconstructions of the porosity from the µCT analyses for selected runs 1, 4, and 7 
are presented in Figure 5-4 with the reconstructions from the other runs available in Figure C-1 in 
Appendix C. The selected runs represent each of the three melting zones as identified in Section 2.3.4, 
which are insufficient energy input (Run1 in Figure 5-4(a)), stable melting (Run 7 in Figure 5-4(b)), 
and excessive energy input (Figure 5-4(c)).  
 
Large pores, irregular in shape with some interconnectivity, can be seen in Figure 5-4(a). The total 
relative porosity was the highest for this run with 5.35%. The observations are typical for porosity 
which results from insufficient melting of the metal powder due to a lack of energy input per unit 
volume per unit time (Kasperovich et al., 2016; Mierzejewska, 2019). In the bottom right of Figure 
5-4(a), an enlarged area of the exposed vectors is presented. Several discontinuities in the scan vectors 
can be identified confirming insufficient energy input to maintain a stable melt pool for the formation 
of continuous tracks.  
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VED = 16.76 J.mm-3 
prel = 5.35% 
Run 7 
VED = 57.26 J.mm-3 
prel = 0.18% 
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Figure 5-4: Porosity from µCT analyses for (a) Run 1, (b) Run 7, and (c) Run 4 
 
The observed discontinuities appear at random within the exposed vectors. The default island scanning 
strategy and interlayer islands position shift (Figure 5-2) promotes the spatial randomisation of these 
discontinuities. This is corroborated by the relatively even distribution of the pores throughout the 
entire specimen volume and pores do not appear to be concentrated in certain areas. This is an 
important observation regarding the induction of porosity for permeability. A spatially independent 
distribution of process induced pores throughout the specimen volume simplifies design and LPBF 
building setup aspects (for the specific LPBF machine in question) with regard to potential effects on 
pore distribution as a result of part geometry and build orientation.  
 
Figure 5-4(b) presents the run with the least porosity (0.18%). From the enlarged area on the bottom 
right, it can be observed that the exposed vectors are characterised by smooth, continuous tracks. It is 
likely that a stable melt pool was formed and the main cause of porosity is unlikely to be strongly 
related to the values of the investigated process parameters. It would be more likely to originate from 
the laser exposure pattern and control system (Hagedorn-Hansen et al., 2017). For example, with the 
default scanning strategy the 5 x 5 mm islands are shifted 1 mm in the x- and y-directions after each 
layer (Figure 5-2). These 1 x 1 mm layer shifts are clearly visible in Figure 5-4(b) (indicated with red 





VED = 159.95 J.mm-3 
prel = 1.28% 
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dashed square). It is also evident that when observing the distribution of the pores throughout the 
reconstructed specimen volumes that exceptionally few pores were detected in the volumes contained 
within this shift pattern. This supports that the pores were more likely a result of the scanning strategy 
than unstable melting due to the laser processing parameters. Even though these pores are relatively 
small (yielding a relative porosity of 0.18%), it should be noted as a hard-to-control factor specifically 
for the default scanning strategy of the LPBF system in question that contributes to total part porosity.  
 
Figure 5-4(c) presents a case of excessive energy input. The smaller overall pore sizes and near 
spherical morphology is corroborated by the literature which relates these pores mainly to the effects of 
gaseous artefacts produced by the high temperatures reached during processing (Gong et al., 2014). 
The spherical morphology can be observed in the bottom view of the 3D reconstructed view as well as 
the 2D CT slice in the bottom right of Figure 5-4(c). The pores are distributed more evenly throughout 
the specimen volume. An effect related to the scanning pattern can however be identified with pores 
concentrated on the apexes (shape of apex visible in Figure 5-9(b)) of the exposed vectors (example 
encircled). At these apexes the laser slows down and accelerates, increasing the dwell time. This in turn 
increases the effective input energy density and subsequently the maximum temperature reached in 
these areas (Martin et al., 2019). 
 
Prior to DoE model fitting analysis, the data were explored with the compilation of a correlation matrix 
and scatter plots. The correlation matrix, presented in Table 5-3, is a useful tool in exploring the 
influences of independent variables on the response within the obtained data. Correlation magnitude 
and direction are indicated with the colour of the corresponding cell with darker colours representing 
stronger correlation. Positive correlation is indicated with red shades and negative correlation with 
purple shades.  
 
Table 5-3: Correlation matrix for relative porosity investigation input factors and responses 
 Run ID P (W) v (mm.s
-1
) h (µm) prel (%) VED (J.mm
-3
) 
Run ID 1.000 -0.038 -0.076 0.261 -0.417 0.115 
P (W)  -0.038 1.000 0.020 0.000 -0.371 0.310 
v (mm.s
-1
) -0.076 0.020 1.000 0.000 0.370 -0.696 
h (µm) 0.261 0.00 0.00 1.000 0.160 -0.234 
prel (%) -0.417 -0.371 0.370 0.160 1.000 -0.220 
VED (J.mm
-3
) 0.115 0.310 -0.696 -0.234 -0.220 1.000 
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From Table 5-3 it can be observed that the relative porosity is negatively correlated with laser power, 
positively correlated with scan speed, and slightly positive correlated with hatch spacing. Furthermore, 
the correlation of relative porosity with hatch spacing is less than half of that with laser power and 
scanning speed. The resulting porosity is negatively correlated with VED, suggesting that pores 
resulting from insufficient energy input have a larger total effect that pores resulting from excessive 
energy input. This is in accordance with the images in Figure 5-4 and Figure 2-15 (Mierzejewska, 
2019). Within the range of values investigated for the variables, it is also evident that scanning speed 
had the largest influence on the resulting input VED, which is not unexpected given the relatively large 
range compared to that of laser power and hatch spacing. 
 
The obtained relative porosity data ranged from 0.18 – 5.35%. Figure 5-5 presents a plot of relative 
porosity against applied VED. A similar plot for relative porosity versus VED has been reported in 
literature by Hassanin et al. (2016) for LPBF of Ti6Al4V, although the ranges for the variables that 
were investigated differ. This entails a reduction in relative porosity with increasing VED up to a 
certain range (around 57.26 J.mm
-3
) within which the relative porosity reached a minimum. Beyond 
this range, the relative porosity increased with further increase in applied VED. This trend is typically 
observed for the transitions from insufficient melting, to full melting, to overheating (Gong et al., 2014; 
Hassanin et al., 2016; Kasperovich et al., 2016). These transitions are also reflected by the difference in 
visible pore morphology in the 2D CT-scan slices included in Figure 5-5 for Runs1, 7, and 17. 
Although a similar spike in porosity to that of Run4 (VED of ~160 J.mm
-3
) compared to Run17 (VED 
~260 J.mm
-3
) has been reported by Hassanin et al (2016) where VEDs of 142.86 and 200 J.mm
-3
 
resulted in relative porosities of 0.76 and 0.34 % respectively, potential reasons for this were not 
discussed. A potential reason could be the increase in effective VED at the scan track turning point. 
Figure 5-6 presents an estimate on the effective VED as the laser decelerates. In both studies, the lower 
static VED resulted in a higher effective VED at the scan track apex. The higher laser power and lower 
hatch spacing of Run4 (165 W, 80 µm) to that of Run 17 (123 W, 105 µm) thus resulted in a higher 
localised effective VED at the apex of the scan track which may have led to a higher concentration of 
pores observed at these locations (Figure 5-4c) (Run17 3D reconstruction available in Appendix C) 
which contributed to a higher overall relative porosity (Martin et al., 2019). 
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Figure 5-5: Scatter plot of the relation of relative porosity to the input VED 
 
 
Figure 5-6: Estimated effective VED at scan track apex 
 


























































Scanning Speed, (mm.s-1) 
Run4 VED 159.95 J.mm^-3
Run17 VED 260.13 J.mm^-3
Hassanin et al. (2016) VED 142.86 J.mm^-3
Hassanin et al. (2016) VED 200 J.mm^-3
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The correlation matrix (Table 5-3) suggests that the individual factors investigated, within the 
respective ranges, are not equal in their influence on the resulting relative porosity and further 
processing of the data is required. However, the ratio of the maximum to the minimum porosity is 
29.72, which is greater than 10, and thus indicates that the data may need to be transformed in order to 
perform a multiple linear regression analysis (Stat-Ease, 2020). The software diagnostics detected that 
the residuals were not normally distributed and suggested a natural log transformation.  
 
The residuals for untransformed data were detected to be a function of the magnitude of the predicted 
value, presented in Figure 5-7(a). The normal plot of the residuals for the untransformed data (Figure 
5-7(b)) confirmed this departure from the normality assumption, which underlines the Analysis of 
Variance (ANOVA) analysis method (Montgomery & Runger, 2007). Transformation of the data with 
the natural logarithm removed the observed trend in the residuals (Figure 5-7(c)) and imparted linearity 
to the residuals along the normal plot of residuals (Figure 5-7(d)). Therefore, the subsequent analysis 
for this data set in Design Expert was performed with the application of a natural logarithm 
transformation to the data. 
 
A quadratic model was fitted to the transformed data with coefficients estimated by multiple linear 
regression analysis (Myers & Montgomery, 2002). The general form of the three factor quadratic 
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Figure 5-7: Diagnostic plots for (a-b) raw data and (c-d) transformed data 
 
 𝑙𝑛(𝑌) =  𝛽0 + 𝛽1𝑋1 +  𝛽2𝑋2 + 𝛽3𝑋3 +  𝛽11𝑋1
2 + 𝛽22𝑋2
2 +  𝛽33𝑋3
2
+ 𝛽12𝑋1𝑋2 +  𝛽13𝑋1𝑋3 +  𝛽23𝑋2𝑋3  
(5-1) 
 
Table 5-4: ANOVA results for quadratic model of the effects of laser power, scanning speed, and hatch 
spacing on the relative porosity 
Source Sum of Squares df Mean Square F-value P-value 
Model 13.10 9 1.46 18.55 0.0002 
A-Laser Power 1.61 1 1.61 20.54 0.0019 
B-Scanning Speed 0.7923 1 0.7923 10.09 0.0131 
C-Hatch Spacing 0.3084 1 0.3084 3.93 0.0827 
AB 4.77 1 4.77 60.77 <0.0001 
AC 0.3055 1 0.3055 3.89 0.0840 
BC 1.76 1 1.76 22.38 0.0015 
A
2
 1.95 1 1.95 24.90 0.0011 
B
2
 2.37 1 2.37 30.16 0.0006 
C
2
 0.2380 1 0.2380 3.03 0.1198 
Lack of Fit 0.5093 6 0.0849 1.43 0.4663 
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The low P-value in the first row indicates that the model is significant. This is also supported by the 
non-significant lack of fit of the model and the adjusted R
2
 value of 0.903. The analysis is described 
here in reference to the objective of identifying the significance of the factors, within their respective 
investigated ranges, on the resulting porosity. More detailed diagnostic and surface plots are presented 
in Figure C-3 in Appendix C. The P-values in Table 5-4 indicate that laser power and scanning speed 
are both significant factors in the model, with their interaction (AB) of particularly high significance. 
Hatch spacing is detected as a borderline insignificant factor. Furthermore, the interaction of hatch 
spacing with laser power (AC) is also not detected as significant, but the interaction of hatch spacing 
and scanning speed (BC) is detected as significant. When initially only considering the single factors 
and their respective F- and P-values from the ANOVA significance test, it is suggested that laser power 
is the most important factor, followed by scanning speed, and then hatch spacing, subject to the 
investigated ranges.  
The model equation is presented in both coded and actual factors in Table 5-5. In coded form, the fitted 
equation is useful for evaluating the relative impact of individual factors on the response by 
comparison of their coefficients. The equation in terms of the actual factors can be applied for 
predictions about the response for the given levels of each of the factors.  
 
Table 5-5: Equation of the fitted quadratic empirical model in terms of coded and actual 
Equation in terms of coded factors Equation in terms of actual factors 
                   Ln(prel) =  
                                    - 1.16  
                                    - 0.337       × A  
                                    + 0.236      × B 
                                    + 0.148      × C 
                                    - 0.769       × AB 
                                    + 0.195      × AC 
                                    + 0.469      × BC 
                                    + 0.388      × A2 
                                    + 0.428      × B2 
                                    + 0.134      × C2 
                   Ln(prel) =  
                                      7.64  
                                    - 0.041           × P  
                                    - 3.2 × 10-3    × v 
                                    - 0.096            × h 
                                    - 4.6 × 10-5     × P  × v 
                                    + 1.8 × 10-4     × P × h 
                                    + 4.6 × 10-5     × v × h 
                                    + 2.2 × 10-4     × P2 
                                    + 2.8 × 10-6     × v2 
                                    + 2.0 × 10-4     × h2 
 
From the coded equation, when only regarding the single factor terms (A, B, and C) it is apparent that 
laser power (A) has the greatest effect, followed by scanning speed (B) and, then the hatch spacing (C). 
Overall, however, the interaction factor of laser power and scanning speed has the greatest influence, 
nearly double that of any interaction with hatch spacing. From this initial analysis regarding the 
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ANOVA and coded model equation, it thus appear that the effects of laser power and scanning speed, 
as well as their interaction, on the relative porosity dominates that of hatch spacing within the 
investigated ranges for the respective process parameters. 
Figure 5-8 presents the two factor interaction plots, with the third factor stationary at its high and low 
level. For scanning speed at its low level (black line) and hatch spacing at both its high and low levels 
(Figure 5-8(a) and (b)), the porosity increased with increasing laser power. This can be attributed to the 
effects of excessive energy input on the resulting porosity as the laser power exceeds a certain 
threshold leading to excessive energy input (Yang et al., 2016). However, for the high level of scanning 
speed, an increase in laser power reduced the porosity at both low and high hatch spacing. The effect 
however, is more pronounced at high hatch spacing. Increasing the laser power increases the input 
VED, and increasing the hatch spacing decreases the VED.  
Furthermore, when substituting hatch spacing and layer thickness from the VED equation with laser 
spot size to consider an area energy density (J.mm
-2
) (AED), the scan track width is affected by the 
applied AED. Lowering the AED below a certain threshold significantly reduces the scan track width 
(Yang et al., 2016). Subsequently, the hatch spacing required to ensure overlapping of scan tracks 
becomes smaller. The pronounced increase in porosity at high hatch spacing and scanning speed with 
decreasing laser power in Figure 5-8(b) therefore encompasses a combination of effects related to melt 
pool formation, stability, and dimensions. To counter these effects, a significant increase in laser power 
is required to cause sufficient melting and overlapping of scan tracks. This is in accordance with 
previous observations (Figure 5-4 and Figure 5-5) which demonstrates the transition from insufficient 
melting and scan track discontinuities to stable melting and smooth scan tracks. 
In Figure 5-8(c) and (d) it can be observed that, although the confidence interval bands interact, no 
significant interaction is present in the data for laser power and hatch spacing At the low level of 
scanning speed (Figure 5-8(c)), the trends of resulting relative porosity for both high and low hatch 
spacing are similar with high hatch spacing consistently yielding a lower porosity across the full 
investigated range of laser power. This indicates that the low level of scanning speed (435 mm.s
-1
) 
required both a decrease in laser power and an increase in hatch spacing to reduce the VED and 
subsequent excessive energy input effects on the relative porosity. For the high level of scanning speed 
the opposite was observed. Thus, at the high level of scanning speed (1215 mm.s
-1
) both an increase in 
laser power and decrease in hatch spacing was required to counter the effects of insufficient energy 
input. 
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Although the interaction for scanning speed and hatch spacing has been detected as significant in the 
ANOVA (Figure 5-8 (e) and (f)), the interaction plots follow the same general trends with regards to 
the effects on relative porosity. The direction of the curves seem to depend more on the value of laser 
power, which governs whether porosity is increased or decreased with scanning speed rather than the 
hatch spacing value (except for the case at low laser power and high scanning speed as discussed 
above). This is especially visible in Figure 5-8(f), where the plots largely overlap within the confidence 
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Figure 5-8: Two factor interaction plots with high and low variations for third factor with (a-b) laser 
power and scanning speed, (c-d) laser power and hatch spacing, and (e-f) scanning speed and hatch 
spacing 
This decreased effect of hatch spacing on the relative porosity compared to the effects of laser power 
and scanning speed appears inconsistent with reported literature, where hatch spacing is typically 
reported to be a significant factor regarding the porosity of LPBF-produced components (Hassanin et 
al., 2016). In line with the problem solving framework developed throughout this study, this indicates a 
requirement for further diagnostics into possible causes. When examining the exposed vectors, a 
phenomenon in the laser exposure path control of the LPBF equipment hardware was identified that 
could contribute to the reduced effect of hatch spacing on the porosity.  
The observation is presented at various magnifications in Figure 5-9. An entire island with adjacent 
islands visible is presented in Figure 5-9(a). The ridge like appearance is exaggerated due to this 
scanning artefact which is visible in Figure 5-9(b). In all four islands at this junction it is clear that the 
vector positioning is not according to expectation and potentially leads to a contribution in porosity. At 
higher magnification in Figure 5-9(c), the measured distance between the centres of adjacent scan 
vectors is twice that of the set hatch spacing distance of 105 µm. Further diagnostics revealed that the 






, … seemed to be positioned 
correctly, but the even numbered vectors move in and out of phase with regards to their required 
position as the schematic in Figure 5-9(d) indicates.  
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Figure 5-9: Detected laser exposure issue on machine with regards to positioning of scan vectors with (a) 
the entire island visible, (b) a junction of four islands with perpendicularly alternating island fill vector 
directions, (c) measurements showing the positioning to be double the hatch spacing, and (d) schematic 
describing the observations of the phenomenon 
 
It was also observed that this error does not occur consistently throughout or within each layer and is 
therefore hard to monitor or detect in situ. In the 3D reconstructions from the CT data, this irregularity 
could be positively identified on the top surface in 14 of the 18 runs. To demonstrate that this 
positioning issue did not occur consistently throughout the part volume, Figure 5-10 presents the top 
and bottom surface of the specimen produced with Run1. On the top surface the laser positioning 
irregularity is identifiable, whereas on the bottom surface the tracks appear to be aligned correctly. 









1 2 3 4 5 6
b c
a = a = 2 x Hatch 
Space, consistently
b unequal to c, varies 
throughout layer
bi + ci+1 =  210 = a,    
where
i = 1,2,3,...,n
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The apparent randomness of occurrence could therefore be a source of the noise within the hatch 
spacing variable, rendering it a borderline insignificant factor with regards to porosity within the 
screening experiment. In view of this unpredictable scanning irregularity combined with the lack of 
significance of the effect of hatch spacing on the relative porosity within the data of this pilot study, it 
was decided to fix hatch spacing as a constant at the default value of 105 µm in all subsequent 
experimental work and focus on laser power and scanning speed as independent variables. 
 
 
Figure 5-10: 3D reconstructions for Run1 with top (left) revealing exposure irregularity and bottom 
(right) revealing correct laser positioning 
 
For the application of the framework, this knowledge would be added to the integration section of 
“Process and Machine”. It emphasizes that expected functionality of the LPBF hardware should not be 
assumed outright. The range of LPBF machines on the market is also expanding and new models of 
existing machines and software as well as hardware and software updates, are released periodically. It 
is therefore important to study the specific machine and process combination beforehand, as insights 
gained in this stage through screening tests can streamline the design and resource requirements of 
subsequent investigations.  
~260 µm
~130 µm
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5.4 Permeable Thin Walls for Vancomycin Release Screening 
5.4.1 Fabrication of Thin Wall Specimens 
The next step was an investigation into the feasibility of creating permeable structures by inducing 
porosity through the variation of laser power and scanning speed. For this purpose, 10 x 10 x 0.4 mm 
thin walls were built with different settings for laser power and scanning speed. As stated above, the 
hatch spacing setting was maintained constant at 105 µm, and layer thickness was kept constant at 
30 µm. The different parameter sets are presented in Table 5-6. Values for process parameters were 
selected to reflect a wide range of VED in order to assess whether vancomycin permeable structures 
can be produced by either insufficient energy input or overheating. The thickness of 400 µm was 
selected to ensure that more than one scan vector would be required, whilst maintaining a thickness 
close to the build minimum wall thickness, which has been determined both in-house and in literature 
to be in the range of 150 – 200 µm (Abele et al., 2015) for the respective machine. By applying more 
than one scan vector, the porosity should be such that there is sufficient interconnectivity between 
pores in order to allow drug transport. 
 
Table 5-6: Process parameter settings for induced porosity screening 




) Selected (Y/N) 
1 40 150 84.66 N 
2 40 600 21.16 Y 
3 40 1100 11.54 Y 
4 100 150 211.64 N 
5 100 600 52.91 N 
6 100 1100 28.86 Y 
7 180 200 285.71 N 
8 180 600 95.24 N 
9 180 1100 51.95 Y 
 
A qualitative screening of manufactured thin walls was done by evaluating whether light could pass 
through the structures. The samples were placed on a light source and observed through an Olympus 
SX7B optical microscope. Elimination was done conservatively and where for example, it was not 
clear whether light passing through or a reflection was observed; the samples were included for 
vancomycin release screening. Selected parameter sets are indicated in Table 5-6. 
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5.4.2 Experimental Setup and Design 
For vancomycin release screening of the thin walls built with the identified parameter sets, diffusion 
wells were custom designed and 3D-printed on an UPBox FDM machine from acrylonitrile butadiene 
styrene (ABS) filament. Prior to introduction of the thin walls, all wells were monitored for leakages 
for at least 24 hours and no leakages were detected. Permeable walls were introduced and meticulously 
sealed off using a commercial silicone sealant appropriate for use with both metals and polymers. The 
assembled wells for parameter set 6 are presented in Figure 5-11. 
 
 
Figure 5-11: Custom 3D-printed diffusion wells for vancomycin release screening of parameter set 6 
 
Unless otherwise stated all materials used were of analytical grade. On the numbered side of the thin 
wall 1 mL of a 2 mg/mL solution of vancomycin (Sigma Aldrich) in distilled water was placed and on 
the other side a buffer of 1 mL distilled water. Since the objective here was only to screen for 
vancomycin transport, a 25 µL sample was taken from the buffer side at 0, 15, 30, 45, and 60 min. 
Regarding the short duration of the experiment and the solubility of vancomycin in water of greater 
than 100 mg/mL, a buffer of 1 mL was regarded as an adequate sink for the objective of the 
experiment. Furthermore, a 60 min test duration was specified as, ideally, drugs should be available at 
the target site as soon as possible after administration. Vancomycin concentration was determined by 
the Microbiology Department with a bicinchoninic acid (BCA) assay. For the standard curve, a dilution 
series of 0, 25, 125, 250, 500, 750, 1000, 1500, 2000 µg/mL was added in duplicate to each sampling 
time point. A volume of 200 µL BCA working solution (Thermo Scientific) was added to each sample 
and vortexed to ensure a homogenous solution. Plates were incubated at 37 °C for 30 min before 
loading into the microtiter plate reader and absorbance was read at a wavelength 562 nm. Parameter 
sets were analysed in triplicate (Figure 5-11). 
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5.4.3 Experimental Results 
The standard curves for each of the plates corresponding to the sampling time points of 0, 15, 30, 45, 
and 60 min are available in Appendix C (Figure C-4). All curves show a linear correlation of the 
measured absorbance with the full dilution series of vancomycin standard concentrations and R
2
 values 
greater than 0.994. The measured vancomycin concentrations for samples in the screening experiment 
are presented in Figure 5-12. It can be observed from the release curves that Runs 2 and 3 allowed for 
vancomycin transport with detectable signals starting after 15 min. Runs 6 and 9 did not allow passive 
diffusion of vancomycin within the 60 min screening period. This indicates a potential cut-off for 
diffusive vancomycin transport in the zone of 21.16 (Run 2) and 28.86 J.mm
-3
 (Run 6). Nevertheless, 
the release curves provided evidence that Ti6Al4V ELI permeable thin walls (PTWs) can be fabricated 
with the LPBF process using appropriate process parameter settings.  
 
 
Figure 5-12: Vancomycin diffusion screening across LPBF Ti6Al4V ELI thin walls 
 
To qualitatively visualise the diffusion, a blue dye was introduced to distilled water in the reservoir side 
of a diffusion well containing a PTW built with parameter set 3. This is presented in Figure 5-13. It is 
important to note that the diffusion appears uniform across the PTW and not concentrated at a specific 
area. This implies that pores are distributed throughout the structure and not concentrated in one area of 
the PTW. This corroborates the relatively even distribution of pores resulting from insufficient energy 
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Figure 5-13: Qualitative representation of blue dye diffusion through PTWs 
 
5.5 Conclusion 
This chapter presented screening experiments regarding the application of the LPBF process for 
inducing porosity into Ti6Al4V ELI components to enable the fabrication of PTWs across which 
vancomycin can be transported by passive diffusion. From the above discussed investigations the 
following conclusions were made: 
 Pores induced through insufficient energy input were larger and irregular in shape than pores 
produced with excessive energy input 
 Overall, VED is a useful DoE criterion to identify different processing regimes and relate them 
to the type of resulting porosity, however, VED should be utilised with care as it does not 
account for the complex physics of the melting process which, among other, influences the melt 
pool dimensions and resulting scan track profile (Bertoli et al., 2017) 
 Within the investigated ranges, laser power and scanning speed were identified as the main 
process parameters affecting the porosity with hatch spacing borderline insignificant 
 The importance of studying the specific LPBF machine for use is underlined, as results 
suggested that both the scanning strategy (inclusive of layer exposure pattern and exposure 
pattern interlayer shift) as well as the laser positioning control system contributed to the total 
porosity 
 400 µm PTWs were successfully fabricated for screening of vancomycin permeability through 
passive diffusion 
 Porosity resulting from insufficient energy input allowed vancomycin transport whereas 
porosity from excessive energy input was not sufficient to allow passage of light  
 A potential cut-off zone for VED to produce PTWs which allow transportation of vancomycin 
was identified between 21.16 and 28.86 J.mm
-3
 
 Based on these screening results, a more detailed investigation is presented in the next two 
chapters regarding the production of PTWs for vancomycin release with VEDs below the 
identified cut-off limit of ~29 J.mm
-3. 
0.5 min 1 min 3 min 5 min
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6. Tailored Drug Release with LPBF-Produced PTWs – Experimental 
Setup and Design 
This chapter presents the experimental setup and design for an investigation into the LPBF of 
integrated Ti6Al4V ELI PTWs for controlled drug delivery of vancomycin from an aqueous solution. 
The study was done in two main stages. Firstly, the fabrication of 400 µm PTWs for vancomycin 
release with differing laser power and scanning speeds, based on the identified VED limits from the 
screening study in the previous chapter. Secondly, the part consolidation capability of LPBF was 
utilised for the fabrication of integrated PTW and dense reservoir samples. Vancomycin release from 
the integrated reservoirs and, importantly, the resulting antimicrobial efficacy were evaluated. 
6.1 PTWs 
The experimental study roadmap for investigating tailored vancomycin release through LPBF-produced 
PTWs is presented in Figure 6-1. The roadmap entails three main phases namely Part Fabrication, Part 
Inspection, and Antimicrobial Efficacy. The PTWs (400 µm in thickness) were fabricated with 
differing values of laser power and scanning speed, followed by investigations into the wettability, 
relative porosity, vancomycin release and antimicrobial activity against S. aureus Xen 36.  
 
                                  
Figure 6-1: PTW experimental study roadmap 
 
LPBF-Produced Ti6Al4V ELI Permeable Walls  
400 µm PTWs with different processing 
parameters 
Static water contact angle 
measurement 
Relative porosity analysis with micro 
computed tomography 
Scanning electron microscopy 
Vancomycin release in custom 3D- 
printed ABS reservoir 
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6.1.1 Part Fabrication 
Thin walled parts, 10 mm x 10 mm x 0.4 mm, were designed using Autodesk PowerSHAPE. To enable 
in-process assembly of the parts the PTW component was oversized to create an interference with the 
support frame (Figure 6-2). The current machine software restricts the allocation of different process 
parameters to different regions within a part volume. Therefore, parts were kept as separate sliced files 
and loaded individually to the machine software which allowed the allocation of different process 
parameters. This oversizing of components and subsequent interference of their geometries in space 
allows for the possibility of in-process assembly of components built with different process parameters 
through essentially a re-melt at the interfering regions. Build files were created with Magics 15.0.  
 
 
Figure 6-2: PTW and support frame showing interference of geometries 
 
The process parameters laser power and scanning speed were specified as the independent test 
variables with hatch spacing and layer thickness kept respectively at the manufacturer default values of 
0.105 mm and 0.03 mm. The effects of laser power and scanning speed on the release of vancomycin 
from an aqueous solution were investigated by means of a face centred cubic (FCC) response surface 
DoE. The experimental design encompassed two factors, each with three levels. The DoE was set up 
using Design Expert statistical software. Augmentation of the DoE involved the duplication of all 
design points, adding a third centre point, and the addition of a previously in-house identified point 
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Table 6-1: Parameter variation DoE for production of PTWs 





PS-1 50 800 19.84 
PS-2 30 1200 7.94 
PS-3 50 1600 9.92 
PS-4 30 800 11.91 
PS-5 70 800 27.78 
PS-6 70 1600 13.89 
PS-7 50 1200 13.23 
PS-8 30 1600 5.95 
PS-9 70 1200 18.52 
PS-10 40 1000 12.70 
 
Parts were built directly onto the building plate with a 1 mm machining allowance in the z-direction for 
part removal with w-EDM. The non-permeable features were built with LPBF machine manufacturer’s 
default parameters, 100 W laser power and 600 mm.s
-1
 scanning speed. After removal from the 
building plate, the fabricated parts were cleaned by sonication in acetone, ethanol and distilled water 
for 15 min, respectively. 
6.1.2 Part Inspection 
6.1.2.1 Water Contact Angle 
The static water contact angles of the fabricated PTWs were evaluated with the sessile drop method 
(ASTM International, 2013). Images were obtained with a Smile 400 tool presetting and measuring 
machine from Zoller Inc. For reference, two non-permeable surfaces were included in as-built vertical 
(ABV) and mechanically polished (MP) condition respectively. Mechanical polishing was done 
according to standard guidelines to obtain a mirror finish by sequential grinding with SiC paper of 600, 
800, and 1200 grit size, followed by polishing with 9 µm diamond suspension and 0.04 µm colloidal 
silica respectively (Struers, 2016).  
 
The physical setup involved configuration of a custom jig (Figure 6-3(a)) with which the specimen was 
set at a distance of 2.999 ± 0.003 mm from the drop source (Figure 6-3(b)) which was within 
specification according to ASTM D7334-08 (ASTM International, 2013). The volume of the water 
droplet was determined by depositing a single droplet on a PTW and weighing the specimen on an 
analytical balance. Mass measurements of the distilled water droplet were converted to volume using a 
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density of 1 g.cm
-3
. The mass measurements are presented in Table 6-2. The water droplet volume was 
estimated as 3.48 ± 0.16 µL which allows for the spherical assumption (Extrand & Moon, 2010). A 
droplet was deposited in three different locations on the specimen surface and the measured contact 
angles averaged. During the entire test the environment was climate-controlled at 21-22 °C. Images 
were taken at a minimum of 10 s after deposition to allow the droplet to stabilise.  
 
                
(a) 
      
 (b) 
Figure 6-3: Static water contact angle measurement experimental setup with (a) the physical 
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Table 6-2: Mass measurement of water droplet on PTW 








Average ± Standard Deviation 3.48 ± 0.16 
 
Contact angles were measured in the ImageJ software environment using a Contact Angle plugin 
(Brugnara, 2006). To obtain the contact angle, images were adjusted for brightness and contrast to 
identify the contact line of the droplet and PTW as well as the droplet profile. Five points on the droplet 
profile were then specified as input to the contact angle plugin (Figure 6-4(a)). The points are used to 







Figure 6-4: Contact angle measurement procedure using Image J and Contact Angle plugin showing (a) 
the image adjustment and points selection and (b) the best fit output 
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6.1.2.2 Surface Roughness 
Reported surface roughness measurements were all obtained using a portable MarSurf PS10 tactile 
perthometer. Where applicable, the mean surface roughness, Ra, and five-point mean peak to valley 
height, Rz, were recorded for three profiles on the respective specimen, traced in the building direction. 
6.1.2.3 Relative Porosity 
PTW surfaces were qualitatively observed with a Zeiss MERLIN FE-SEM at the Electron Microscopy 
unit of the CAF at SU. PTW specimens were fixed on aluminium stubs using conductive carbon tape. 
A beam potential of 5 kV was used.  
 
The relative porosity of the PTW structures was evaluated non-destructively with µCT using a General 
Electric Nanotom S and a custom method developed by the CT-Scanner unit of CAF at SU. System 
parameters for scanning and data acquisition were specified according to the standard guidelines as 
published by the CT-Scanner unit (Du Plessis et al., 2017). The X-ray parameters were a potential of 
140 kV, a current of 40 μA, copper beam filtration of 1.5 mm, and an exposure time of 0.5 s. Scans 
were performed at a voxel size resolution of 5 µm. 3D reconstructions and porosity analysis were done 
using VGStudioMax 3.1 software. Similar to the screening experiment in Chapter 5, the relative 
porosity percentage was calculated as the total sum of pore volume to the total bulk part volume.  
 
To avoid difficulties in the porosity detection algorithm which is based on the grayscale values of an 
image, a volume of interest (VOI) within the part volume was specified. A 5 x 5 x 0.1 mm VOI was 
identified for each part in the centre of the CT reconstruction. The specified VOI is presented in Figure 
6-5. The build direction is indicated in Figure 6-5(a) by the downwards arrow. The VOI border is 
indicated in the x-z plane in Figure 6-5(a), in the x-y plane in Figure 6-5(b), and the VOI contained 
within the 3D reconstruction is presented in Figure 6-5(c). To evaluate the repeatability of PTW 
relative porosity, three samples at the DoE centre point, and two samples at each of the highest and 
lowest energy densities were analysed. An additional sample in the DoE range was randomly selected 
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Figure 6-5: Specification of 5 mm x 5 mm x 0.1 mm VOI with (a) 2D view in x-z plane, (b) 2D view in x-y 
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6.1.3 Antimicrobial Efficacy 
6.1.3.1 Vancomycin Release through PTWs 
In order to investigate the release of vancomycin through the PTWs, release cells were custom 
designed and 3D-printed from ABS polymer using a commercial FDM machine (Figure 6-6). The cells 
contained a 1 mL reservoir and a 7 mL buffer. The PTW parts were fixed in place to separate the 
reservoir and buffer and sealed (Figure 6-6(a)). The release cell assemblies were monitored for any 
leakages over a period of 48 h. To standardise the area in contact with antibiotic solution, the reservoir 
side of each PTW was covered with a polyvinyl chloride (PVC) mask (Figure 6-6(b)) and sealed to 






Figure 6-6: Photographs of PTWs assembled in ABS custom made diffusion wells (a) showing the buffer 
side of the PTW and (b) showing the reservoir side of the PTW 
 
The reservoir was filled with 1 mL of vancomycin solution at a concentration of 1 mg/mL. The buffer 
side contained 7 mL of sterile phosphate buffered saline (PBS) (pH 7.4) solution. Release cells were 
then incubated at 12 h at 37°C. Sampling times were 1, 3, 6, and 12 h. At each sampling point 1.5 mL 
was extracted from the buffer and the removed volume was replaced with fresh PBS solution. Samples 
were homogenised by vortex. Aliquots of 200 µL were filtered using 0.22 µm polyvinylidene fluoride 
(PVDF) syringe filters and injected into autosampler vial inserts. The vancomycin concentration within 
each aliquot was quantified using a Waters Synapt G2 QTOF reversed-phase ultra-high performance 
liquid chromatography (RP-UHPLC) machine at the LC-MS unit of CAF at SU. The RP-UHPLC was 
fitted with a Hypersil GOLD C18 column. An injection volume of 2 µL was used, and ultraviolet 
absorbance was detected at a wavelength of 280 nm. The mobile phase consisted of deionized (DI) 
water and acetonitrile (AcN) containing 0.1% formic acid respectively. A gradient elution protocol was 
adapted from literature
 
and is presented in Table 6-3 (Baranowska et al., 2010).  
Reservoir 
Buffer 
400 µm PTW 
PVC  
mask 
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Table 6-3: Mobile phase elution protocol for RP-UHPLC 
Time (min) 0.1% Formic Acid AcN with 0.1% Formic Acid 
0.00 100.0 0.0 
0.50 100.0 0.0 
2.50 75.0 25.0 
3.00 10.0 90.0 
4.00 100.0 0.0 
5.00 100.0 0.0 
 
6.1.3.2 Activity of Released Vancomycin 
Antimicrobial tests were prepared by the Department of Microbiology at SU. Release cells were rinsed 
with double-distilled water, prepared with a milli-Q system. The reservoir side was filled with 1 mL of 
vancomycin at a concentration of 1 mg/mL and the buffer side contained 3 mL of sterile PBS (pH 7.4). 
At time points 0 h, 5 h and 18 h, 1 mL samples were taken from the buffer and replaced with fresh 
PBS. Antimicrobial activity of the samples was evaluated with an agar-well diffusion assay. Brain heart 
infusion (BHI) agar (1% w/v) was seeded with an overnight (18 h) culture of S. aureus Xen 36 (1 %, 
v/v). Wells of 5 mm in diameter were made into the solidified agar using a sterile glass pasteur pipette. 
An aliquot volume of 100 uL from each of the samples was introduced into a well. Plates were then 
incubated for 18 hours at 37 °C. 
6.2 Integrated Reservoir Specimens 
The experimental study outline for investigating the fabrication and vancomycin release of LPBF-
produced reservoirs with integrated PTWs is presented in Figure 6-7. Whereas part of the focus for the 
experiment outlined in Section in 6.1 was to investigate the effects of LPBF process parameters on 
vancomycin release, the main objective here was to integrate PTWs and investigate the effect of 
geometry on vancomycin release. The identified geometry for investigation was limited to the size of 
the channel opening, referred as hole diameter, and the thickness of the integrated PTW. It entailed two 
main phases namely Part Fabrication and Antimicrobial Efficacy.  
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Figure 6-7: Integrated reservoir specimens study layout 
 
6.2.1 Part Fabrication 
Integrated PTW reservoir specimens were design using Autodesk PowerSHAPE. The reservoir 
consisted of a cuboid volume of 10 x 10 x 12 mm with a circular drug release opening (dark grey parts 
in Figure 6-8) varying between 2 and 8 mm and an integrated PTW varying in thickness from 0.4 – 1.5 
mm. Similar as before, the PTW was sufficiently oversized in all dimensions to ensure interference 
with the dense reservoir and subsequent assembly due to remelting at the interference zones of the part 
volumes. Examples of selected design variants are presented in Figure 6-8. A treatment with a 2 mm 
hole and 0.4 mm PTW is shown in Figure 6-8(a), a 5 mm hole 0.95 mm PTW in Figure 6-8(b), an 8 
mm hole and 1.5 mm PTW in Figure 6-8(c), and a fabricated specimen with 5 mm hole and 0.95 mm 
PTW in Figure 6-8(d). 
 
             
                (a)                                       (b)                                      (c)                             (d) 
Figure 6-8: Examples of integrated reservoir specimen design variations with (a) 2 mm hole and 0.4 mm 
PTW, (b) 5 mm hole and 0.95 mm PTW, (c) 8 mm hole and 1.5 mm PTW, and (d) fabricated specimen 
with 5 mm hole and 0.95 mm PTW 
 
LPBF-Produced Ti6Al4V ELI Integrated Reservoir Specimens  
Reservoirs with different hole diameters 
and integrated PTW thicknesses 
Vancomycin release in cell culture wells 
Selected specimen incubated with 
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According to the LPBF machine manufacturer’s guidelines, holes or channels built parallel to the build 
plate should not be not smaller than 2 mm in diameter to avoid collapse and not greater than 8 mm in 
diameter to ensure reasonable geometrical accuracy and avoid caving in of the overhanging material 
without the use of support structures. These values are at the limits of the specified machine capability, 
and therefore a FCC DoE was selected. The treatment combinations are presented in Table 6-4, ‘F’ 
refers to factorial point, ‘A’ to axial point, and ‘C’ to centre point. All dense parts of the reservoir were 
built with default parameters and the PTWs with PS-10 as defined in Table 6-1. 
 
Table 6-4: Design parameter variation for production of integrated reservoir specimens 
Sample Name Hole Diameter (mm) PTW Thickness (mm) 
1F 2.0 0.40 
2F 8.0 0.40 
3F 2.0 1.50 
4F 8.0 1.50 
1A 5.0 0.40 
2A 2.0 0.95 
3A 8.0 0.95 
4A 5.0 1.50 
C 5.0 0.95 
 
6.2.2 Antimicrobial Efficacy 
6.2.2.1 Vancomycin Release from Integrated Reservoirs 
The integrated reservoir specimens were loaded with 1 mL of 1 mg/mL vancomycin and placed in the 
wells of a 12 multiwell cell culture plate, with each well containing 2.5 mL sterile PBS (Figure 6-9). 
The plates were incubated at 37°C for a total of 24 hours. At each of the specified time points, 1, 3, 6, 
12, and 24 hrs, samples were taken from the PBS buffer and the integrated reservoir specimens were 
transferred to a fresh 2.5 mL PBS buffer in a clean cell culture well. The order of sampling and transfer 
of integrated reservoir specimens to fresh PBS buffers were randomised at all times. 
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Figure 6-9: Photographic representation of experimental setup for vancomycin release from integrated 
reservoir specimens 
 
Vancomycin concentrations in the buffers were quantified at the Department of Microbiology with 
reversed-phase high performance liquid chromatography (RP-HPLC) on a Finnigan Surveyor Plus 
system using a Hypersil GOLD C18 column. Samples were filtered using 0.22 µm PVDF syringe filters 
and injected into autosampler vials. For RP-HPLC analysis an injection volume of 20 µL was used. 
Ultraviolet absorbance detection was done at a wavelength of 254 nm using a Surveyor UV/Vis Plus 
detector. The mobile phase consisted of DI water and AcN containing 0.1% trifluoroacetic acid (TFA) 
respectively. The gradient elution protocol used has been developed previously in-house and is 
presented in Table 6-5 (Bezuidenhout et al., 2015). Standard vancomycin concentrations for the 
calibration curve were 0, 5, 20, 62.5, and 125 µg/mL. 
 
Table 6-5: Mobile phase elution protocol for RP-HPLC 
Time (min) 0.1% TFA AcN with 0.1% TFA Elution type 
0.0-1.0 95.0 5.0 Isocratic 
1.0-5.0 95.0 – 0.0 5.0 – 100.0 Linear gradient 
5.0-6.0 0.0 100.0 Isocratic 
6.0-11.0 0.0 – 95.0 100.0 – 5.0 Linear gradient 
12.00 95.0 5.0 Isocratic 
 
Multiwell plate 
PBS buffer solution  
Vancomycin solution 
inside reservoir 
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6.2.2.2 S. aureus Xen 36 Colonisation Prevention Potential 
The surface colonisation prevention potential tests were prepared by the Department of Microbiology 
at SU. The integrated reservoir specimens were sterilized by soaking them in 70% ethanol (v/v) for 15 
min after which the ethanol was left to evaporate. A 300 µL overnight culture of S. aureus Xen 36 was 
inoculated in 30 mL melted 1% w/v BHI agar (cooled to 40 °C) for an S. aureus concentration of 
1% v/v. The agar solution was then swirled and plated out. Integrated reservoir specimens were then 
fixed in the agar. The reservoirs were filled with 0.7 mL of 1 mg/mL vancomycin. Incubation of the 
plates was done at 37 °C for 18 h. Clear zones surrounding the titanium block would be indicative of 
effective release of vancomycin and successful prevention of surface colonisation.  
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7. Tailored Drug Release with LPBF-Produced PTWs – Results and 
Discussion 
This chapter presents the main part of the results to the partial problem of “Enabling drug delivery from 
implant reservoir” within the overall problem breakdown structure as presented in Figure 3-6. 
Investigation of the PTWs can be regarded as problem decomposition where insight is gained for the 
establishment of an LPBF process window within which permeable structures can be produced for 
passive diffusion of vancomycin from an aqueous solution. The integrated reservoir specimens 
thereafter represent a recomposition phase where in-process assemblies representing potential drug 
release location of an eventual demonstrator prototype were evaluated. The IKPs which resulted from 
this work were implemented in the design of the demonstrator cementless hip stem prototype. 
7.1 PTWs 
7.1.1 Fabricated PTWs Part Inspection 
The as-built in-process assembled PTWs and support frames on the LPBF building plate are presented 
in Figure 7-1. Two parameter sets, PS-2 (VED = 7.94 J.mm
-3
) and PS-8 (VED = 5.95 J.mm
-3
) did not 
build and one set, PS-4 (VED = 11.91 J.mm
-3
) resulted in fragmented parts. An example of a non-built 
and of a fragmented PTW is indicated with dashed ellipses in Figure 7-1.  
 
 
Figure 7-1: As-built PTWs within support frame on build plate 
 
Subsequently, these parameter sets, all involving a laser power of 30 W, were excluded from further 
analyses. However, PS-3 (VED = 9.92 J.mm
-3
) resulted in a successful build but had a laser power of 
50 W. This means parts with higher VED but lower laser power failed to build. It implies that at certain 
processing boundaries the laser power alone may have a greater effect on melt pool stability than the 
combination of laser power and scanning speed. Successful builds were obtained with PS-10 (VED = 
12.70 J.mm
-3
, P = 40 W). Therefore, considering the investigated range of scanning speed, a lower 
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boundary between 30 and 40 W can be inferred for the required laser power to cause intermittent 
melting of the Ti6Al4V ELI powder. 
7.1.1.1 Water contact angle 
Selected images of the droplets on specimens are presented in Figure 7-2. The static contact angle on 
the reference dense specimens, ABV and MP, indicates that the bulk of the LPBF Ti6Al4V ELI is 
hydrophilic. For implant applications, hydrophilic surfaces are preferred as this reduces bacterial 
adhesion through hydrophobic effects. The averages of contact angles on 400 µm PTWs, however, are 
all in the range of 114 – 127° and thus consistently indicative of hydrophobic surfaces. However, after 
using water for pre-wetting of the 400 µm PTWs, water droplets were no longer repelled.
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In contrast to this, the 950 µm PTW imbibed a water droplet within 222 ± 50.41 ms. A time series of 
screen shots of the water droplet imbibed into the 950 µm PTW is presented in Figure 7-3. Video 
frames before surface contact and after imbibition were identified using a commercially available 
digital audio workstation software. The wetting behavior is therefore influenced by the thickness of the 
porous structure. Similar observations have been reported for macroporous anodised aluminium oxide 
layers, but reasons for the wetting transition based on thickness were stated as unclear and residual 
electrolyte in the thicker porous structure was suspected (Buijnsters, et al., 2013).  
 
 
t = 19.528 s 
 
t = 19.636 s 
 
t = 19.735 s 
 
t = 19.880 s 
Figure 7-3: Image frames for creation of a time series of water droplet imbibed into 950 µm thick 
permeable wall fabricated with PS-10 
 
The Young equation for theoretically describing the contact angle, θ, of a droplet on an ideal, smooth 
surface is, 
 
 𝑐𝑜𝑠𝜃𝑌𝑜𝑢𝑛𝑔𝛾𝑙𝑣 =  𝛾𝑠𝑣 −  𝛾𝑠𝑙 (7-1) 
 
where 𝛾𝑙𝑣 , 𝛾𝑠𝑣 , and 𝛾𝑠𝑙  denotes the liquid-vapour, solid-vapour, and solid-liquid interfacial tensions 
respectively (Rupp et al., 2014). This is schematically presented in Figure 7-4(a). However, the ideal 
nature of the model does not account for real surfaces. Two theories developed more than 70 years ago 
aim to describe the contact angle on a rough surface. In the Wentzel wetting model (Figure 7-4(b)), a 
water droplet interacts with the full surface profile. The measurable Wenzel contact angle, θW, is 
expressed by,  
 
 𝑐𝑜𝑠𝜃𝑊 =  𝑟𝑊𝑐𝑜𝑠𝜃𝑌𝑜𝑢𝑛𝑔 (7-2) 
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where 𝑟𝑊 is a roughness parameter which relates the actual surface area to the projected surface area 
and is therefore greater than one. Considering the hydrophilic nature of the ABV specimen which had a 
mean surface roughness, Ra, of (8.382 ± 1.01 µm), and the Ra of the PS-10 PTWs (16.70 ± 1.18 µm), it 
is unlikely that the contact angles for the PTWs could be accounted for by the Wenzel wetting model. 
This is because the contact angle on the ABV specimen is significantly lower than that of the MP 
specimen and if this trend is assumed to be indicative with regards to surface roughness, according to 
the Wenzel model the increase in roughness of the PTW should further decrease the contact angle 
(Rupp et al., 2014). 
 
Cassie and Baxter (1944) described a situation where the water droplet interacts with a heterogeneous 
surface comprising both the rough solid material and air (Figure 7-4(c)) (Lembach et al., 2010). In this 
case, the measurable contact angle, θc is described by, 
 
 𝑐𝑜𝑠𝜃𝐶 =  𝑓𝑐𝑜𝑠𝜃𝑌𝑜𝑢𝑛𝑔 + 𝑓 − 1 (7-3) 
 
where 𝑓 is the area fraction of the solid that is in contact with the droplet. According to Rupp et al. 
(2014), high contact angles on microrough blasted and acid-etched titanium surfaces are likely to be a 
result of the Cassie-Baxter state. Whereas this may account for the apparent large contact angles on the 
400 µm PTWs it does not explain the transition to rapid imbibition with an increase in PTW thickness. 
 
 
                               (a)                                                     (b)                                                        (c) 
Figure 7-4: Schematic of models for wetting with (a) the Young model, (b) the Wenzel model, and (c) the 
Cassie-Baxter model (Han et al., 2019) 
 
The transition suggests that the increase in PTW thickness essentially alters the physical classification 
from a hydrophobic surface to a hydrophilic complex porous volume with capillary action sufficiently 
large to act as a wicking medium for water. Furthermore, Bico et al. (2002) showed that imbibition 
takes place if the contact angle is below a certain critical contact angle, θcrit, define by, 
vapour vapour vapour 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 7                               Industrial Engineering 
   Page 130 
 
 
𝑐𝑜𝑠𝜃𝑐𝑟𝑖𝑡 =  
1 −  ∅𝑠




where ∅𝑠 is called the emerged fraction of solid, in other words, the part of the surface which is above 
the film level. As the thickness of the PTW increases, the effective surface area and subsequently 𝑟𝑊 
increases. For sufficiently thick porous materials 𝑟𝑊  →  ∞  which means that 𝑐𝑜𝑠𝜃𝑐𝑟𝑖𝑡  → 0  and 
therefore 𝜃𝑐𝑟𝑖𝑡  →  
𝜋
2⁄  or 90° which is also the criterion for capillary rise (Bico et al., 2002). In Figure 
7-3 it can qualitatively be observed that upon contact with the 950 µm PTW the apparent contact angle 
is less than 90° indicating that this condition for imbibition was met. The mechanistic aspects of 
imbibition and spreading of droplets on dry porous layers is complex and beyond the scope of this 
study (Starov et al., 2002). Nonetheless, these observations are particularly highlighted as an avenue for 
further research into LPBF for fabrication of integrated permeable components where wicking 
properties are required such as, among other, heat pipe sections, tissue engineering structures, and 
smart drug delivery applications. 
7.1.1.2 Relative Porosity 
A summary of the relative porosities for the fabricated 400 µm PTWs is presented in Table 7-1. 
Parameter sets that yielded non-build or fragmented parts are excluded (PS-2, PS-4, and PS-8). For the 
fabricated PTWs the relative porosities varied from 33.62% (range = 0.81%) at the lowest VED of 
9.92 J.mm
-3
 to 2.73% (range = 1.37%) at the highest VED of 27.78 J.mm
-3
. This constitutes a tailorable 
range of more than a factor ten. The mean surface roughness of the PTWs is consistently higher for all 
parameter sets than that produced with the default parameters. This is likely due to the ragged textures 
resulting from intermittent melting and the partial sintering of powder particles forming agglomerates 
on the surface visible on the FE-SEM images of the PTW surfaces in the bottom left of Figure 7-5.  
 
Table 7-1: Summary of fabricated 400 µm PTWs 
Parameter 
Set 




) Ra (µm) prel (%) 
PS-1 50 800 19.84 15.08 ± 1.38 17.37 15.24  
PS-3 50 1600 9.92 16.88 ± 1.57 34.02 33.21  
PS-5 70 800 27.78 12.35 ± 1.01 3.41 2.04  
PS-6 70 1600 13.89 19.78 ± 3.42 21.17   
PS-7 50 1200 13.23 18.30 ± 3.06 28.01 26.66 26.87 
PS-9 70 1200 18.52 16.94 ± 1.39 12.27   
PS-10 40 1000 12.70 16.70 ± 1.18 26.74   
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The relative porosity results for the PTWs are presented in Figure 7-5. The “Front” view (top left) 
depicts a section in the x-z plane through the centre of the VOI (at a depth of 0.05 mm in the y-
direction). The “Top” view represents six lateral sections (x-y plane) spaced 1 mm apart in the z-
direction. A 3D reconstruction showing the pore distribution throughout the VOI is presented in the 
bottom right. PTWs are arranged in order of increasing VED applied. PTWs analysed for repeatability 
evaluation are presented in Appendix D (Figure D-1).  
 
From the reconstructions of the µCT scans, pores can be observed to be evenly distributed throughout 
the VOI. This suggests intermitting melting during the LPBF process to yield parts with pores 
dispersed throughout and not centred within a certain number of layers. The enabling factor is, 
arguably, the fabrication of layers with a defect factor which subsequently extends through the entire 
part height. This can be observed in the “Top” view images, especially for Figures 7-5 (a) – (d) and (f), 
where through-pores in the VOI are not confined within a single section, but can be observed in 
multiple sections taken throughout the entire height of the PTW VOI. In Figure 7-5 (e) less through 
pores can be observed with nearly none in Figure 7-5 (g). Figure 7-5 therefore visualises that, 
generally, as the VED decreased, the pores became more interconnected to the point where nearly one 
large interconnected pore has been obtained (Figure 7-5(a)).  
 
The intermittent melting of the metal powder resulted in short lengths of fused molten powder material. 
For the part to be built successfully, sufficient bonding is required between layers. The molten material 
sections within each layer should therefore sufficiently overlap with that of the preceding layer to 
establish sufficient bonding. However, when the energy input was too low, adequate bonding between 
successive layers was not achieved. Consequently, the parts were fragmented. Whereas 
interconnectivity of pores is essential for generating a path through the PTW structure for diffusion, it 
is, however, not recommended to work at the minimum VED boundary as this risks part fragmentation. 
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Energy Density: 12.70 J.mm-3
Relative Porosity: 26.74% 
Front Top
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Energy Density: 13.23 J.mm-3




Energy Density: 13.89 J.mm-3
Relative Porosity: 21.17% 
Front Top
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Energy Density: 18.52 J.mm-3
Relative Porosity: 12.27% 
Front Top
Parameter Set: PS-1
Energy Density: 19.84 J.mm-3
Relative Porosity: 16.31% 
(2.13%) 
Front Top
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Figure 7-5: Relative porosities with FE-SEM images of the front surfaces for 400 µm PTW samples in 
order of ascending VED with (a) PS-3, (b) PS-10, (c) PS-7, (d) PS-6, (e) PS-9, (f) PS-1, and (g) PS-5 
 
The relationship of obtained relative porosities to input VED is presented in Figure 7-6. For the 
investigated range of VED, relative porosity values can be simplified to follow a negative linear trend 
(R
2
 = 0.931).  
 
 
Figure 7-6: Scatter plot of obtained relative porosity for different input VED 
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Considering that the VED range investigated was specifically selected for intermittent melting, the 
trend in Figure 7-6 fits well with trends reported elsewhere for the insufficient energy input report as 
well as that of Figure 5-5 (Abele et al., 2015; Hassanin et al., 2016). The dashed circle regards PS-1 
(Figure 7-5(f), 19.84 J.mm
-3
, 16.31%) and PS-9 (Figure 7-5(e), 18.52 J.mm
-3
, 12.27%). Although PS-1 
has a slightly larger VED, a substantially higher porosity than that of PS-9 was obtained. Moreover, in 
the “Top” view images of Figures 7-5(e) and (f) more through-pores for the VOI can be observed for 
PS-1. Due to the range of PS-1 relative porosity measurements, 2.13%, and the standard deviation for 
the centre point PS-7, 0.73%, the inherent variation of the process is unlikely to account for this 
observation. From the screening experiment in Section 5.3 laser power was identified as the main 
factor affecting the relative porosity. The laser power for PS-1 and PS-9 was 50 W and 70 W 
respectively. This increase in laser power could account for the marginally higher level of powder 
particle fusion, decreasing the number of µCT detected through pores. This is reflected in the obtained 
vancomycin release profiles which are further discussed in the next section. Nevertheless, these results 
present a process window, within which parts can be produced from nearly dense to highly porous. 
7.1.2 Vancomycin Release Testing 
The RP-UHPLC vancomycin calibration curve had a R
2
-value of greater 0.999 and is presented in 
Appendix D (Figure D-2). Vancomycin concentration in the buffer at sampling times could thus be 
accurately determined up to the maximum selected standard concentration of 250 µg/mL. 
 
The cumulative mass of vancomycin removed from the release cell at each sampling point during the 
test duration was determined using the following equation, 
 
𝑀𝑏 =  (𝐶𝑛  ×  𝑉𝑏) +  ∑ (𝐶𝑖 ×  𝑉𝑠,𝑖)
𝑛−1




the total mass of drug released in the buffer (µg), Cn the measured concentration at sampling 
point n (µg/mL), Vb the buffer volume (mL), Ci the concentration measured at the previous sampling 
point (µg/mL), and Vs,i the sampling volume at the previous sampling point (mL). The average 
cumulative vancomycin release percentages are presented in Figure 7-7. In order to ease reading of the 
graphs, the profiles have been divided according to the applied laser power, with 50 W and less in 
Figure 7-7(a) and 70 W in Figure 7-7(b). 
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Figure 7-7: Average vancomycin release profiles across PTWs with (a) the process parameter sets with 
laser power of 40 and 50 W, and (b) the process parameter sets with laser power of 70 W. Error bars 
represent the Standard Deviation (n = 3) for PS-7 and the Range (n = 2) for all other parameter sets. The 
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The release profiles generally correlate negatively with applied VED. However, some exceptions can 
be observed similar to that of Section 7.1.1. The quickest release rates were observed for PS-3, PS-7, 
and PS-10 which corresponds to the parameter sets with the highest porosities and through-pores in the 
investigated VOI. The vancomycin release profile for these parameter sets are similar and resemble a 
near-free diffusion profile. A constraint diffusion profile can be observed for PS-1 and PS-6 with 
heavily constraint to little release for PS-9 and PS-5 (Jeon et al., 2012). Therefore, decreasing the VED 
to below a threshold of 13.23 J.mm
-3
 while maintaining a laser power of 50 W, led to the generation of 
sufficient pore interconnectivity that did not significantly inhibit vancomycin transport. This is 
corroborated by the “Top” view images in Figure 7-5. Conversely, a greater difference between the 
profiles of PS-6 and PS-7 was observed, even though the VED differed by only 0.66 J.mm
-3
. The laser 
power, however, differed by 20 W, reflecting the significance of the effects of laser power further 
investigated below. The difference in release profiles demonstrates the application opportunity of LPBF 
to induce porosity for PTWs which resulted in different rates of drug diffusion across the structures. 
Currently, this work appears to be the only publically available results on this specific application 
(Bezuidenhout et al., 2018). 
 
The correlation matrix for the cumulative vancomycin release percentage in the buffer at 12 hours, 
(Mb/M∞|t = 12) to the input variables laser power, P, and scanning speed, v, is presented in Table 7-2. 
The colour coding of the matrix is the same as that used in Table 5-3.  
 
Table 7-2: Correlation matrix for cumulative vancomycin release after 12 hours to laser power and 
scanning speed 
 Run ID P (W) v (mm.s
-1
) Mb/M∞|t = 12 (%) 
Run ID 1.000 0.095 -0.031 -0.283 
P (W)  0.095 1.000 0.131 -0.800 
v (mm.s
-1
) -0.031 0.131 1.000 0.342 
Mb/M∞|t = 12 (%) -0.283 -0.800 0.342 1.000 
 
From Table 7-2 it can be observed that Mb/M∞|t = 12 is strongly negative correlated with P, and 
moderately positive correlated with v. This reflects the effects of P and v on porosity as identified both 
in the screening experiments and in Figure 7-5, albeit here the effect is more pronounced as the ranges 
of the process parameters are limited to a range of interest identified through the preceding screening 
experiments.  
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To statistically analyse the effects of laser power and scanning speed within the investigated ranges on 
vancomycin release through PTWs, a two-factor interaction (2FI) model was fitted according to the 
standard equation below. The ANOVA output for fitting of the 2FI model is presented in Table 7-3. 
 
 𝑌 =  𝛽0 +  𝛽1𝑋1 +  𝛽2𝑋2 + 𝛽12𝑋1𝑋2  (7-6) 
 
Table 7-3: ANOVA for fitted 2FI model 
Source Sum of Squares df Mean Square F-value P-value 
Model 4599.90 3 1533.30 42.28 < 0.0001 
A-Laser Power 3557.52 1 3557.52 98.10 < 0.0001 
B-Scanning Speed 303.17 1 303.17 8.36 0.0161 
AB 150.03 1 150.03 4.14 0.0693 
Lack of Fit 26.6 3 8.87 0.1847 0.9035 
 
The low P-value in the first row indicates that the model is significant. This is also supported by the 
non-significant lack of fit of the model and an adjusted R
2
 value of 0.905. Model fitting and diagnostic 
plots are presented in Figure D-3 in Appendix D. The model equation is provided in Table 7-4. 
 
Table 7-4: Equation of the fitted 2FI empirical model in terms of coded and actual 
Equation in terms of coded factors Equation in terms of actual factors 
                   Mb/M∞|t = 12  =  
                                    + 40.29  
                                    - 21.15       × A  
                                    + 7.09        × B 
                                    + 6.29        × AB 
                   Mb/M∞|t = 12 =  
                                      165.73581  
                                    - 2.66759           × P  
                                    - 0.039919         × v 
                                    + 0.001048        × P × v 
 
The 3D response surface plot is presented in Figure 7-8(a) with the associated interaction plot in Figure 
7-8(b). For the purpose of graphic representation and the discussion which follows, the ‘Laser Power’ 
axis was adjusted to descend away from the intersection with the ‘Scanning Speed’ axis.  
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Figure 7-8: Effect of process parameters on vancomycin release with (a) response surface of two factor 
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Both of the factors have been identified to exert a significant influence on the vancomycin release. 
Laser power was detected as the main significant factor with a P-value of < 0.0001 in comparison to 
scanning speed which has a P-value of 0.0161. The interaction of the factors was detected as borderline 
insignificant (P-value = 0.0693). From the response surface and interaction plots, however, it is clear 
that the effect of scanning speed depended on the corresponding laser power. This is consistent with the 
observations in Figures 7-5 and 7-6. A near-zero gradient can be observed for the low level of laser 
power (40 W) over the full investigated range of scanning speed. This suggests that over the range 
investigated of scanning speed, it is likely that a laser power of 40 W would lead to structures that do 
not inhibit free diffusion of vancomycin from an aqueous solution. However, a significant increase in 
the 12 h cumulative vancomycin release percentage is observed at a high laser power (70 W) as the 
scanning speed increased and the VED decreased. For a laser power of 70 W, little vancomycin was 
released after 12 h (6.88%) at 800 mm.s
-1
 whereas at 1600 mm.s
-1
 a vancomycin release of 33.70% was 
recorded. It supports the argument that laser power is the main factor at lower processing boundaries 
for PTWs. Figure 7-9 presents a pairwise comparison performed using Design Expert software. A 
horizontal reference line is constructed for a selected design point with the least significant difference 
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(b)   
Figure 7-9: Pairwise comparison on predictions for (a) low scanning speed and low laser power and (b) 
low scanning speed and high laser power (adapted from Bezuidenhout et al., 2018) 
 
Figure 7-9(a) statistically supports the observation that scanning speed did not exhibit a significant 
influence with the laser power at the low setting (black-coloured data points). When the laser power 
was at the high setting (red-coloured data points), Figure 7-9(b) demonstrates that the 12 h cumulative 
release percentages were significantly different from that of the reference point for all other extreme 
design points. 
The relation of VED on cumulative release percentage after 12 hours is shown in Figure 7-10(a). 
Cumulative vancomycin release revealed a decrease with an exponential trend (R
2
 = 0.871) as VED 
was increased. This can be attributed to the reduction of pore size, pore interconnectivity and number 
of through pores in the PTWs as the VED was increased. Figure 7-10(b) presents the relation of relative 
porosity on the cumulative release percentage after 12 h of incubation. Initially the trend is highly 
linear (R
2
 = 0.9434, inset in Figure 7-10(b)), but deviates from linearity beyond a relative porosity 
above 21.17% and a VED of 13.89 J.mm
-3
. It is therefore possible that around this point structures were 
obtained with an interconnected porosity which altered the vancomycin release profile from constraint 






X1 = B: Scanning Speed = 800
X2 = A: Laser Power = 70
A- 40
A+ 70
Y = Release (%) = 5.76563
Pairwise comparisons for B-,A+
Point = (Prediction, Interval)
Significantly different:
B-,A- = (60.6379, 45.6267)
B+,A- = (62.2434, 46.609)
B+,A+ = (32.5265, 19.1904)
Scanning Speed, v (mm/s)

















Point = (Prediction, 
Interval)
Significantly different:
v-, P- = (60.64, 45.63)
v+, P- = (62.24, 46.61)
v+, P+ = (32.53, 19.19)
Laser r, P (W)

















P+,  70 W 






Scan i g Spe d, v . -  
Stellenbosch University  https://scholar.sun.ac.za
Chapter 7                               Industrial Engineering 







Figure 7-10: Graphic representation of (a) investigated volumetric energy density and 12 h cumulative 
release percentage and (b) relative porosity to 12 h cumulative vancomycin release percentage (adapted 
from Bezuidenhout et al., 2018) 
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7.1.3 Activity of Released Vancomycin 
The antimicrobial activity of vancomycin released through PTWs produced with PS-10, evaluated 
against S.aureus Xen 36 (MSSA) in duplicate is presented in Figure 7-11. Zones of inhibition (ZOIs) 
around the wells containing vancomycin indicate the area where effective concentrations of 
vancomycin were present. The observed vancomycin activity correlates with the release graphs. 
Effective vancomycin concentrations were released within 5 h and maintained for at least 18 h. 
 
The average and standard deviation of the diameters of the ZOIs were determined with Image J 
software to be 12.29 ± 0.96 mm at 5 h and 12.88 ± 0.60 mm at 18 h, based on five measurements for 
each of the ZOIs at 5 and 18 h from Figure 7-11. The released vancomycin can therefore be considered 
to retain its antimicrobial activity after diffusing through the PTWs, that is, the interaction with LPBF-
produced Ti6Al4V ELI did not cause the vancomycin molecule (Figure 4-1) to degrade. Furthermore, 
the resistance to wetting as indicated by the static water contact angle measurements (Section 7.1.1.1) 
did not restrict vancomycin from transport across the PTW to reach an effective antimicrobial 
concentration in the buffer. 
 
 
Figure 7-11: Activity against S. aureus Xen 36 of vancomycin released through PTWs produced with PS-
10 for different time points (0, 5, and 18 h) as indicated on the petri dishes (adapted from Bezuidenhout et 
al., 2018) 
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7.2 Integrated Reservoir Specimens 
7.2.1 Fabricated Integrated Reservoir Specimens 
Reservoir specimens with integrated PTWs built with PS-10 and the in-process assembly method are 
presented in the as-built state on the LPBF building plate in Figure 7-12 (encircled with the dashed 
line). All specimens were fabricated successfully and no cracked or fractured PTWs were observed.  
 
 
Figure 7-12: LPBF-produced integrated reservoir specimens (encircled) 
 
7.2.2 Vancomycin Release Testing 
The RP-HPLC vancomycin calibration curve had a R
2
-value of 0.987 (Figure D-4, Appendix D). 
Vancomycin concentration in the buffer at sampling times could thus be determined with reasonable 
accuracy up to the maximum selected standard concentration of 125 µg/mL. Since the entire buffer was 
replaced at each sampling point, no correction equation was required as was the case for the 
vancomycin release results presented in Section 7.1.2 for the case of the PTWs (Equation 7-5).  
 
The average cumulative vancomycin release profiles for the integrated reservoir specimens are 
presented in Figure 7-13. For deconvolution of the representation, curves have been split into the 
factorial DoE points (Figure 7-13(a)), axial DoE points (Figure 7-13(b)), and the centre point (Figure 
7-13(c)). Similar to Figure 7-7, error bars in Figures 7-13 (a) and (b) represent the range (n = 2) and 
error bars in Figure 7-13(c) represent the standard deviation (n = 3) for the centre point treatment. 
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Figure 7-13: Average vancomycin release profiles from integrated reservoir specimens for (a) the factorial 
points (error bars represent the range, n = 2), (b) the axial points (error bars represent the range, n = 2), 
and (c) the centre point (error bars represent standard deviation, n = 3. The hole diameter, Ø (mm), and 
PTW thickness (mm) values are indicated at the end of the profiles. 
 
The effect of PTW thickness at the low level of hole diameter (2 mm) is pronounced (profiles 1F and 
3F in Figure 7-13(a) and 2A in Figure 7-13(b)). A significantly quicker release was observed through a 
PTW thickness of 1.5 mm than through a 0.4 mm PTW. This is consistent with the wettability tests 
presented in Section 7.1.1.1. The lagging phase of 1F (< 3 h) can potentially be accounted for by the 
time required to displace the air according to the initial Cassie-Baxter like wetting of the dry 0.4 mm 
PTW. Once the air has been displaced the release rate drastically increased. This implies that a 
percolation type threshold existed where the increased surface free energy of the PTW during wetting 
exceeded the energy required to overcome the surface tension of the aqueous vancomycin solution 
(Bico et al., 2002). Subsequently the PTW was rapidly penetrated by the liquid solution leading to the 
observed increase in vancomycin transport rate. 
 
For diameters 5 mm and 8 mm the observations were different. Vancomycin release profiles for the 8 
mm hole diameter (2F, 3A, and 4F in order of increasing PTW thickness) appear similar. The contact 
area for wetting is thus likely to be large enough at a diameter of 8 mm to quickly overcome the 
apparent hydrophobicity of the 0.4 mm PTW. Furthermore, the effects of the investigated PTW 
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diameter, however, a similar effect to that of the 2 mm hole was observed between the profiles for 
PTW thickness of 0.4 and 1.5 mm respectively (1A and 4A). However, the lowest release rate was 
observed for a PTW thickness of 0.95 mm. The reason for this is not clear. A lag phase can be 
observed, but considering the rapid imbibition observed during the contact angle test (Figure 7-3), this 
lag phase cannot directly be attributed to a resistance to wetting and further research into the transport 
processes within the PTW is required. Nevertheless, it imparts a desirable property for local drug 
delivery leading to a more near-zero order release profile  
 
Furthermore, when considering all the release series represented in Figure 7-13 from a DoE 
perspective, it is not directly evident whether significant effects exist between from the DoE treatments. 
This is corroborated by the result that a meaningful model fit in Design Expert software could not be 
obtained when evaluating the cumulative percentage of drug released at each sampling time point 
respectively. It can, however be observed that differences did occur in the diffusional release rates, 
especially during the first 6 hours of the experiment. To investigate this further, the release data was 
modelled according to a first order diffusive mass transfer model derived by (Lin et al., 2009). Briefly, 




 =  𝑘1𝐴(𝐶𝐴𝑒 −  𝐶𝐴) 
(7-7) 
 
Where k1 is a mass transfer coefficient incorporating the diffusivity and thickness of the diffusion layer, 
A is the surface area for the mass transfer process, CA and CAe is the concentration in the buffer at time t 
and an equilibrium concentration respectively. With regards to CAe it is important to respect the 
limitations of the study such as release time and environmental influences which could unintentionally 
have influences on the diffusion process. When considering a constant volume, as is the case in this 







(𝐶𝐴𝑒  −  𝐶𝐴) 
(7-8) 
 
Equation 7-8 strongly reflects the Noyes-Whitney equation as expressed by Costa and Lobo (2001) for 
drug release from a dosage with constant area under sink conditions,  
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 = 𝑘2(𝐶𝐴𝑒 − 𝐶𝐴) 
(7-9) 
where k2 represents a volumetric mass transfer coefficient (Lin et al., 2009). Integrating Equation 7-9 
with the initial conditions, CA = 0 at t = 0 and CA = CA at t = t yields,  
 
 𝐶𝐴  =  𝐶𝐴𝑒 [1 −  𝑒
−𝑘2𝑡] (7-10) 
 
which can be expressed in terms of release percentage as, 
 
 𝑅 =  𝑅𝑒 [1 −  𝑒
−𝑘2𝑡] (7-11) 
 
where R and Re represents the cumulative percentage drug released into the buffer at time t and at 
equilibrium respectively (Lin et al., 2009). Model parameters were estimated with MSExcel Solver 
using nonlinear least squares fit (Brown, 2001). The nonlinear coefficient of fit R
2
 was computed 
according to Equation 7-12 below (Brown, 2001)  
 
 







The resulting model parameters are presented in Table 7-5. With the exception of treatment 1F all 
treatments show a high coefficient > 0.95 of correlation with the first order model. This is mainly due 
to the lag phase that can be observed for treatment 1F in Figure 7-13(a). After this lag phase however, 
the release follows a typical diffusion profile. Furthermore, as the interest is in sustaining drug release, 
the interest is in lower values of k2, with treatment C exhibiting the lowest value and therefore the 
slowest mass transport of vancomycin across the PTW. Treatment C is also promising for its trend of 
continued release at 24 h rather than presenting a plateau as do most of the other treatments in Figure 
7-13. 
 
The fitted models are plotted with continuous lines to the observed data points for the DoE treatments 
in Figure 7-14. Again, the plots have been split according to the DoE factorial points (Figure 7-14(a)), 
axial points (Figure 7-14(b)), and centre point (Figure 7-14(c)). It is evident that the release profile can 
be described well by this first order model. For the factorial treatments in Figure 7-14(a), the profiles 
are clearly distinguished and closely correlate with the value of k2 with regards to the relative rates of 
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vancomycin release. That is, a higher k2 indicates faster release. For the axial points, this is not the 
case. The profiles are not all clearly distinguished and can be observed to cross each other as a result of 
diffusion rate and a subsequent plateau effect. This is also reflected by the larger range of parameter Re 
for the axial points (43.86 – 57.42) compared to that of the factorial points (43.17 – 50.18). Since Re 
can essentially be regarded as a scaling parameter, it is important to consider also this parameter for the 
axial points. It can therefore be seen that although treatments 1A and 3A have similar mass transfer 
coefficients, the difference in Re yields the total cumulative release to differ considerably. For 
treatments 2A and 4A having similar Re, the difference in release profile can be predicted by the mass 
transfer coefficient k2 from which it could be expected that treatment 4A will have a quicker diffusion 
rate, as is confirmed in the data. 
 
Table 7-5: Model parameters for vancomycin release profiles from integrated reservoir specimens 
Treatment Re k2 R
2
 
1F 43.17 0.1248 0.8874 
2F 44.09 0.2554 0.9916 
3F 50.18 0.3598 0.9925 
4F 46.13 0.3446 0.9586 
1A 43.86 0.1830 0.9638 
2A 51.89 0.2187 0.9930 
3A 57.42 0.1831 0.9768 
4A 50.17 0.3472 0.9992 
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Figure 7-14: Fit of model to the average experimental data for (a) the factorial points (n = 2), (b) the axial 
points (n = 2), and (c) the centre point (n = 3) 
 
As mentioned above, treatment C offered the most sustained release profile, slightly constraining the 
diffusion process. This is clearly correlated with treatment C having the lowest k2 parameter of 0.0969. 
Therefore, treatment C was identified for antimicrobial efficacy testing against S. aureus Xen 36 to 
evaluate the colonisation prevention potential of the strategy of delivering vancomycin locally through 
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7.2.3 Colonisation Prevention Potential 
The antimicrobial activity of vancomycin released from the integrated reservoir specimens produced 
with DoE treatment ‘C’ is presented in Figure 7-15. Specimens were removed from the solidified agar 
to improve visibility of the inhibition zones. The locations of the surface with the PTW are indicated by 
the arrows in Figure 7-15. All three specimens tested prevented S. aureus Xen 36 from reaching the 
surface containing the PTW. This is the surface of interest as bacterial colonisation should be prevented 
on the surfaces which contain the PTWs. The concept evaluated here of utilising LPBF to produce 
reservoirs with in-process integrated PTWs for local delivery of vancomycin offers the possibility of 
effective drug release as well as potential for colonisation prevention of implant surfaces by a 
vancomycin susceptible S. aureus species.  
 
 
Figure 7-15: Inhibition zones showing effective prevention of colonisation of the surface where the 
integrated PTW is situated (indicated with arrows) for integrated reservoir specimens with DoE 
treatment ‘C’ (adapted from Bezuidenhout et al., 2018) 
7.3 Conclusion 
This chapter presented the results from the investigation into the LPBF of integrated Ti6Al4V ELI 
PTWs for controlled drug delivery of vancomycin from an aqueous solution. A method was presented 
for local drug delivery from Ti6Al4V ELI reservoirs with integrated PTWs by utilising LPBF 
technology with a specific emphasis on part consolidation and inducing porosity through tailored 
settings of laser power and scanning speed.  
 
For the 400 µm PTWs investigation, test specimens were fabricated with different sets of process 
parameters. Failed builds or fragmented parts were obtained at a laser power of 30 W. At a laser power 
of 40 W, the effect of scanning on the resulting porosity is predicted to not significantly alter the 
10 mm 10 mm 10 mm10 mm 10 mm 10 mm 
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expected vancomycin release for at least 12 h. A lower boundary was thereby identified for laser power 
where PTWs could be produced considering the investigated range of scanning speed. The drug release 
profile could be altered from constraint to near-free diffusion. It is likely related to the intermittent 
melting occurring at a low laser power (and VEDs below 13,89 J/mm
3
). This constitutes a process 
window for the respective process parameters within which PTWs were produced. Main findings to 
incorporate into the framework are concluded as follows: 
 Permeable features were assembled to dense parts in-process with LPBF by oversizing their 
dimensions and fabricating each feature as a distinct part. 
 Dry PTWs can be tailored from hydrophobic to hydrophilic by either increasing the PTW 
thickness or by pre-wetting. 
 A range of interconnected porosity can be induced in LPBF-produced Ti6Al4V ELI through 
adjustment of the process parameters within the identified insufficient energy input range. 
 Vancomycin was released from an aqueous solution introduced in parts containing PTWs. 
Different release profiles were obtained, offering an alternative drug delivery strategy through 
the utilisation of the implant rather than a temporary spacer. Vancomycin transported across 
LPBF-produced Ti6Al4V ELI PTWs retained antimicrobial activity against S. aureus Xen 36. 
 Cumulative vancomycin released across 400 µm PTW revealed a linear relation to a relative 
porosity of up to 21.17%, after which deviations from linearity were observed. 
 VED should be utilised cautiously as an indicator for the prediction of relative porosity and 
vancomycin release. This is due to the observation that at the low processing boundary within 
the investigated range, laser power became the main factor. Laser power also played a pivotal 
role in the resulting pore size and interconnectivity (Figure 7-5). 
 
For the integrated reservoirs investigation, test specimens were produced with PS-10 to evaluate 
possible effects of geometry in the form of channel opening diameter and PTW thickness on 
vancomycin release. The main implications are summarised as follows: 
 By utilising the method developed it is possible to successfully manufacture reservoirs with 
different hole sizes and integrated PTW thicknesses within the investigated ranges. 
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 For a 2 mm channel opening, the release can be altered by the PTW hydrophobicity. The effect 
is dependent on the hole diameter. A trade-off and potential exist here to tailor the desired 
release to the intended application. 
 Although differences in the resulting release profiles can be observed, a convincing statistical 
model describing the significance of the factors is not readily obtainable from the measured 
data. The rate of release however can be quantified with a first order diffusional mass transfer 
coefficient. Based on this, the centre point (hole diameter of 5 mm and PTW thickness of 0.95 
mm) offered the best release profile within the investigated DoE treatments for the intended 
application. 
 For larger diameter holes, a measure of freedom towards design decisions for the channel 
opening diameter and PTW thickness can thus be transferred to the framework with regard for 
the limitations imparted by the investigated ranges of these two geometric factors. 
 Within the investigated range and within reason unless confirmation experiments are to be 
executed, it is therefore possible to prioritise other aspects that may arise such as compression 
strength and certain requirements for post processing operations above a strict prescription on 
channel opening diameter and PTW thickness. 
 For the purposes of this study it is advised to not depart significantly from the centre point 
treatment ‘C’ and generally the trends indicate that a thicker structure (data limited up to 1.5 
mm) accelerates vancomycin release. The reasons for this are likely to be in physicochemical 
interactions and elucidation of these mechanistic aspects is outside of the scope of this study, 
but emphasised as an important avenue for future research. 
 With the variety of available LPBF systems, it should be noted that the results were obtained 
with the specific applied LPBF system and environmental conditions. 
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8. Implant Internal Structure Functionalisation 
This chapter presents the design, manufacture and antibacterial efficacy testing of the demonstrator 
prototype. It addresses the partial problem of “Prototype fabrication” which is largely a recomposition 
process relying on the output of the preceding partial problems. The antibacterial efficacy of the 
demonstrator prototype is subsequently the evaluation of the functionality of an overall solution. A 
functional demonstrator confirms that a prototype overall solution has been achieved for the overall 
problem within the defined scope. 
8.1 Internal Channel Layout Design 
The process flow of the internal channel layout is shown Figure 8-1. Bullet points indicate the main 
considerations at each process step. The following sections in this chapter systematically discuss each 
of the steps listed and their corresponding considerations. 
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8.1.1 Implant Bulk Geometry and ZOI parameters 
The bulk geometry of the implant body belongs to that of a commercial implant manufacturer, of which 
the details are protected for confidentiality reasons. The main argument influencing the design 
approach is that the external surface of the hip stem can be covered with an arrangement of circles, 
uniform in radius, which represents the ZOI of vancomycin against vancomycin susceptible S. aureus 
strains. Together with the results from Section 7.2.3, Table 8-1 has been compiled which lists a number 
of reported ZOIs for vancomycin susceptible S. aureus. From the control data in Table 8-1 a value of 
15 mm is identified for the working diameter of the ZOI. The value, 15 mm, represents the lower limit 
of the control data and is thus a conservative approach.  
 
Table 8-1: ZOIs reported for vancomycin as positive control against S. aureus strains 
Reference Strain ZOI (mm) Std Dev (mm) Utilisation 
(Hannan et al., 2008) ATCC 25923 21.31 0.79 Positive control 
  UHS Imm 12 19.91 0.38   
  UHS Imm 25 20.86 0.62   
  AFIP 23845 20.66 0.99   
  AFIP 2079 20.66 0.77   
  AFIP 26763 21.85 0.17   
  AFIP 23807 19.88 0.21   
  AFIP 23197 20.53 0.44   
  AFIP 21089 21.9 0.48   
  AFIP 23804 20.36 0.74   
(Gibbons et al., 2002) XU212 18 n/a Positive control 
(Chandrasekaran et al., 2008) n/a 17-21 n/a Positive control 
(Pesewu et al., 2008) UELSHB 102 20 n/a   
  UELSHB 103 22 n/a   
(Mojab et al., 2008) ATCC 33591 17 n/a Positive control 
(Abdallah et al., 2009) ATCC 25923 17.8 1 Positive control 
  MRSA-1 18.0 1   
  MRSA-2 17.6 0.8   
  MRSA-3 18.3 0.8   
  MRSA-4 17.6 0.8   
  MRSA-5 20.0 0.5   
  MRSA-6 21.8 1.3   
  MRSA-N32064 17.8 0.9   
(Percival et al., 2011) MRSA non-spec 17.9 0.9   
(Chan et al., 2014) ATCC 33591 21.0 0.0 Positive control 
  Clinical Isolate 20.2 0.3   
  Clinical Isolate 18.5 0.5   
(Basri et al., 2014) ATCC 33591 18.0 0.0 Positive control 
(Saiful et al., 2011) ATCC 33591 18.83 n/a Positive control 
(Arullappan et al., 2009) Various Isolates 16.0-22.0   Positive control 
(Alshaibani et al., 2016) ATCC 43300 18.0   Positive control 
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(Junaidah et al., 2015) ATCC 49476 16.0   Positive control 
  ATCC 43300 15.0     
  ATCC 33591 15.0     
 
8.1.2 Placement of Channel Openings 
Circles of constant diameter representing the 15 mm ZOI were patterned according to a hexagonal 
arrangement, the densest packing possible. However, as could be expected, a hexagonal packing did 
not perfectly fall within the contours of the implant (Figure 8-2(a)) and what is termed here a ‘pseudo-
hexagonal’ packing arrangement was subsequently implemented using PowerSHAPE. Firstly, a 
position was located where the tessellated centre points yielded circles that just cover the immediate 






Figure 8-2: Channel opening placement approach with (a) full hexagonal arrangement over implant 
profile and (b) starting point identification for pseudo-hexagonal packing 
 
From the intersection point of the three starting circles, indicated with the coordinate system in Figure 
8-2(b), half the distance between a vertical line running through this intersection point and the implant 
profile, and the distance between the centre points of vertically oriented intersecting circles (the vertical 
side of the green triangle in Figure 8-2(b)) were utilised as pattern generation for the circle centre 
points (Figure 8-3(a)). Circles were placed manually for the proximal part (three circle diagonals), with 
the circles on the medial and lateral sides completely ensuring ZOI surface coverage in 3D space 
(Figure 8-3(a)-(c)). 
Stellenbosch University  https://scholar.sun.ac.za









Figure 8-3: Pseudo-hexagonal circle packing with (a) placement of channel openings on anterior surface 
(b) on the medial and anterior surfaces and (c) on the lateral and anterior surfaces 
8.1.3 Internal Channel Generation 
Once channel opening positions have been established, it needed to be configured how the drug 
formulation will reach these release points. This led to many possibilities and possible channel layouts. 
With the main selection criteria being simplicity and maintaining a solid core within the stem for 
strength, the channel layout development for the prototype is presented in Figure 8-4. First a spline was 
fitted to the selected channel fill pattern and manually edited to fit inside the margin lines set for 
maintaining a wall thickness of 3 mm (based on conformal cooling channel designs (Armillotta et al., 
2014) (Figure 8-4(a))). Therefore, at the channel openings, situated at the apices (which represent exit 
points) of the smoothed spline (Figure 8-4(b) and (c)), the effective margin is 3 − (0.5 × channel 
diameter) mm. The remaining margin is thus the distance from an exit point of the channel to the 
surface. To avoid the channel running into itself, the maximum constant profile diameter was found to 
be ± 2.5 mm (Figure 8-4(d)). It was also ensured that the channel remained within the internal margin 
on the medial-lateral sides of the stem (Figure 8-4(e)). 
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          (d)                                         (e)   
Figure 8-4: Internal channel layout with (a) anterior-posterior view  of channel fill variant, (b) repointed 
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The PowerSHAPE software operates largely with Boolean operations for trimming, cutting, combining, 
or splitting solid models. Subsequently, the surface channel model was converted to a solid and ensured 
to be watertight. A cutter insert was then designed for the channel openings. A cutter was placed at 
each of the channel opening points and moved inwards to interfere with the stem perpendicular to its 
own work plane situated at the respective channel opening. This allowed control over the orientation of 
the curves leading into the margin and to the surface of the implant. Figure 8-5(a) shows the channel 
(converted to a solid for Boolean operations) with cutter inserts (cutter insert with dimensions showed 
in breakout image). The channel with cutters was then Boolean subtracted from the implant body, 
yielding the stem with integrated channel and openings (Figure 8-5(b)). The internal channel is 
designed with loading and extraction points in the recess where the surgeon impacts the implant during 
insertion (Figure 8-5). Utilising this area for channel main entry and exit theoretically provides the 
opportunity for reinforcing the existing drug, or extraction, rinsing, and loading of a different drug with 
minimally invasive procedures.  
 
         
             (a)                                     (b)  
Figure 8-5: Internal channel generation in hip stem with (a) channel solid model and cutter inserts and (b) 
hip stem solid model with internal channel 
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8.1.4 Static Stress Analysis Simulation 
The stem design was evaluated with a static stress analysis in ANSYS 2020 R2 according to the 
orientation, load, and boundary conditions specified for fatigue testing in ISO 7206-4 – Orientation of 
specimen under test – Implant with no anteversion (ISO 7206-4:2002(E), 2002). Use of this 
international standard for static stress analysis was also regarded as a standardisation approach for 
design evaluations within the larger collaborative Intelligent Implants project. The orientation and load 
case applied to the cementless stem with internal channel model is presented in Figure 8-6(a). A load of 
2.3 kN is applied to the face in contact with the femoral head in the negative z-direction (Ploeg et al., 
2009) and the outer surfaces of the embedding medium are fixed. The tetrahedral (Tet10 elements) 
mesh is presented in Figure 8-6(b). Mesh refinement at the contact regions included reduction of 
element size and matching of the nodes of contacting elements between the two bodies (inset in Figure 
8-6(b)). The resulting mesh consisted of 419,380 nodes and 267,485 elements. The material properties 
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Figure 8-6: Prototype hip stem static stress analysis setup with (a) orientation, load, and boundary 
conditions of model and (b) mesh setup in ANSYS 2020 R2 with inset showing nodes matching at contact 
surfaces 
 
Table 8-2: Material properties used in the static stress analysis simulation 
Material Reference Property Value 
Ti6Al4V ELI  Density (kg.m
-3
) 4430 
(ASTM International, 2013) Elastic modulus (GPa) 104.8 
(Bari & Arjunan, 2019) Poisson’s ratio 0.32 
(Hocking et al., 2019) Tensile yield strength (MPa) 795 
 Tensile ultimate strength (MPa) 860 
 Compressive yield strength (MPa) 825 
   
Embedding medium Elastic modulus (GPa) 4.5  
(ISO 7206-4:2002(E), 2002) Poisson’s ratio 0.35 
(Kurtz et al., 2001) Tensile ultimate strength (MPa) 35.3 
(Lee, 2005) Compressive ultimate strength 93.0 
 
The von Mises equivalent stress and total deformation distributions resulting from the simulation are 
presented in Figure 8-7. The maximum von Mises equivalent stress (Figure 8-7(a)) is approximated as 
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289.03 MPa (compared to 156.97 MPa of the solid stem reference presented in Figure F2 in Appendix 
F), which is safely below the yield strength of wrought Ti6Al4V ELI, the benchmark material (795 
MPa used as reference) as well as reported fatigue strengths for post processed LPBF-produced 
Ti6Al4V ELI (Li et al., 2016). Initial inspection of the simulation results revealed a possible concern 
regarding the current design which is the location of the areas of maximum simulated stress, visible in 
Figure 8-7(b).  
 
However, when regarding the total deformation in Figure 8-7(c), it can be observed that the simulated 
deformation in areas of maximum stress is low, in the range 0 – 0.06 mm (Figure 8-7(d)). Furthermore, 
the overall maximum total deformation is 0.54 mm, situated at the same site of that of the reference 
stem, which has a maximum simulated deformation of 0.45 mm (Figure F2 in Appendix F). The 
deformation distribution contours of the two stems are highly similar, suggesting that no large 
deformations are introduced to the stem with the internal channel design. Considering the simulation 
results with regard to the maximum stress and deformation distributions, the current design is deemed 
safe as a proof of concept with reference to the properties of wrought Ti6Al4V ELI. As stated 
previously, this study assumes that comparable properties can be obtained for LPBF-produced 
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Figure 8-7: Selected static stress analysis results with (a) full prototype model view, (b) view of maximum 
stress areas, and (c) total deformation approximation, and (d) zoomed view of total deformation in max 
von Mises equivalent stress area 
 
8.2 Implant Prototype Manufacture 
8.2.1 First Iteration Prototype Fabrication 
To produce an in-process assembly of the implant prototype with permeable structures, oversized discs 
of 1 mm thickness were placed at each channel opening, presented with the purple discs in Figure 8-8. 
The first manufacturing iteration involved the production of sections of the hip stem to demonstrate the 
internal geometry inside the proximal part while allowing for testing of loading and release screening 
of a blue dye to demonstrate the intended drug release capability through passive diffusion. The Magics 
build setup for the partial prototypes are presented in Figure 8-9(a) and the built parts in Figure 8-9(b). 
Splitting the proximal part in three sections, the interior surfaces are exposed and accessible for 
demonstration purposes. The distal stem parts were kept intact for the evaluation of antimicrobial 
efficacy with the addition of a foot piece to act as a jig to enable stable upright positioning. 
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Figure 8-9: First iteration of LPBF prototype build with (a) Magics build setup and (b) actual parts.  
 
Solid parts were built with the default process parameters and permeable discs with PS-10 from Table 
6-1. The support structure parameters are presented in Table 8-3 below. 
 
Table 8-3: First prototype build iteration support structure parameters 
Support Parameters 
Hatching 1 mm x 1 mm – no rotation 
Hatching Teeth  
Height 1 mm 
Top Length 0.5 mm 
Base Length 1 mm 
Base Interval 0.2 mm 
Fragmentation  
X Interval 5 mm 




Border Teeth Same as hatching teeth 
Perforations Diamond 
Beam 0.8 mm 
Angle 60° 
Height 1 mm 
Solid Height 3 mm 
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8.2.2 Post Processing 
Parts were removed with w-EDM. Removal of support remnants was done by hand. Reduction of 
surface roughness was done on the proximal parts for cosmetic purposes only as the parts were not 
subjected to mechanical testing. Silicon carbide sandpaper of various grit sizes (600 – 1200) was used 
for manual sequential grinding of the surfaces with support remnants using water as grinding fluid. 
Internal areas of the top sections were cleaned for demonstration purposes with an air drill and brass 
abrasive wheels.  
 
Distal surfaces were kept in the as-built state (Figure 8-10) as the LPBF-produced mean surface 
roughness (11.99 ± 3.49 µm measured at six randomly selected locations along the build direction) is 
advantageous for osseointegration (Maher et al., 2017). To remove unfused powder particles, parts 
were repeatedly cleaned with a sequence of compressed air and sonication in acetone, ethanol, and 
distilled water respectively, and air dried. 
 
 
Figure 8-10: First iteration prototypes for inspection and demonstration purposes  
 
8.2.3 Part Inspection 
The main aspect for inspection was channel continuity and permeability of all PTWs. A qualitative 
demonstration has been performed with loading of a blue dye aqueous solution and passive diffusion 
through the PTWs into a reservoir containing distilled water (Figure 8-11). The aqueous dye solution 
was introduced with ease using a siphon method (Figure 8-11(a)). It was evident that no obstructions 
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existed within the channel and that all the channel openings could be sufficiently reached. The partial 
stem was then lowered into the distilled water reservoir (Figure 8-11(b)) and diffusion of the blue dye 








Figure 8-11: Distal part of prototype blue dye diffusion screening with (a) dye loading, (b) stem 
immersion, (c) continued diffusion of blue dye 
 
8.3 Antimicrobial Testing of Prototype 
8.3.1 Experimental Setup and Design 
The estimated channel volume within the partial stem was extracted from the 3D CAD model as ~ 3 
mL. With reference to the vancomycin release and activity from integrated reservoirs discussed in 
Sections 7.2.2 and 7.2.3 the objective was to load the channel of the partial prototype with a 
vancomycin concentration which would near 1 mg per PTW channel opening. Considering the 47 
PTWs in the partial prototype, the vancomycin concentration was rounded to 15 mg/mL (~45 mg of 
vancomycin) to yield a theoretical availability of ~ 957 µg vancomycin per PTW. This approach was 
used as a guideline only and assumed total and even availability of the loaded vancomycin solution at 
the PTWs which in practice would not necessarily be the case. The physical setup for the vancomycin 
loading procedure is demonstrated in Figure 8-12.  
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Figure 8-12: Physical setup of vancomycin solution loading procedure 
 
A reduction container was made from cellulose acetate foil and placed inside a glass beaker. All 
equipment was sterilised by 70% ethanol and UV irradiation. Sterile tubing was fixed and sealed to the 
channel to enable loading of the vancomycin solution. A 5 mL syringe with an 18 gauge hypodermic 
needle was used to drop 3 mL of the 15 mg/mL vancomycin solution into the stem and an empty 5 mL 
syringe with an 18 gauge needle was connected to the secondary sterile tube (not present in Figure 
8-12) to assist in removing air which may obstruct the flow of the vancomycin solution. Directly after 
introduction of the vancomycin solution the reduction container was filled with ~ 120 mL media 
containing an inoculum of S. aureus Xen 31 (MRSA strain) which was prepared by the Department of 
Microbiology with the same process as described in Section 6.2.2.2 and incubated at 37 °C for 24 
hours. A retrieved commercial Ti6Al4V (ISO 5832-3 specification) cementless stem (the porous 
surface of Ra 15.66 ± 1.44 µm consists of plasma sprayed titanium and a hydroxyapatite coating) was 
kindly donated for research purposes and incubated with the same process as the prototype partial stem, 





















Stellenbosch University  https://scholar.sun.ac.za




The prototype and commercial stems after 24 hours incubation are presented in Figures 8-13(a) and (b) 
respectively. Initial evaluation indicated that for the prototype stem no visible S. aureus Xen 31 growth 
was observed and subsequently, the results were treated in a qualitative manner to demonstrate the 
antimicrobial functionality of the partial prototype. The growth media surrounding the prototype stem 
had an absence of the typical observations for S. aureus Xen 31 proliferation on the top surface (Figure 
8-13(a)), with the contrary observed for the commercial stem in Figure 8-13(b) as indicated by the 
annotations. Furthermore, when qualitatively considering the turbidity of the growth medium which 
increases with bacterial growth, visibility through the growth medium was noticeably greater for the 
prototype stem than for the commercial stem. In Figure 8-13(c) details such as the PTWs and the 
chamfer on the corner of the prototype stem are clearly distinguishable. In comparison, the embedded 
part of the commercial stem in Figure 8-13(d) is only visible as an indistinguishable dark mass and no 
features on the stem can be clearly identified. The lack of bacterial growth for the prototype stem is 
visually observed throughout the entire media surrounding the stem after removal of the stem (Figure 
8-13(e)). For the commercial stem, S. aureus Xen 31 growth can be observed in the media surrounding 
the stem (Figure 8-13(e)). These observations corroborate both observations regarding bacteria 
proliferation on the top of the media as well as the differences in visibility related to the resulting 
turbidity caused by the absence and presence of S. aureus Xen 31 in the surrounding media of the 
prototype and commercial stems respectively. It is therefore concluded that vancomycin was 
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Figure 8-13: Photographs after 24 hours incubation of (a) prototype stem, (b) commercial stem, (c) 
enlargement of prototype stem, (d) enlargement of commercial stem, (e) surrounding media of prototype 
and commercial stem visible after stem removal 
 
8.4 Conclusion 
This chapter presented the design, manufacturing, and colonisation prevention potential testing of the 
prototype cementless hip stem. The process involved recomposition of the preceding partial solutions 
to generate an overall solution which has effectively addressed the overall problem. Considering 
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the antibiotic resource consumption could potentially significantly be lowered through the concept 
developed in this study. The main conclusions are summarised as follows: 
 A method has been developed to design an internal reservoir based on ZOI of the target 
pathogen and antibiotic combination. It could be defined as a circle packing problem for the 
minimum amount of circles of constant radius required to cover an arbitrary geometry. 
Therefore, a pseudo hexagonal approach was utilised. 
 Based on a static stress analysis, the design was considered safe. However, fatigue testing 
would be required to truly determine this. This was outside of the scope due to the focus being 
on antimicrobial efficacy. 
 The demonstrator components were manufacturing in-house using a basic LPBF process chain. 
The internal reservoir was open throughout and did not obstruct flow of aqueous solutions. 
 Recomposition of partial solutions from the systematic investigation into LPBF for PTWs in 
Chapters 5-7 amounted to specifying PTWs which were successfully fabricated and assembled 
in-process. All PTWs were highly permeable when inspected with blue dye. 
 A custom setup was developed to evaluate the potential for colonisation prevention of an 
MRSA strain. The demonstrator released vancomycin in sufficient concentrations to effectively 
prevent growth or subsequent surface colonisation of the prototype by S.aureus Xen 31. 
 This provides a platform from which further research can be conducted regarding the 
optimisation of drug and device combination. 
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9. Framework Update and Implementation 
This chapter presents an updated version of the high-level overall problem solving framework 
presented in Chapter 3. The implementation of the framework within the specifics of this study is then 
demonstrated in a table format. It provides a summary of the collaborative effort and the integrated 
concepts developed during the project to yield an overall solution prototype for prevention of 
cementless hip stem surface colonisation by pathogenic bacteria. 
9.1 Updated Interdisciplinary Problem Solving Framework 
The high-level overall problem solving framework consisting of five levels as presented in Figure 3-2 
has been revised within the context of this study and is presented in Figure 9-1. The original five levels 
are now indicated with the shaded pillars. Each pillar is detailed with process steps with the aim of 
yielding an integrated outcome for input to the following level (indicated with the shaded document 
flowchart objects below the process steps). For the decomposition of partial and single problems, as 
well as the recomposition of single solutions to partial problems, the steps should be applied to each 
identified partial and single problem. Where possible, the single problems should be addressed 
concurrently to increase efficiency and provide real time information for the evaluation of interfacing 
and integration adequacy. Trade-offs and potentials identified as well as IKPs should be documented 
and stored with access for future projects. 
 
The updated overall framework is considered to be a product of both a deductive and inductive process. 
Initially, a high-level framework was derived from literature to serve as a point of departure. During 
execution of the various interdisciplinary aspects of this project, each part of the overall problem was 
decomposed to partial and single problems. Within each of these problems, with the exception of the 
vancomycin sustained release alternative, an integrative approach from the main perspective of the 
LPBF was followed.  
 
Recomposition of solutions to single problems thus does not blindly assemble generated elements to a 
functional whole, but strives to impart an IKP at each of these processes. This further aims to 
continuously develop creativity and innovation within each of the collaborative disciplines as project 
members are exposed to knowledge areas outside of their traditional focus area and perspective.  
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Figure 9-1: Updated overall framework 
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9.2 Framework Implementation Summary 
As indicated in the framework, the implementation is based on the breakdown and clarification of 
overall, partial, and single problems. The initial problem breakdown structure is updated with 
communication lines between single problems and presented in Figure 9-2. Interdisciplinary 
communication was therefore essential in execution of the single problems. A summary of the 
framework implementation is presented in Table 9-1. 
 
 
Figure 9-2: Communication lines that developed between single problems during execution of the project 
 
Release testing of specified 
model drug formulation 
through PTWs
Application of LPBF for the Passive Functionalisation of a Cementless Hip 
Stem to Enable Drug Delivery and Prevent Bacterial Colonisation
Enabling drug release 
from implant reservoirDrug formulation
Specification of model drug 
formulation
Prototype fabrication
Integrating permeable and 
solid components for 
reservoir and release 
functionality
Design of internal channel 
layout
Fabrication of alternative 
sustained release 
formulation
Inducing porosity for 
fabrication of permeable 
thin walls (PTWs)
Manufacturing of prototype 
cementless hip stem











Release testing of specified 
model drug formulation 




• IE – Industrial Engineering
• MB – Microbiology
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Table 9-1: Summary of overall framework implementation 

























High level problem 
description 
IE Literature review and proposal for 
project based on high level 
description of overall problem and 
proposal of potential solution 
concept 
Description of problem of bacterial colonisation and biofilm 
formation of surfaces of cementless hip stems 
 
Proposal of research opportunity into identified potential 
overall solution concept of utilising LPBF for the production of 
implants with drug delivery functionality to prevent 
colonisation of the surface by a bacterial pathogen 
 
Overall problem title: “Application of LPBF for the Passive 
Functionalisation of a Cementless Hip Stem to Enable Drug 
Delivery and Prevent Bacterial Colonisation” 
Identify disciplines IE Approach departments and 
researchers with result from high 
level problem description to discuss 
collaboration opportunity. 
Initial meetings between IE and MB regarding potential 
collaboration. Establishment of commitment and confirmation 




IE/MB In depth discussion of a 
collaboration commitment 
including initial budget 
requirements 
Collaborative commitment between IE and MB: 
 Two professors from IE 
 One professor from MB 
 One research student from IE 




IE/MB Revision of problem description 
and involved disciplines - a single 
party may be able to account for 
more than one discipline 
Confirmation of overall problem, involved disciplines and a 
suitable collaboration team for project execution. Agreement 
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IE/MB High level definition of partial 
problems and responsible members 
– first listed member takes main 
responsibility where responsibility 
is shared 
MB/IE: Drug formulation 
IE/MB: Enabling drug release from implant reservoir 
IE: Prototype fabrication 
IE/MB Breakdown of overall problem into 








IE/MB Within each discipline, a literature 
review was done to identify key 
knowledge areas  





IE/MB Initial single problems were 
collaboratively defined for each of 
the partial problems to map out the 
objective logic towards obtaining a 
prototype solution for each partial 
problem. The specific methods and 
infrastructure required are not yet 
defined at this point. 
Problem breakdown structure for overall problem, partial 





IE/MB Evaluation of work breakdown 
structure and identification of early 
fundamental constraints to aid in 
establishing initial boundaries for 
the solution search space 
 Model pathogens are strains of S. aureus 
 Model drug formulation is aqueous vancomycin 
 Cementless hip stem (no head or cup) 
 Main manufacturing technology is LPBF 
 Feature size limitations of LPBF machine 
 Trade-off between formulation and demonstration of drug 
release from implant: at MB a sustained release vancomycin 
formulation was being developed while concurrent 
evaluations of drug release functionality of manufactured 
components at IE were done with aqueous vancomycin 
solutions at MB  
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IE/MB Deeper evaluation of initial single 
problems within partial problems 
and identification of available 
infrastructure and feasibility of 
executing the work within the high-
level budget limitations. Identified 
infrastructure can be available 
within the department, the 
university (other departments or 
analytical services), or third party, 
subject to the necessary non-
disclosure agreements and costs. 
Within departments: 
 CAD, CAM, and CAE software 
 LPBF machine and material 
 Fused deposition modelling (FDM) machines 
 EDM wire cutter 
 Sandblaster 
 General power and hand tools 
 General microbiology laboratory equipment and 
consumables 
 BCA assay machine 
 HPLC machine and column 
 Optical microscopes 
Within university: 
 SEM facility 
 UHPLC facility 
 CT-scanning facility 




IE/MB From the initial problem structure, 
collaboration team members should 
identify and discuss the potential 
information flow between partial 
problems as well as required 
collaborative work efforts. The 
specifics regarding the 
collaborative work efforts are 
elucidated at the single problem 
stage.  
All partial problems interact.  
Drug formulation and Enabling release from implant reservoir:  
 PTWs were evaluated and specified for prototype 
based on tests with model drug formulation 
Drug formulation and Prototype fabrication: 
 Drug formulation should be introducible to prototype 
and sufficiently reach all channel openings 
 
Enabling drug release from implant reservoir and Prototype 
fabrication: 
 Developed PTWs were integrated into the actual 




IE/MB Meetings to review preceding 
outcomes and compile a project 
proposal document. 
The results from steps were above were consolidated into a 
project proposal document for evaluation by the project 
funders. 
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and gathering of 
available historical 
data 
MB/IE Specification of clinically relevant 
antibiotic and literature review on 
sustained release formulations of 
the identified; Study models for 
understanding polymer erosion to 
gain a functional understanding 








MB/IE Evaluate literature and propose a 
solution concept; adapt a computer 
simulation from literature to 
improve understanding of polymer 
erosion 
For model drug formulation, release from the implant 
prototype and antimicrobial efficacy were evaluated with an 
aqueous vancomycin solution 
 
For a sustained release alternative, a PLGA nanoparticle 
formulation was proposed as solution concept 
 
A stochastic simulation program aids in the visualisation and 
functional understanding of PLGA bulk erosion  
Problem specific 
methodologies 
MB/IE Problem specific methodologies 
where available were identified 
from literature. Where literature did 
not provide clear guidelines, 
custom experimental setups were 






















MB/IE Evaluate results in terms of 
communication and interfacing 
with each other. 
The prototype was required to release vancomycin formulated 
as an aqueous solution. 
 
The alternative sustained drug formulation was developed as 
an independent branch to demonstrate that vancomycin could 
be supplied to a reservoir for an extended duration. 
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and gathering of 
available historical 
data 
IE/MB Literature was reviewed regarding 
inducing porosity with the LPBF 
process for drug delivery 
application 
Little to no available literature on the specific LPBF 
application of inducing porosity to fabricate PTWs for drug 
delivery (Section 2.3.4), signalling an opportunity and the need 






IE/MB Using available literature as a guide 
as well as LPBF process knowledge 
a solution concept was mapped out 
Utilising the LPBF process to induce porosity with tailored 
process parameter settings and in-process of components using 
interference geometry for separate components and effectively 





IE/MB Applicable methodologies were 
both identified from literature and 
drawn from in-house experience. 
Some trial and error approaches 
were required to develop custom 
experimental setups for 
vancomycin release testing. 
















IE/MB Evaluate results in terms of 
communication and interfacing 
with each other. 
The interfacing between PTWs and solid reservoirs for the 
release of vancomycin from an aqueous solution was deemed 
acceptable. Care should be taken to the placement of PTWs 
and potential effects on the accumulation of stresses. Although 
an in-depth investigation of this was outside the scope of this 
study, circular geometries in the dimensional ranges used were 
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and gathering of 
available historical 
data 
IE Literature review on ZOI for 
vancomycin against S. aureus 
strains; Review of LPBF design 
guidelines; Studying LPBF 
machine specifications and 
capabilities; studying LPBF process 
chain 






IE Conversion of categorised 
knowledge for a strategy to design 
and manufacture the demonstrator 
prototype cementless hip stem 
Strategy for the design of the channel layout (Section 8.1) and 
for the manufacturing of a demonstrator prototype cementless 
hip stem (Section 8.2) 
Problem specific 
methodologies 
















IE Evaluate design and manufacturing 
outcome in terms of 
communication and interfacing 
with each other. 
The design of the prototype solution was fabricated with LPBF 
for a physical demonstrator model. 
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interfacing to other 
partial problem 
solution 
IE/MB Evaluate if partial problems are 
adequately fulfilled and integrated 
Partial problems are fulfilled and no conflicts regarding 















































of overall solution 
concept prototype 
according to overall 
problem 
IE/MB Custom experimental setup to 
evaluate functionality of overall 
prototype solution (Section 8.3) 
S. aureus Xen 31 (MRSA) was successfully prevented from 
colonising the demonstrator stem surface (Section 8.3) 
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10. Conclusion and Future Research 
The research presented aimed at contributing a prototype strategy for the prevention of periprosthetic 
joint infection (PJI) in the context of cementless hip stems by utilising the capabilities offered by metal 
additive manufacturing (MAM). This required an interdisciplinary approach. Therefore, in order to 
support the research aim, a framework was developed for systematic interdisciplinary problem solving 
from a laser powder bed fusion (LPBF)-centred perspective. An overall problem for investigation was 
defined as “Passive Functionalisation of a Cementless Hip Stem Inner Structure to Enable Drug 
Delivery and Prevent Bacterial Colonisation”. Using the high-level framework, the overall problem 
was decomposed into partial and single problems which were systematically investigated through 
further literature study and experimentation. The prototype solutions obtained for each single problem 
were recomposed for solutions to partial problems, which were finally recomposed to an overall 
prototype solution. This study therefore encompassed deductive as well inductive approaches as 
insights gained during the systematic problem solving were utilised to update the framework for a 
generically applicable detailed procedural representation. This project formed part of a larger 
international interdisciplinary collaborative project towards the development of intelligent implants 
under the lead of the Fraunhofer Institute for Machine Tools and Forming Technology (IWU).  
 
A significant gap was identified between external and internal drug delivery strategies in research 
where external refers to the surface and internal to the incorporation of reservoir structures within the 
bulk of the implant. The systematic study and investigation of LPBF for an internal local drug delivery 
strategy resulted in the successful prevention of bacterial colonisation onto a prototype cementless hip 
stem surface, confirming that the research objectives were achieved. The original contributions of the 
study can be summarised in two main categories corresponding to the experimentation and framework 
development phases respectively.  
 
In the first case, this involves the systematic application of LPBF to enable drug delivery from 
cementless hip stems and secondly, an LPBF-centred approach for interdisciplinary problem solving to 
develop an effective prototype solution for prevention of implant bacterial surface colonisation. It 
directly addressed the research gap in order to contribute to local drug delivery strategies for 
cementless implants. It also contributes to the advancement of LPBF as manufacturing technology by 
demonstrating the efficacy of the prototype solution. The contributions in this case can be summarised 
as follows: 
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 A method has been developed to directly integrate PTWs with dense components through an in-
process assembly technique. Oversizing the components enables a re-melt at the interfering 
dimensions. This enables the production of in-process assemblies of components built with 
different process parameters without the need for expensive aftermarket software modules. 
 A process window was developed for LPBF fabrication of permeable thin walls (PTWs) 
Ti6Al4V ELI structures based on lowering of the volumetric energy density (VED) through 
suitable values for laser power and scanning speed. Pores resulting from intermittent melting 
and sintering due to insufficient energy input are evenly distributed and interconnected to 
enable vancomycin diffusion across the PTWs. The process window constitutes a VED range of 
~10 – 20 J.mm
-3
. It is however subject to the specific LPBF system and should be adapted 
accordingly. 
 VED as a criterion, however, should be considered in conjunction with the individual process 
parameters, especially at processing boundaries. At the lower processing boundary laser power 
became the main factor. Within the investigated ranges laser power had a significant effect on 
the resulting pore size and interconnectivity. 
 For 400 µm PTWs vancomycin release profiles from an aqueous solution could be altered by 
the induced porosity from constraint to near-free diffusion at a relative porosity above 21.17% 
(VED of 13.89 J.mm
-3
). 
 Pore shapes are irregular with constricting dimensions below 50 µm, which is significantly 
smaller than pore sizes obtainable on current commercial LPBF machines with lattice structures 
and full density process parameters. 
 The PTW structure can be altered from hydrophobic due to a Cassie-Baxter wetting state to 
highly hydrophilic by increasing the thickness of the PTW within the investigated range of 0.4 – 
1.5 mm. 
 Vancomycin released from Ti6Al4V ELI PTWs produced with LPBF retains its antibiotic 
efficacy. 
 A method has been developed to design an internal reservoir for antimicrobial drug delivery 
based on the zone of inhibition of the target pathogen and antibiotic combination.  
 The manufactured cementless hip stem released vancomycin effectively to prevent surface 
colonisation by S. aureus Xen 31, confirming the efficacy of the developed drug delivery 
strategy. 
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In the second case, a framework for interdisciplinary problem solving was developed that guided the 
creation of an LPBF-centred process chain aimed for enabling local drug delivery from cementless hip 
stems. During the conceptualisation phase of an LPBF-centred project, the interdisciplinary nature can 
be underestimated, especially the required depths of understanding within each of the involved 
disciplines. The framework can be used to provide insight for potential manufacturers into the 
necessary skills requirements for such projects. Due to its intended level of genericity, the framework 
can be adapted for other interdisciplinary overall problems based on the enabling technology through 
which the solution must be integrated. The framework promotes the continuous build of experience and 
lateral approaches spanning across disciplines. This has benefits specifically pertaining to finding 
customised solutions for experimental setup and infrastructure requirements within research 
organisations.  
 
Through the research presented in this thesis, possible areas for further investigation and development 
have been identified. These are summarised as follows: 
 Evaluation of the mechanical properties of PTWs in comparison to designed lattice structures to 
develop application limitations regarding load-bearing environments. 
 The capillary action of the PTWs can be researched for wicking applications such as heat pipes. 
It can also be investigated for tissue engineering as capillary action may drive nutrients through 
the structure enhancing cell growth.  
 The effects of increasing PTW thickness on cleaning and powder removal difficulties can be 
investigated. For example the use of piranha solution can potentially remove the loosely 
sintered powdered particles while avoiding significant material removal of the PTWs and 
simultaneously oxidise the entire PTW structure to enhance the biocompatibility.  
 Different drugs and release formulations can be investigated to systematically build an 
application profile.  
 Framework software can be developed to build a database of historic data and generated IKPs. 
This would enhance efficiency in future projects where trade-offs and potentials can already be 
studied from a database as well as relevant IKPs retrieved. Any insights regarding trade-offs, 
potentials, and generated IKPs should be fed back to the database to build an integrated 
knowledge system for interdisciplinary research projects. 
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Appendix A: Supplementary Information to Chapter 1 
Table A-1: Commercially produced MAM medical implants (non-exhaustive list) 
Company AM Type Surgical Application Material Year  Reference 
Adler Ortho S.R.L. EBM Acetabular cup Ti-6Al-4V 2007 (Ohldin, 2010) 
Lima-Lto EBM Acetabular cup Ti-6Al-4V 2007 (Ohldin, 2010) 
Advanced Medical 
Technologies 
EBM Interbody fusion cage Cp Ti 2009 (Ohldin, 2010) 
Stanmore Implants 
Worldwide Ltd 
LPBF Pelvic reconstruction Ti-6Al-4V 2010 (Unwin, 2013) 
Layerwise  LPBF Facial reconstruction Ti-6Al-4V 2012 (Nickels, 2012) 
Exactech EBM Acetabular cup Ti-6Al-4V 2012 (FDA, 2012) 
4WEB Medical EBM Interbody fusion cage Ti-6Al-4V 2014 (FDA, 2014) 
BioArchitects EBM Patient specific 
cranioplasty plate 
Ti-6Al-4V ELI 2015 (FDA, 2015) 
Stryker LPBF Interbody fusion cage Ti-6Al-4V 2016 (FDA, 2016) 





Bone fixation fastener Ti-6Al-4V 2016 (FDA, 2016) 
  Bone fixation plate Ti-6Al-4V ELI 2016 (FDA, 2016) 
  Locking lattice plate Ti-6Al-4V ELI 2017 (FDA, 2017) 
Emerging Implant 
Technologies GmbH 
LPBF Interbody fusion cage Ti-6Al-4V ELI 2017 (FDA, 2017) 
Materialise NV LPBF Maxillofacial 
reconstruction system 
Cp Ti 2017 (FDA, 2017) 
(Heufelder, et al., 
2017) 
Medacta EBM Tibial cone Ti-6Al-4V 2017 (FDA, 2017) 
Stryker LPBF Interbody fusion cage Ti-6Al-4V 2017 (FDA, 2017) 
CoreLink, LLC PBF Interbody fusion cages Ti-6Al-4V ELI 2017 (FDA, 2017) 
Camber Spine EBM Interbody fusion cages Ti-6Al-4V 2017 (FDA, 2017) 
Medtronic Sofamor 
Danek, USA Inc. 
LPBF Interbody fusion cages Stainless steel; 
Ti-6Al-4V ELI 
2017 (FDA, 2017) 
Stryker LPBF Interbody fusion cage Ti-6Al-4V 2018 (FDA, 2018) 
4WEB Medical EBM Bone fixation appliance  Ti-6Al-4V ELI 2018 (FDA, 2018) 
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Appendix B: Vancomycin Encapsulation Biodegradable Polymers 
 
The resulting publications list from the literature search described in Section 4.1.1 is summarised in 
Table B-1. The following notes accompany the table: 
 In many of the studies the polydispersity index (measure of particle size uniformity) has not 
been reported and was therefore not included 
 An important factor influencing the drug release is the pH of the release medium (Liu et al., 
2017). Where studies investigated release at different pH levels, preference was given to 
release performed at pH values of or closest 7.4; that of the PBS buffer solution typically 
used in-house (Bezuidenhout et al., 2015).  
 Burst release was evaluated according to whether more than 20% of the loaded drug was 
released in the first phase of release 
 In the column “Release Testing Period” the duration was either approximated from reported 
release curves or in the case where testing was stopped prior to full release indicated with a 
greater than sign 
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Table B-1: Summary of publications for sustained vancomycin drug delivery formulations 












Potato starch         
 1,300 kDa Nanoparticles 0.164 – 0.165 0.05 - 0.08 
 
43.50 – 81.10 n/a n/a (Barthold et al., 2016) 
         
Dextran         
 500 kDa Nano complex
a
 0.501 ± 
0.0003 
0.085 ± 0.004 
0.29 ± 0.07 
0.45 ± 0.02 
 
95.26 ± 0.18 





(Hassan et al, 2019) 
         
Gelatin         
 n/a Microspheres 20.8 ± 6.5 n/a n/a N 3 (Lan et al., 2013) 
 Type A. gel, 
strength ~ 300 b 
Bloom 
Microspheres 36.26 ± 0.2 n/a 67.40 ± 2.50 Y 36 (Aksoy et al., 2019) 
         





< 500  n/a 69.80 ± 8.80 
25.60 ± 7.80 







(Sahiner et al., 2019) 
Silk protein         
 n/a Nanoparticles
d









(Besheli et al., 2017) 
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PHBV         
 PHBV with 12 
wt% PHV 
Microspheres D50 = 3.5, d90 
= 7.0 
n/a 27.30 N ~31 (Li et al., 2014) 
Albumin         
 BSA Microspheres
e
 < 16 n/a n/a N > 2 (Nettey et al., 2006) 
         
PLGA       +  
 (75:25) 10 kDa Nanoparticles 0.187 ± 0.001 0.201 ± 0.072 12.1 ± 13 n/a n/a (Barichello et al., 1999) 



















(Özalp et al., 2001) 
 (70:30) 12.5 kDa Microparticles
f, i






(Özalp et al., 2001) 







11.75 ± 1.31 
10.96 ± 0.08 









< 1  
(Gavini et al., 2004) 
 (50:50) 12kDa Microparticles 1.6 11.8 n/a 94.33 N < 1 (Hachicha et al., 2006) 
 (75:25) 136 kDa Microspheres
 
77 ± 1.7 n/a 60 Y > 60 (Sayin et al., 2006) 
 (75:25) 30 kDa Microspheres
f 
61.57 ± 4.37 
64.33 ± 6.96 
67.45 ± 8.13 
n/a 75.27 ± 1.60 
68.67 ± 1.78 







(Wang et al., 2011) 
 (50:50) 12 kDa Nanoparticles
f
 0.450 ± 0.035 0.006 78.6 ± 2.38 N 1 (Zakeri-Milani et al., 
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0.461 ± 0.033 
0.466 ± 0.039 
0.0053 
0.0069 
67.1 ± 1.46 






 (50:50) 36 kDa Microparticles
f
 33.1 ± 28.7 
36.9 ± 28.1 






(Shah et al., 2014) 
 (85:15) 100 kDa Microparticles
 
5.2 ± 2.9 n/a 61 ± 6 N ~ 50 (Rumian et al., 2017) 
 (50:50) 30-60 
kDa 
Nanoparticles 0.05 – 0.1 n/a n/a n/a > 20 (Liu et al., 2017) 
 (50:50) 30 kDa Microspheres n/a n/a n/a N > 8 (Du et al., 2017) 
 (75:25) 10 kDa Microspheres 69.9 n/a 48.51 ± 14.83 Y > 7 (Yang et al., 2017) 
 (50:50) 30 kDa Microspheres 15.6 ± 3.1 n/a 30.2 Y > 40 (Wang et al., 2017) 
 (75:25) 40 kDa Microspheres 28.4 ± 0.59 n/a 10.34 ± 2.02 Y > 50 (Yu et al., 2018) 
 (50:50) 33 kDa Microparticles
f 








(Hsu et al., 2018) 
 (75:25) 70 kDa Microparticles 10 n/a n/a N ~ 17 (Hsu et al., 2018) 




















Nanoparticles ~0.239 ± 
0.002 
0.1 28.3 N ~ 4 (Gaspar et al., 2018) 
 (50:50) Resomer 
RG503 33 kDa 
Microparticles 3.7 ± 0.91 n/a n/a n/a > 30 (Tseng et al., 2020) 
         
PLA         
 85 – 160 kDa Nanoparticles 0.35 ± 0.089 0.299 ± 0.002 n/a n/a n/a (Herrera et al., 2017) 
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PCL         
 n/a Microparticles 174.51 ± 9.20 n/a n/a Y > 14 (Iooss et al., 2001) 
 150 kDa Microparticles
g








48.93 ± 5.29 
57.28 ± 4.18 








(Le Ray et al., 2003) 
 n/a Microparticles 216.3 ± 66.0 n/a 49.6 ± 3.6 N > 21 (Le Ray et al., 2005) 
 65 kDa Microspheres 25.49 ± 1.05 n/a n/a N > 60 (Ryu et al., 2014) 
 45 kDa Microparticles 1.18 ± 0.05 n/a 54.6 ± 9.1 Y > 3 (Ferreira et al., 2015) 








58.05 ± 0.09 
58.08 ± 0.10 
71.84 ± 0.62 
76.36 ± 1.93 
134.12 ± 1.98 
120.15 ± 1.43 
n/a 4.70 ± 0.01 
4.10 ± 0.08 
40.60 ± 0.21 
47.10 ± 0.27 
54.80 ± 0.16  













(Sarigöl et al., 2017) 
 45 kDa Nanoparticles n/a n/a n/a N ~ 56 (Tsiapla et al., 2019) 
a
 Various vancomycin to dextran concentrations investigated and treatments classified according to charge ratios 
b
 Generally accepted as safe 
c
 Different crosslinker (divinyl sulfone) to hyaluronic ratios 
d
 Different silk fibroin to vancomycin ratios 
e
 Results for BSA microspheres cross-linked with 4% glutaraldehyde 
f
 Different vancomycin to PLGA ratios used 
g
 Different preparation methods 
h
 Ineffective drug release, < 5% in 7 days 
I
 Different stabiliser concentrations during preparation 
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PLGA bulk erosion and drug delivery MATLAB code: 
%Simulate Polymer Bulk Erosion as Poisson Process according to Göpferich 1997 
%Author: M.B. Bezuidenhout 
  
nloop = 1; %specify number of program loops 
nt = 1000; %specify number of time steps 
ft = linspace(1,nt,nt); %initiate timestep vector for plot 
fetaveM = zeros(nloop, nt); %global erosion matrix for record keeping of     loops 
fdtaveM = zeros(nloop, nt); %global degradation matrix for record keeping of loops 
fdrugtaveM = zeros(nloop, nt); %global drug release matrix for record keeping of 
loops 
  
for loop = 1:nloop 
  
    %Define elements of computational grid 
    nx = 300; %number of pixels in x direction 
    ny = 300; %number of pixels in y direction 
    n = 300; %number of pixels per direction 
     
    CSij = zeros(ny, nx); 
    Pij = zeros(ny, nx); %initialise full black polymer matrix 
    Drugij = zeros(ny, nx); %initialise drug distribution matrix 
    p = 0.07; %specifiy mass ratio of drug-to-polymer 
    Dij = zeros(ny, nx); %initialise effect matrix for degradation 
    Eij = zeros(ny, nx); %initialise effect matrix for erosion 
  
    tdegrade = zeros(ny, ny); %initialise matrix for interarrival times 
    fdt = zeros(1, nt); %initialise row vector for degradation plot 
    fet = zeros(1, nt); %initialise row vector for erosion plot 
    fdrugt = zeros(1, nt); % initialise row vector for drug release plot 
  
    %Poisson paramter 
    lmdaA = 0.0001; %arrival rate for amorphous hydrolysis 
    lmdaC = 0.000005; %arrival rate for crystalline hydrolysis 
    pcs = 0.3; %probability of crystalline structure 
    rnd = rand(); %random variable uniform dist [0,1] 
  
    %specifiy indexes at which a pixel is a drug 
    for i = 1:ny 
        for j = 1:nx 
            Drugij(i, j) = binornd(1,p,1,1); 
        end 
    end 
  
    Drugs = sum(sum(Drugij)); %number of pixels that represent drugs 
  
    %calculate interarrival times tij for each pixel 
    for i = 1:ny 
        for j = 1:nx 
            cs = binornd(1,pcs,1,1); %assign structure according to Bernoulli 
trials 
            if cs == 1   
                CSij(i, j) = 0; %crystalline pixel set to black 
                tdegrade(i, j) = (1/(lmdaC*log(n^2))) * (log(1-rand())); 
            else 
                CSij(i, j) = 0.5; %amorphous pixel set to grey 
                tdegrade(i, j) = (1/(lmdaA*log(n^2))) * (log(1-rand())); 
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            end 
            if Drugij(i, j) == 1 
                Pij(i, j) = 0.5; %set drug loaded indexes to behave as 'degraded 
bond' 
                tdegrade(i, j) = 0; %these pixels do not have life times 
                CSij(i, j) = 1; %set drug loaded pixels white in structure matrix 
            end 
        end 
    end 
  
    figure 
    imshow(CSij); 
    title('Starting Polymer State: Crystalline(black), Amorphous(grey), and 
Drug(white)');  
  
    figure 
    imshow(Drugij); 
    title('Drug Distribution through Polymer Matrix'); 
  
    figure 
    imshow(Pij); 
    title('Starting Polymer Matrix'); 
  
    for t = 1:nt %time steps 
        %lmdat = lmda*t; %factor for degradation rate 
     
        %loop for checking whether pixels should be degraded 
        for i = 1:ny 
            for j = 1:nx 
                if Pij(i, j) == 0 
                    if t < abs(tdegrade(i, j)) 
                        Pij(i, j) = 0; 
                    else 
                        Pij(i, j) = 0.5; 
                    end 
                end 
            end 
        end 
     
        %loop for checking whether pixels should be eroded 
        %first row at surface in contact with erosion medium 
        for j = 1:nx 
            if Pij(1, j) == 0.5  
                Pij(1, j) = 1; 
                Drugij(1, j) = 0; 
            end 
        end 
     
        %loop for bulk of matrix except three boundaries 
        for i = 2:ny-1 
            for j = 2:nx-1 
                if Pij(i, j) == 0.5 
                    for a = i-1:i+1 
                        for b = j-1:j+1 
                            if Pij(a, b) == 1; 
                                Pij(i, j) = 1; 
                                Drugij(i, j) = 0; 
                            end 
Stellenbosch University  https://scholar.sun.ac.za
Appendix B   Page 234 
   
 
                        end 
                    end 
                end 
            end 
        end 
     
        %loop to test for periodic right boundary 
        for i = 2:ny-1 
            if Pij(i, nx) == 0.5 
                for b = i-1:i+1 
                    if Pij(b, 1) == 1 
                        Pij(i, nx) = 1; 
                        Drugij(i, nx) = 0; 
                    end 
                end 
                for a = i-1:i+1 
                    if Pij(a, nx-1) == 1 
                        Pij(i, nx) = 1; 
                        Drugij(i, nx) = 0; 
                    end 
                end 
            end 
        end 
     
        %loop to test for periodic left boundary 
        for i = 2:ny-1 
            if Pij(i, 1) == 0.5 
                for b = i-1:i+1 
                    if Pij(b, nx) == 1 
                        Pij(i, 1) = 1; 
                        Drugij(i, 1) = 0; 
                    end 
                end 
                for a = i-1:i+1 
                    if Pij(a, 2) == 1 
                        Pij(i, 1) = 1; 
                        Drugij(i, 1) = 0; 
                    end 
                end 
            end 
        end 
     
        %loop to test for reflective bottom border 
        for j = 2:nx-1 
            if Pij(ny, j) == 0.5 
                for a = j-1:j+1 
                    if Pij(ny-1, a) == 1 
                        Pij(ny, j) = 1; 
                        Drugij(ny, j) = 0; 
                    end 
                end 
            end 
        end 
     
        %test for bottom left corner pixel 
        if Pij(ny, 1) == 0.5 
            for j = 1:2 
                if Pij(ny-1, j) == 1 
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                    Pij(ny, 1) = 1; 
                    Drugij(ny, 1) = 0; 
                end 
            end 
            if Pij(ny-1, nx) == 1 
                Pij(ny, 1) = 1; 
                Drugij(ny, 1) = 0; 
            end 
        end 
  
        %test for bottom right corner pixel 
        if Pij(ny, nx) == 0.5 
            for j = nx-1:nx 
                if Pij(ny-1, j) == 1 
                    Pij(ny, nx) = 1; 
                    Drugij(ny, nx) = 0; 
                end 
            end 
            if Pij(ny-1, 1) == 1 
                Pij(ny, nx) = 1; 
                Drugij(ny, nx) = 0; 
            end 
        end     
  
        %populate matrices for degradation and erosion 
        for i = 1:ny 
            for j = 1:nx 
                if Pij(i, j) == 0 
                    Dij(i, j) = 1; 
                else 
                    Dij(i, j) = 0; 
                end 
     
                if Pij(i, j) == 1 
                    Eij(i, j) = 0; 
                else 
                    Eij(i, j) = 1; 
                end 
            end 
        end 
     
        dt = (1/n^2)*sum(sum(Dij)); %fraction of non-degraded bonds in grid 
        fdt(1, t) = dt; %enter timestep-specific value into row vector 
        fdtaveM(loop, t) = dt; %enter into global matrix for record keeping 
        et = (1/n^2)*sum(sum(Eij)); %fraction of non-eroded pixels in grid 
        fet(1, t) = et; %enter timestep-specific value into row vector 
        fetaveM(loop, t) = et; %enter into global matrix for record keeping 
        drugt = (1/(Drugs))*sum(sum(Drugij)); %fraction of unreleased drugs 
        fdrugt(1, t) = (1-drugt); %Cumulative drug release at time step 
        fdrugtaveM(loop, t) = (1-drugt); %enter into global matrix for record 
keeping 
    end 
  
    figure 
    imshow(Drugij); 
    title('Drug Distribution After Release Period'); 
  
    figure 
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    imshow(Pij); 
    title('Eroded Polymer After Release Period'); 
     
    %section to calculate average values  
    if loop < 2 
        fdtprevsum = fdt; 
        fetprevsum = fet; 
        fdrugtprevsum = fdrugt; 
    else 
        fdtsum = fdtprevsum + fdt; 
        fdtave = fdtsum / loop; 
        fdtprevsum = fdtsum; 
    
        fetsum = fetprevsum + fet; 
        fetave = fetsum / loop; 
        fetprevsum = fetsum; 
         
        fdrugtsum = fdrugtprevsum + fdrugt; 
        fdrugtave = fdrugtsum / loop; 
        fdrugtprevsum = fdrugtsum; 
    end 
    figure 
    plot(ft, fdt, 'k'); 
    hold on 
    plot(ft, fet, 'r'); 
    xlabel('Time Steps'); 
    ylabel('Degradation(black) and Erosion(red)'); 
    hold off 
  
    figure 
    plot(ft, fdrugt); 
    xlabel('Time Steps');    
    ylabel('Cumulative Fractional Drug Release'); 
     
end 
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Appendix C: LPBF-Induced Porosity Screening 
Images of 3D reconstructions from the CT data for the cylindrical specimens from runs 






VED = 47.14 J.mm-3 
prel = 0.28% 
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Discontinuities in laser exposed vectors
3D Reconstruction
Run 3 
VED = 77.55 J.mm-3 
prel = 0.78% 
Run 5 
VED = 27.76 J.mm-3 
prel = 2.58% 
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VED = 96.55 J.mm-3 
prel = 0.89% 
Run 8 
VED = 75.46 J.mm-3 
prel = 0.46% 
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3D Reconstruction 2D CT Slice
3D Reconstruction 2D CT Slice
Run 9 
VED = 47.14 J.mm-3 
prel = 0.44% 
Run 10 
VED = 82.42 J.mm-3 
prel = 0.28% 
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3D Reconstruction 2D CT Slice
3D Reconstruction 2D CT Slice
Run 11 
VED = 47.14 J.mm-3 
prel = 0.30% 
Run 12 
VED = 33.01 J.mm-3 
prel = 0.53% 
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3D Reconstruction Discontinuities in laser exposed vectors
Balling
3D Reconstruction 2D CT Slice
Run 13 
VED = 18.81 J.mm-3 
prel = 1.52% 
Run 14 
VED = 46.81 J.mm-3 
prel = 0.28% 
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3D Reconstruction 2D CT Slice
3D Reconstruction 2D CT Slice
Run 15 
VED = 25.92 J.mm-3 
prel = 1.24% 
Run 16 
VED = 34.52 J.mm-3 
prel = 0.92% 
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3D Reconstruction 2D CT Slice
Run 17 
VED = 260.13 J.mm-3 
prel = 0.72% 
Run 18 
VED = 52.91 J.mm-3 
prel = 0.26% 
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Response surfaces and contour plots for the quadratic model are presented below in 
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Figure C-2: Response surfaces for the quadratic model with (a-b) the low level of hatch 
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The diagnostic plots for the model fitting on the influences of the key LPBF process 
parameters on part porosity are presented in Figure C-3. All data points are coloured 



















Normal Plot of Residuals
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Figure C-3: Diagnostic plots for quadratic model of porosity 
 
The calibration curves for the BCA vancomycin duplicate standard concentrations are 


















































Color points by value of
Porosity:
-1.715 1.677
y = 0.0013x + 0.1469 




















y = 0.0014x + 0.184 




















y = 0.0014x + 0.1457 




















y = 0.0014x + 0.1336 
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Figure C-4: BCA assay calibration curves for a) 0 min, b) 15 min, c) 30 min, d) 45 min, and 





y = 0.0013x + 0.1309 
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Appendix D: PTWs for Vancomycin Release 
The measurements of the diameter and calculated area within the PVC masks used to standardise the 
contact area for the 400 µm PTW reservoir vancomycin release are presented in Table D-1. 
 
Table D-1: Release contact area for permeable structures 
Reservoir Diameter (mm) Area (mm^2) 
D. 5.62 24.81 
D.. 5.61 24.72 
D… 5.60 24.63 
22 5.61 24.72 
29 5.62 24.81 
9 5.64 24.98 
16 5.61 24.72 
6 5.58 24.45 
20 5.65 25.07 
27 5.65 25.07 
15 5.60 24.63 
13 5.63 24.89 
2 5.62 24.81 
8 5.60 24.63 
17 5.63 24.89 
11 5.60 24.63 
7 5.64 24.98 
28 5.61 24.72 
25 5.58 24.45 
30 5.60 24.63 
31 5.59 24.54 
24 5.61 24.72 
18 5.58 24.45 
23 5.62 24.81 
Average 5.61 24.74 
StdDev 0.02 0.18 
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Images representing the relative porosity of 400 µm PTWs CT-scanned for repeatability are presented 







Energy Density: 9.92 J.mm-3
Relative Porosity: 33.21%  
Front Top
Parameter Set: PS-7
Energy Density: 13.23 J.mm-3
Relative Porosity: 28.01%  
Front Top
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Energy Density: 13.23 J.mm-3
Relative Porosity: 26.66%  
Front Top
Parameter Set: PS-1
Energy Density: 19.84 J.mm-3
Relative Porosity: 17.37%  
Front Top
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Figure D-1: : Relative porosities of 400 µm in order of ascending VED with (a) PS-3, (b) PS-7, (c) PS-7, (d) 
PS-1, and (e) PS-5 
 
The vancomycin RP-UHPLC calibration is shown in Figure D-2. 
 
 
Figure D-2: RP-UHPLC vancomycin calibration curve 
 
Parameter Set: PS-5
Energy Density: 27.78 J.mm-3
Relative Porosity: 2.04%  
Front Top
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The diagnostic plots for two factor interaction the model fitting of the DoE investigation of 
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Figure D-3: Diagnostic plots for two factor interaction model 
 
The vancomycin RP-HPLC calibration is shown in Figure D-4. 
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Appendix F: Prototype Design and Manufacturing 
The orientation and load case applied to the reference stem model are presented in Figure F-1(a). Mesh 
refinement at the contact regions included reduction of element size and matching of the nodes of 
contacting elements between the two bodies (Figure F-1(b)). The resulting mesh consisted of 111,533 
nodes and 70,470 elements.  
Figure F-1: Static stress analysis setup for reference stem with (a) orientation, load, and boundary 
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The von Mises equivalent stress and total deformation simulation results for the reference solid stem is 






Figure F-2: Simulation results for reference stem with (a) von Mises equivalent stress distribution and (b) 
the total deformation 
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